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Abstract
Development of an Injectable Methylcellulose Hydrogel System for Nucleus Pulposus
Repair and Regeneration
By Nada A. Haq-Siddiqi
Advisor: Dr. Steven B. Nicoll
Low back pain is the most common cause of disability in the world and is often caused by
degeneration or injury of the intervertebral disc (IVD). The IVD is a complex, fibrocartilaginous
tissue that allows for the wide range of spinal mobility. Disc degeneration is a progressive
condition believed to begin in the central, gelatinous nucleus pulposus (NP) region of the tissue,
for which there are few preventative therapies. Current therapeutic strategies include pain
management and exercise, or surgical intervention such as spinal fusion, none of which address
the underlying cause of degeneration. With an increasingly aging population, the socioeconomic
impact of disability associated with low back pain and disc degeneration cannot be understated.
Tissue engineering strategies are increasingly being investigated as an alternative therapy by which
early-stage degeneration may be halted and reversed, thus restoring disc mechanics and inducing
biological repair to prevent more painful long-term degeneration and disability. In order to prevent
further injury to the IVD, an ideal therapeutic should be injectable via small gauge needle, be
retained within the high-pressure intradiscal space, restore biomechanical properties, and deliver
therapeutic agents and/or cells to drive tissue regeneration. Therefore, the overall objective of this
thesis was to develop and characterize an injectable, bioactive, cellulose-based hydrogel system
for NP replacement and repair.
Methylcellulose (MC) is cellulose derivative that forms physically crosslinked gels at
increasing temperatures. Methacrylation of MC allows for the formation of more robust,
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chemically crosslinked hydrogels with lower effective macromer concentration. The first aim of
this thesis investigated the influence of methacrylation on the thermoresponsive behavior of MC
with implications for injectability and in situ retention. Results showed that increasing
methacrylation percentage increased hydrophobic interactions that drive thermogelation, lowering
the thermogelation onset temperature to within physiologic range, and produced robust, rapidly
gelling, dual-crosslinked hydrogels when formed at physiologic temperature versus room
temperature with redox initiators. The addition of anionic groups to MC would allow the polymer
to mimic the sulfated glycosaminoglycan-rich matrix of the NP, enhancing water retention and
sequestration of cationic proteins such as TGF-b3 that are critical for regenerative repair. Thus,
the second aim was to develop an injectable, sulfonated MC hydrogel capable of forming stable
gels in situ and electrostatically sequestering TGF-b3 to improve bioavailability of the therapeutic
molecule. Findings showed that using sulfonated methacrylate monomers, negatively charged
moieties could be incorporated into the MC hydrogels without sacrificing thermoresponsiveness
below 37°C. Sulfonation was easily tunable by increasing monomer concentration, and TGF-b3
sequestration was closely correlated with sulfonate concentration, resulting in a viable bioactive
acellular biomaterial for NP replacement. Factorial design of macromer and sulfonate
concentration allowed for selection of a sulfonated MC (sMC) formulation with optimal chemical
and mechanical properties for injection into the NP. The third aim evaluated the bioactivity of the
sMC hydrogels by encapsulating human bone-marrow derived mesenchymal stromal cells
(hMSCs) with and without TGF-b3. Results demonstrated that sMC hydrogels with TGF-b3 were
able to support NP-like matrix elaboration and maintained relevant mechanical properties. Overall,
this work advanced the development of injectable cellulose-based hydrogels as potential bioactive
NP replacements for IVD repair and regeneration.
vi
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Chapter 1: Introduction to Intervertebral Disc – From Structure
and Function to Regeneration and Repair

1

1.1

An Unmet Clinical Need: Low Back Pain and the Intervertebral Disc
The intervertebral disc (IVD) is a fibrocartilaginous tissue that exists between vertebral bones

within the spinal column. Its primary function is loadbearing, as it provides crucial shock
absorption to the spine during motion (Neidlinger-Wilke et al. 2013). The IVD is a composite
organ made up of three primary tissues: the nucleus pulposus (NP), annulus fibrosus (AF), and
cartilaginous endplates (CEP), which together provide support and range of motion to the spine
(Humzah and Soames 1988). Injury and degeneration of the IVD critically impair the IVD’s ability
to perform that function (Raj 2008). Intervertebral disc degeneration (IVDD) is linked to chronic
low back pain and neck pain, the leading cause of disability worldwide (Hartvigsen et al. 2018).
Although IVDD and low back pain are not life threatening, the personal and economic burdens of
chronic pain are enormous; in 2016 low back and neck pain accounted for the highest amount of
healthcare spending in the US, totaling approximately $134.5 billion in total spent on care, and is
responsible for 60.1 million disability adjusted life years (DALYs) globally, which translates to
hours of lost work opportunities and lost wages (Dieleman et al. 2020).
Degeneration generally begins in the NP, where altered loading or injury can initiate aberrant
cellular catabolism and breakdown of the proteoglycan-rich matrix that mediates NP hydration
and hydrostatic pressure (Urban, Roberts, and Ralphs 2000). Loss of hydration and pressure leads
to altered loading on the total disc, placing increased stress on the AF, giving rise to bulging,
fissures, and even herniation of the NP out of the AF, as well as calcification and fracture of the
CEP, and osteophyte formation (Iatridis et al. 2013; Setton and Chen 2006; Urban, Roberts, and
Ralphs 2000). Pain management and physical therapy remain the standard of care for early to midstage symptomatic degeneration, while eventually late-stage degeneration can necessitate a
complete discectomy and spinal fusion (Desmoulin, Pradhan, and Milner 2020). Because the IVD
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is mainly avascular, it has little to no capacity for repair, and so IVDD is a progressive condition
for which there remains no effective treatment that addresses the cause of the degeneration or
prevents progression of the disease.
Tissue engineering solutions aim to address this issue by combining cell therapy with a
scaffold that will both restore IVD mechanics and support further tissue repair. Because IVDD is
understood to begin in the NP, the degenerate NP and mid-stage degeneration are the preferred
targets for early intervention. The ideal tissue engineering construct attempts to recapitulate nature
in an engineered implant by mimicking the environmental cues (i.e. mechanical and chemical)
found in the natural tissue, to promote the differentiated phenotype of the incorporated cells. The
construct must withstand the mechanical loads of the native NP, as well as allow for fluid and
nutrient transport in a manner similar to the native IVD. Additionally, delivery of a tissueengineered system must be minimally invasive; injury to the AF can further IVDD by causing a
reduction in the pressurization of the IVD, and therapeutic delivery must be injectable through a
fine gauge needle to prevent further disruption of the AF. The combination of mechanical
demands, limited nutritional and regenerative capacity, and need for minimally invasive and
disruptive delivery present unique challenges for tissue engineering repair of the IVD. In the
current chapter, physiology of the healthy and pathological IVD will be discussed, with emphasis
on the NP as the therapeutic target, and current existing and investigative solutions for NP
replacements will be outlined. Components of traditional tissue engineering – scaffold materials,
cell source, and instructive signaling cues – will then be reviewed, in addition to the critical design
criteria for evaluating success in NP tissue engineering. Finally, the scope and aims of the present
investigation will be introduced.
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1.2

Intervertebral Disc Anatomy and Physiology

1.2.1

Anatomy and function

The spinal column is made up of repeating vertebral bones separated by a unique connective
tissue of the IVD that allows for a broad range of motion (Figure 1.1.A). The function of the IVD
is mechanical, as it transmits loads through the spine. The IVD allows for 6 degrees of freedom in
motion: compression, anterio-posterior and lateral shear, flexion, and torsion (Buckwalter et al.
2000; Neidlinger-Wilke et al. 2013; Iatridis et al. 2013). It does so by virtue of its composite
structure: the NP, a gel-like structure, resists vertical compression via hydrostatic pressure, and is
surrounded by the annulus fibrosus (AF), which resists the radial stress from the expanding NP via
circumferential tension. The NP and AF are sandwiched superiorly and inferiorly by the CEP, thin
strips of cartilage which provide adhesion to the adjacent vertebral bodies and allow nutrition
transport (Buckwalter et al. 2000; Raj 2008). The healthy IVD is avascular and mostly aneural.
The NP is a highly hydrated, gelatinous structure. Water makes up approximately 80% of the
wet weight of the NP; the rest of the wet weight is made up of proteoglycans (PGs) (15%),
collagens (4%), and other extracellular matrix proteins (Raj 2008; Buckwalter et al. 2000). It is
similar to hyaline cartilage in that the major collagen in the NP is collagen type II, and the most
common PGs in the NP are aggrecan and versican (Raj 2008; Hayes, Benjamin, and Ralphs 2001).
Aggrecan is high in chondroitin sulfate and keratan sulfate glycosaminoglycans which are
covalently attached to its protein core in an arrangement that resembles a bottlebrush formation.
The high negative charge of the sulfated glycosaminoglycan (sGAG) chains promote the influx of
positive ions and water into the NP, creating hydrostatic pressure within the tissue (Buckwalter et
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al. 2000; Hayes, Benjamin, and Ralphs 2001; Pattappa et al. 2012). The arrangement of fibers
within the NP is isotropic, which enables uniform distribution of compressive loads.

Figure 1.1: Schematic of the anatomy of the IVD and surrounding tissues.
A) The spinal segment consisting of two vertebral bodies and an intervertebral disc sandwiched
between them. B) A sectioned portion of a normal human disc, displaying the location of the NP,
lamellae of the AF, and vertebral endplate (CEP). Adapted from Raj, (2008).

Surrounding the NP is the AF, which consists of circumferential lamellae comprising the outer
region of the IVD. The AF is also highly hydrated, although less so than the NP, with water making
up 70% of the wet weight. Collagen is the next most abundant component of the AF, making up
15% of the wet weight of the AF (70% of the dry weight). The AF contains both type I and type
II collagen, with type I being more abundant in the outer AF, and elastin between lamellae. PGs
make up only 5% of the wet weight of the AF (Raj 2008; Hayes, Benjamin, and Ralphs 2001;
Bruehlmann et al. 2002). The lamellae of the AF are highly anisotropic and are arranged in
concentric rings which maintain circumferential hoop stresses that resist the outward pressure
created by the compressed NP (Figure 1.1.B). The collagen fibers in the lamellae are arranged
parallel within each lamella and approximately 60° to the vertical axis, and alternate in direction
between lamellae, which allow it to resist crack propagation in the case of injury (Raj 2008; Iatridis
et al. 2013; Bruehlmann et al. 2002). The CEPs form the superior and inferior interface of the disc
5

and the vertebral bones. Thin strips of hyaline cartilage, the CEPs are also composed mainly of
water (58% of total tissue weight), although less than each of the other two IVD tissues.
Additionally, the CEP contains collagen and PGs at different weight percentages than the NP and
AF, containing 60-80% collagen/dry weight and only 17%/dry weight of PGs (Roberts, Menage,
and Urban 1989). Viscous fluid flow through the CEP allows for nutrient exchange via diffusion
and convection from capillary beds in the subchondral plate through the CEP to the central portions
of the disc and back (Urban, Smith, and Fairbank 2004).

Figure 1.2: Pathways of nutrient supply in the healthy IVD.
A) Cells of the avascular NP and inner AF are supplied by nutrients via capillary beds emerging from the
vertebrae. B) The center of the disc has the lowest level of nutrients and highest amount of metabolites.
C) Schematic of the nutrient gradients from endplate (0) to endplate (1). Adapted from Huang et. al.
(2014).

The IVD is mostly avascular, and blood supply in the healthy IVD is restricted to the
subchondral plate and the outermost portions of the AF that experience only a few millimeters of
capillary penetration from the surrounding tissue (Figure 1.2.A) (Huang, Urban, and Luk 2014).
Because nutrient and metabolite exchange occurs primarily via diffusion, concentration gradients
exists as a product of the rate of supply and consumption within the IVD, leading the IVD, and in
particular the NP, to be generally a hypoxic, acidic environment with low glucose (Figure 1.2.B-
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C) (Horner and Urban 2001; Raj 2008). Even though the cells of the disc are uniquely
differentiated to thrive in this environment (Guehring et al. 2009), a critical threshold exists beyond
which cells will not remain active or viable, as well as a limit to the number of cells that can be
supported within the tissue.
1.2.2

Cells of the IVD

The adult IVD has a very low cell density, at approximately 0.25-0.5% total tissue volume
(Urban, Roberts, and Ralphs 2000). The NP contains ~4 x 106 cells/cm3 and the AF has a slightly
higher cell density at ~9 x 106 cells/cm3 (Pattappa et al. 2012; Raj 2008). The cells of the outer AF
are fusiform and fibroblast-like and are aligned with the collagen fibers in the AF lamellae. Moving
towards the center of the IVD, the AF cells become more oval shaped (Bruehlmann et al. 2002;
Johnson and Roberts 2003). The cells of the NP are rounded and are often referred to as
chondrocyte-like cells, or IVD-chondrocytes; however, despite many similarities between NP cells
and articular chondrocytes, there are key differences. The NP structure originates from the
notochord in development, and the young NP is populated with large, highly vacuolated
notochordal cells (NCs) (Urban, Roberts, and Ralphs 2000; Rodrigues-Pinto, Richardson, and
Hoyland 2014); by approximately 10 years, these cells are replaced by smaller, more chondrocytelike NP cells (NPCs) (Rodrigues-Pinto, Richardson, and Hoyland 2014; Yang et al. 2009). There
has been debate as to whether the NCs differentiate into NPCs or if they simply disappear and are
replaced by the NPCs through an unknown mechanism (Rodrigues-Pinto, Richardson, and
Hoyland 2014). Histological observations have shown chondrocyte migration from the endplate
towards the central regions of the IVD (Yang et al. 2009; Kim et al. 2003; Kim et al. 2009).
However, recent fate mapping experiments have shown that throughout the aging process of the
NP, the cells within the NP remain notochordal in lineage (Choi and Harfe 2011; Choi, Cohn, and
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Harfe 2008; McCann et al. 2012). It has been hypothesized that the phenotypic shift from highly
vacuolated notochord-like cells to smaller, chondrocyte-like cells contributes to aging and
degeneration of the disc (Risbud and Shapiro 2011; Chen, Yan, and Setton 2005).
The cells of both the NP and AF exist within a dense pericellular matrix (PCM) high in
collagen type VI, similar to the cells of articular cartilage (AC) (Cao, Guilak, and Setton 2007;
Wilusz, Sanchez-Adams, and Guilak 2014). This matrix is both biochemically and
morphologically distinct from the surrounding territorial matrix. NPCs exist both alone and in
groups of 2 to 4 in the NP, and in longitudinal arrangements of up to 10 in the AF. The PCM is
thought to have a mechanoregulatory function, and studies suggest that the pericellular matrix
plays a critical role in both transmitting and attenuating mechanical forces experienced by the
whole IVD to the cells (Cao, Guilak, and Setton 2011; Cappello et al. 2006; Cao, Guilak, and
Setton 2009).
1.3

Mechanics of the Disc
The role of the IVD is purely mechanical: it functions to allow support and motion to the

body. IVDs, along with small amounts of hyaline cartilage between the facets (the zygapophyseal
joint) of two adjacent vertebral bodies, compose a motion segment that allows bending and
twisting of the neck, torso, and waist. The disc thus must withstand compressive loads from both
body weight and muscle tension. While standing, the posterior spinal muscles exert force to
balance the flexion moment caused by body weight (Neidlinger-Wilke et al. 2013). In the healthy
IVD, compressive loads are evenly borne and distributed by the NP. Hydrostatic pressure in the
adult human NP measures at about 0.1-0.2 MPa while in supine position at rest, around 0.5 MPa
when standing, and as high as 2.3 MPa while carrying a weight in a flexed position (Figure 1.3.A)
(Neidlinger-Wilke et al. 2013). The wide range of motion allowed by the spine combined with
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carrying extra weight can significantly alter the load on the spine and create much more complex
loads on the disc (Hsieh and Twomey 2010; Wilke et al. 1999).

Figure 1.3: Forces acting on the IVD.
A) In vivo values of intradiscal pressure at different postures and daily activities. B) Representative
stress profiles in the lumbar IVDs in healthy and degenerative conditions. Adapted from NeidlingerWilke et al. (2013). C) Schematic representation of the multiscale architecture of the IVD and the axes of
force distribution. Adapted from Nerurkar, Elliott, & Mauck (2011).

Load distribution in the IVD is dependent on its composition (Figure 1.3.C). The high
hydrostatic pressure within the NP resists compression from body weight and motion. As the NP
undergoes compression, the AF stretches in tension and provides resistance to expansion, thereby
maintaining high pressure within the NP. The AF also resists strains during twisting and bending
(Buckwalter et al. 2000; Iatridis et al. 2013; Neidlinger-Wilke et al. 2013). When the NP
degenerates and loses hydration, it also loses height, which shifts abnormal loads to the AF,
creating stress peaks which further promote disc degeneration and fissures (Figure 1.3.B). The
figure is simplified in that it represents the stress distribution measured in vitro and does not
9

consider the varied loading conditions involved in vivo. It also only represents compressive stress
and not tensile or shear stress.
There is a wide range of both organization and composition of the ECM environment within
the IVD; this contributes to the wide variety of forces experienced by the cells within the IVD.
The cells in the NP are exposed to predominantly uniform hydrostatic stress (Figure 1.4).
Conversely, the cells of the AF lie along collagen fibers in the lamellae and are exposed to tensile
strain and shear stress as a result of the stretching and sliding of the fibers within the lamellae. NP
cells also undergo compressive stress and fluid shear stress caused by convective flow of water
during loading (Neidlinger-Wilke et al. 2013). The cells of the IVD have been shown to be
sensitive to both magnitude and frequency of stimuli, in what is known as a threshold effect (Setton
and Chen 2006). For example, static compression (0.4-1.3 MPa) has been shown to promote disc
degeneration in a dose-dependent fashion, whereas cyclic loading (0.01- 0.1 Hz) has shown to
balance anabolic and catabolic processes within the disc at the same peak stresses (Lotz et al.
2002). Static compressive load has been reported to increase PG and collagen synthesis in IVD
cells at low stresses of 0.2-0.4 MPa, and gene expression for matrix proteins is stimulated at
stresses even lower than that (~0.1 MPa) (Ohshima, Urban, and Bergel 1995; Chen, Yan, and
Setton 2004). Cellular response to hydrostatic pressure is much the same, with an increase in
synthesis of collagen, PG, and tissue inhibitor of metalloproteinase 1 (TIMP1) under low to
moderate hydrostatic pressures (<0.3MPa), while higher pressures were shown to inhibit PG
synthesis and increase nitric oxide (NO) and matrix metalloproteinase 3 (MMP-3) production
(Handa et al. 1997; Liu et al. 2001).
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Figure 1.4: Complex physical changes that may be transduced as mechanical stimuli to the cells.
Axial compressive loading (represented by the large arrow) of the disc is shown to induce shearing
and tensile stresses as well as radial expansion that results in compression in both axial and radial
directions. These loads will be distributed to the PG-collagen extracellular matrix (inset, bottom left) and
the interstitial fluid phase that undergoes changes in hydrostatic pressure. The physical effects may be
transduced from the matrix and contained fluid to cells that re-side in and interact with the extracellular
matrix (inset, top left). Adapted from Setton & Chen (2006).

1.4

Development, Aging, and Degeneration

1.4.1

Development of the IVD

During vertebrate embryonic development, the cells of the early embryo arrange into three
distinct germ layers, the ectoderm, the mesoderm, and the endoderm, in a process known as
gastrulation, and together they give rise to all the various tissues of the body. The mesoderm is the
germ layer from which most connective tissues are derived. The mesoderm further separates into
subdivisions: the axial mesoderm, paraxial mesoderm, intermediate mesoderm, and lateral plate
mesoderm. The notochord develops from the axial mesoderm while somites form from the
paraxial mesoderm, and together they go on to form the primitive skeleton. The notochord is a rodshaped structure in the developing embryo of vertebrates that defines the primitive axis of the
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embryo. This notochord eventually becomes segmented and forms the NP (Sivakamasundari and
Lufkin 2012; Pattappa et al. 2012; Rodrigues-Pinto, Richardson, and Hoyland 2014).
When the embryo begins to undergo organogenesis, the notochord directs the somites to
migrate. Some of these cells differentiate into sclerotome and migrate towards and encircle the
notochord and neural tube to begin to form the spine (Rodrigues-Pinto, Richardson, and Hoyland
2014; Pattappa et al. 2012). These cells begin to condense around the notochord, forming a perinotochordal sheath (Pattappa et al. 2012). Internal pressure within the vacuolated notochordal cells
causes the structure to elongate along the midline axis. The sclerotome begins to condense in
segmented areas, and will eventually become the AF, while the non-condensed sclerotome forms
the cartilaginous precursor to the vertebral bodies and the CEPs. The segmentation and
condensation of the sclerotome causes the notochord to segment and expand, forming the NP
(Pattappa et al. 2012; Rodrigues-Pinto, Richardson, and Hoyland 2014). Hedgehog signaling is
responsible for pattern regulation and cell proliferation in the developing IVD (Sivakamasundari
and Lufkin 2012; Risbud and Shapiro 2011; Choi and Harfe 2011; Dahia et al. 2009a).
Development of the notochordal sheath depends on this signaling to provide mechanical constraint
to the notochord and aid in its segmentation into distinct discs.
Postnatally, the cells of the NP are notochordal in phenotype, being relatively large (~30 µm
diameter) and containing large vacuoles which enable the cells to generate a large osmotic swelling
pressure within the NP. The matrix of the infant IVD is highly gelatinous, with a clearly
demarcated border between the NP and AF. Within 10 years of birth, the IVD undergoes numerous
changes in matrix composition and cell phenotype (Raj 2008; Roughley 2004). The NCs decline
in number and slowly give way to the more chondrocyte-like NPCs (Rodrigues-Pinto, Richardson,
and Hoyland 2014; Dahia et al. 2009b). Furthermore, there is a reduction in cell clusters, which
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may have an impact on cell-cell signaling and matrix maintenance (Hunter, Matyas, and Duncan
2003; 2004). How this vacuolated NC population is lost to a smaller, chondrocytic phenotype is
still under investigation; elucidation of the mechanism of change might give insight into the
process of NP degeneration (Risbud and Shapiro 2011; Chen, Yan, and Setton 2005;
Sivakamasundari and Lufkin 2012). Blood vessels which populated the CEP and AF regress in the
first two years postnatally as well, minimizing the capacity for nutrient exchange and waste
removal, and thus also cell proliferation and matrix production (Nerlich, Schleicher, and Boos
1997). NPCs are adapted to the low oxygen environment; however, buildup of waste increases the
concentration of lactic acid, making the IVD, and in particular the NP, a more acidic environment.
This acidity enhances proteolytic activity, driving enzymatic breakdown of the matrix (Roughley
2004). While these processes are a normal process of IVD aging, degeneration of the IVD is
characterized as an accelerated progression of this breakdown, mediated by an aberrant cellular
response (Smith et al. 2011).
1.4.2

Degenerative Pathology

The IVD undergoes enormous physiological changes throughout the aging process. Discs
begin to degenerate far earlier than most other skeletal tissues. Signs of structural changes in the
lumbar discs of humans can be found as early as 10 years of age; by 50 years, 10% of discs show
signs of severe degeneration, and this increases to 60% by 70 years of age (Nerlich, Schleicher, &
Boos, 1997; Raj, 2008; Urban et al., 2000). The causes of IVDD can be a multifactorial
combination of aging, trauma, and lifestyle influences (high fat diet, smoking) (Adams and
Roughley 2006; Hartvigsen et al. 2018). Altered loading, either via injury or aging, is strongly
implicated in the degenerative cascade within the IVD. Injury may be dramatic, like disc
herniation, or subtle, such as annular fissures. Studies have shown that violation of the AF as small
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as a needle puncture can induce degenerative changes as a result of loss of IVD pressurization
(Korecki, Costi, and Iatridis 2008; Iatridis et al. 2013). End plate fracture and radial fissures are
also subsequent injuries of the IVD that can occur due to degeneration. Altered loading in one disc
affects the surrounding tissue as well; osteophytes begin to grow in the vertebrae neighboring the
degenerate disc, and ligamentous thickening can contribute to spinal stenosis (Figure 1.5).

Figure 1.5: Sagittal sections of human lumbar discs in various stages of degeneration.
Adapted from Galbusera et al. (2014).

Change in matrix components are the most characteristic changes, as matrix composition
dictates mechanical function. Both normal aging and pathologic degeneration are characterized by
a loss of hydration and height. GAG content in the NP at 40-60 years of age is half that of what it
was as a toddler; similar trends are seen in progressive stages of degeneration. Loss in % of water
content is strongly correlated with loss of sGAGs, and as aging and degeneration progress, the
distinction between both sGAG and hydration of the NP and AF blurs (Antoniou et al. 1996). PGs
are aggregate molecules made up of sGAGs around a core protein, making a bottle-brush structure,
which allows for maximal exposure of negatively charged sulfates for interaction with positively
charged ions and water molecules. Aggrecan is the primary PG of the NP as well as AC and is
often bonded to hyaluronic acid via link proteins, forming large proteoglycan aggregates.
Throughout the aging process, these aggregates break down, reducing the compressive strength of
the NP (Sivan, Wachtel, and Roughley 2014). Along with the decrease in hydration, the NP also
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becomes more fibrotic, with increasing collagen content. Although type II collagen is the
predominant collagen in the NP, it is highest in absolute value/dry weight in the inner AF, giving
way to type I collagen in the outer AF; age-related changes see a reduction in type II collagen as
well as an increase in type I collagen, further blurring the distinction between NP and AF.
Nonenzymatic glycation causes cross-linking of collagens, which stiffens the usually gelatinous
material, and further stimulates enzyme and cytokine release in the degenerating disc (Weber et
al. 2015; Rodrigues-Pinto, Richardson, and Hoyland 2014). This transition in matrix composition
is illustrated in Figure 1.6, where the shift in ECM from mostly PGs to increasing collagen is
accompanied by the temporal break down of PG aggregates (Roughley, 2004).

Figure 1.6 Human NP collagen II fibril and aggrecan proteoglycan composition with age.
(CS – Chondroitin Sulfate, KS – Keratin Sulfate, LP – Link Protein, HA – Hyaluronic Acid).
Adapted from Roughley (2004).

In the healthy disc, there is a constant balance of matrix degradation and synthesis by the IVD
cells. It is still not clear what causes the phenotypic shift that throws off the balance between the
two. Altered loading conditions have been shown to increase the catabolic response of NP cells,
with an increased production of matrix metalloproteinase (MMPs), cathepsins, and aggrecanases
(Rodrigues-Pinto, Richardson, and Hoyland 2014; Urban, Roberts, and Ralphs 2000).
Mechanotransduction is the process by which cells sense mechanical stimuli and convert it to
electrochemical activity (Discher, Janmey, and Wang 2005). Given the complex mechanical loads
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experienced in the disc, numerous studies have investigated how the cells of the IVD sense and
respond to their environment (Fearing et al. 2018; Hsieh and Twomey 2010). Guehring et al.
(2010) showed that NCs are less resistant to mechanical loading than NPCs, suggesting that the
increased loading during growth and aging may contribute to the disappearance of NPCs. Both
integrin binding with the ECM (Gilchrist and Chen 2007; Le Maitre et al. 2009; Nettles,
Richardson, and Setton 2004) and cadherin-mediated traction forces between cells (Hwang, Jing,
et al. 2014) have been implicated in IVD mechanotransduction. The reduction in cell-cell
interactions and subsequent loss of direct cell communication as the NP decreases in cellularity
may be associated with further aberrant cell responses to stress. Indeed, the appearance of
protrusions from the usually round cell bodies of NPCs may be indicative of cells both responding
to increased matrix tension as well as attempting to respond to neighboring cells (Errington et al.
1998; Johnson and Roberts 2003).

Figure 1.7: The degenerative cycle of IVD degeneration.
A) Homeostasis of the intervertebral disc is dependent on the interaction of cells, extracellular
matrix and biomechanical stress, and alterations to the balance at any point can set off a degenerative
cascade. B). Additional factors impacting the degenerative cycle including genetic predisposition to
IVDD, infection, and alterations in nutrition. Adapted from Vergroesen et al. (2015).
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It is becoming increasingly evident that disc degeneration creates a “vicious cycle” wherein
cell-mediated catabolism causes fundamental changes in the matrix, which results in altered loads
on the IVD, and further stimulates cellular pathology (Vergroesen et al. 2015). Because these
factors are connected and amplify each other, researchers have proposed a model wherein these
interrelated factors exist in a cycle that can be entered at any point, all leading to the same
pathology (Figure 1.7).
1.4.3

IVDD Associated Pain

Degenerative changes to the disc are strongly correlated with low back pain (Adams and
Roughley 2006). Vascularized granulation tissue extending from the NP to fissures in the AF have
been associated with low back pain (Peng 2013). Inflammation has also been linked to
symptomatic and painful IVDD (Molinos et al. 2015; Khan et al. 2017). Release of inflammatory
cytokines from within the disc has been implicated in painful neural ingrowth into the AF (Ohtori,
Miyagi, and Inoue 2018). Additionally, dynamic loading of the IVD has been shown to drive the
influx of inflammatory cytokines, such as TNFa, into the disc, furthering cell-mediated
degeneration (B. A. Walter et al. 2015; Molladavoodi, McMorran, and Gregory 2020). Nondiscogenic sources of pain are also common. Hypermobility of the disc subsequent to degeneration
destabilizes the entire spine and requires the local musculature to overwork in compensation
(Iatridis et al. 2013; Ohtori, Miyagi, and Inoue 2018). Furthermore, radicular pain and
radiculopathy (also known as sciatica) frequently occurs due to spinal stenosis, itself a result of
loss of disc height, osteophyte formation, facet joint hypertrophy, and disc herniation (Hartvigsen
et al. 2018; Vassilaki and Hurwitz 2014). Interestingly, IVDD is not always symptomatic. Medical
imaging in the form of magnetic resonance imaging (MRI) is still the standard mode of identifying
IVD injury or degeneration, and usually only called for with symptomatic pain. This presents a
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challenge in timing when disc degeneration is addressed, and the conservativeness or
aggressiveness of the proposed therapy (Wu, Kim, and Jang 2020; Adams, Stefanakis, and Dolan
2010).
1.5

Current Clinical Repair Strategies
Low back pain is a nearly ubiquitous condition, affecting up to 80% of the world’s adult

population, and is highly associated with IVDD (Hoy et al. 2014) and results in $134.5 billion in
healthcare spending in the US alone (Dieleman et al. 2020); IVDD is implicated in nearly 40% of
these patients (Ohtori, Miyagi, and Inoue 2018; L. Zhao et al. 2019). Early non-surgical treatment
strategies usually involve pain management via oral analgesics or non-steroidal anti-inflammatory
drugs (NSAIDs) and physical therapy (Raj 2008; Adams, Stefanakis, and Dolan 2010). However,
discogenic pain is often not noticeable until the disease has progressed considerably. The extent
of intervention varies with the severity of the condition (Figure 1.8). Intradiscal steroid injections
used to suppress inflammation and reduce pain has gone out of favor due to associated chondral
degradation, but epidural injections of steroid are still commonly used for pain management and
inflammation reduction (Nguyen et al. 2017; Schoenfeld and Weiner 2011). Intradiscal
electrothermal annuloplasty (IDEA) and biacuplasty are minimally invasive thermal treatments for
radiofrequency ablation of nociceptive nerve ingrowth, but have shown limited efficacy, and are
focused strictly on resolving discogenic pain (L. Zhao et al. 2019).
Surgical intervention becomes necessary in the case of severe, unremitting symptoms.
Discectomy, or the removal of all or part of the NP, is the most common procedure for
symptomatic herniation, but does not replace the NP, and so does not restore disc height or
mechanics, leaving the AF vulnerable to further degradation (Kim, Park, and Kim 2009). AF
defects are associated with 5-25% of post-operative re-herniation (Ambrossi et al. 2009; Long et
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al. 2016; Shepard and Cho 2019). AF closure and repair is performed in cases of high risk for
reherniation but the quest for a successful biomaterial AF sealant is still undergoing investigation
(Bouma et al. 2013; H. J. Wilke et al. 2013; Thomé et al. 2018; Hom et al. 2019; Likhitpanichkul
et al. 2014; Distefano et al. 2020).

Figure 1.8: Schematic of the progression of IVD degeneration highlighting the traditional timing of
interventions.
Adapted from Hudson et al.(Hudson et al. 2013)

Severe degeneration in which the integrity of the AF has been obliterated may be treated by
spinal fusion, in which the whole disc is removed, and adjacent vertebral bodies are fused together.
These interventions alter the range of motion and consequently negatively impact the mechanics
of the adjacent discs (Iatridis et al. 2013; Yang, Langrana, and Lee 1986; Nunley et al. 2013).
Prosthetic disc replacement of either the nucleus or whole disc has been explored as an alternative
to spinal fusion. NP replacements require the AF to remain intact, while late-stage degeneration
may require total disc replacement (TDR) or disc arthroplasty (Brophy and Hoh 2018). The
efficacy of TDR is still under consideration; while some studies have shown TDR to be safe and
effective, with greater patient satisfaction regarding mobility and short-term efficacy at least equal
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to fusion (Bai et al. 2019; Ding et al. 2017), there have been reports of prosthetic induced osteolysis
(Serhan et al. 2006).
As the origin of IVD degeneration is generally understood to begin in the NP, repair or
replacement of the NP has garnered increased therapeutic interest, with the goal of restoring
biomechanics, thereby interrupting the degenerative cascade. Prosthetic implants such as
Prosthetic

Disc

Nucleus

(PDN-SOLO,

Raymedica,

Inc.,

Bloomington,

MN)

and

NeuDisc™ (Replication Medical Inc., New Brunswick, NJ), fully formed implantable hydrogels,
have shown promise in restoring disc mechanics, but do not sufficiently integrate with the complex
geometry of the NP void space, and ultimately fail by device migration (Di Martino et al. 2005).
DASCOR™ in situ forming polyurethane “balloon” showed promise in restoring disc height and
motion segment stability, but has a preformed shape that does not integrate with the remaining
tissue that surrounds it (Ahrens et al., 2009). Some of these materials have received CE Mark for
marketing in Europe but have yet to receive FDA approval due to safety concerns.
Research efforts have increasingly shifted towards biomaterial and regenerative engineering
strategies for NP repair. As pre-formed NP replacements have largely failed due to device
migration, in situ curing injectable materials are increasingly of interest as they can successfully
integrate with the surrounding tissue and resist migration and extrusion (Lewis, 2012). Acellular
injectable biomaterials focus on the restoration of disc height, mechanics, and hydration, and can
also be used to deliver therapeutics directly to the disc for pain management or biological repair (
Bowles and Setton 2017). Biologic therapy is an appealing alternative to end-stage surgical
treatment, as it attempts to address early and mid-stage degeneration and mitigate further
degeneration before the effects become too severe and spread to adjacent structures (Hudson et al.
2013). Such therapies can include drugs or biomolecules to stimulate anabolic repair processes in
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the remaining native cells or introduce cells in hydrogel carriers in order to drive tissue
regeneration. Current ongoing clinical trials involving both cellular and acellular hydrogels for NP
replacement have focused on patients with symptomatic discogenic pain without bulging or
herniation (indicating gross AF damage) and moderate loss in disc height (30-50%), as more
advanced damage would likely result in extrusion and failure of the implanted material
(Amirdelfan et al. 2021; Ceylan et al. 2019). The subsequent sections will thus focus on injectable
biomaterial-based strategies for NP replacement and repair.
1.6

Polymeric Biomaterials for Nucleus Pulposus Replacement
Biomaterial replacement of the NP aims to repair the IVD by recapitulating the mechanical

behavior of the healthy NP. Hydrogels are a class of biomaterials with high swelling capacity and
highly tunable properties. The high water content in hydrogels allows them to behave like many
natural soft tissues (Peppas et al. 2006). As such, hydrogels have been investigated for a wide
variety of applications, from contact lenses to drug depots and cell scaffolds (Censi et al. 2012;
Gaharwar, Peppas, and Khademhosseini 2014; Lin et al. 2021; Muir and Burdick 2021; Anseth,
Bowman, and Brannon-Peppas 1996; Kretlow, Klouda, and Mikos 2007) Hydrogels may be
synthetic or natural polymers, but they are all characterized as mesh networks swollen with water,
much like the proteoglycan rich network of the NP. The ability to form in situ, conform to the
complex void space in a degenerated or injured IVD and resist migration are all key factors in the
design of a potential NP replacement biomaterial. In addition, biocompatibility and long-term
stability in an acellular scaffold are necessary if the replacement is to persist in the IVD and restore
mechanical function. Biomaterials for cell-based therapies may be biodegradable, and the rate of
degradation must be tuned to match the rate of de-novo tissue development to maintain structural
stability of the repaired IVD; additionally, the degradation byproducts must not be cytotoxic.
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Synthetic hydrogels that have been used include poly(ethylene glycol) (PEG) and poly(Nisopropylacryl-amide) (PNIPAAm) (Yang and Li 2009; Francisco et al. 2014; Thomas et al. 2010).
Synthetic polymers are generally bio-inert, in that they do not illicit an immune response. They
are also very well controlled as there is minimal variation between batches, and so are easily
characterized. While synthetic polymers are usually readily modified and can be delivered with
other natural materials, they themselves are not bioactive. Some polymeric scaffolds, like
PGA/PLA/PLGA are degradable through hydrolysis of the ester linkages (Sahoo et al. 2008;
Jeong, Wang, and Gutowska 2001). Others, such as PEG are not readily degraded, but can be
chemically modified to degrade (Vernengo et al. 2008; Zhu 2010; Buxton et al. 2007).
Natural materials include animal-derived molecules that mimic the native structure of or are
present in the IVD, such as collagen (types I or II) and hyaluronic acid (Neidlinger-Wilke et al.
2005; Cloyd et al. 2007; Bian, Guvendiren, et al. 2013). Scaffolds have also been produced directly
by decellularizing IVD tissue (Liu et al. 2014). Other natural materials have been derived from
plant or animal sources, and are chosen based on their similarity to proteoglycans in the NP as well
as their ability to create swollen networks, such as chitosan (Sukarto et al. 2012; J. Li et al. 2012),
plant-derived agarose, alginate (DiMicco et al. 2007; Chang and Poole 1996; Horner and Urban
2001), methylcellulose and carboxymethylcellulose (Reza and Nicoll 2010a; 2010b; Gupta,
Cooper, and Nicoll 2011; Lin et al. 2016; Varma, DiNicolas, and Nicoll 2018), all of which are
long-chain

polysaccharides.

Cellulose,

chitosan,

and

alginate

are

naturally-derived

polysaccharides that mimic the GAGs of the NP, but because they are not animal derived, they
resist enzymatic degradation, unlike other natural hydrogels like hyaluronic acid and chondroitin
sulfate. This characteristic is important as the degenerate disc space contains an increased amount
of matrix metalloproteinases that can degrade animal-derived polymers. Additionally, animal-
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derived polymers can be immunogenic. Recently, peptide-based hydrogels have also come into
investigation, as researchers use the very building blocks of native tissues to design highly
specialized materials for many biomedical applications (Moss et al. 2011; Leckie et al. 2012).

Figure 1.9: Schematic of hydrogel structure.
A) Polymer chains connected at crosslink point or crosslinking polymers. Mc = Number average
molecular weight between two adjacent crosslinks, directly related to n (degree of crosslinking). x = mesh
size, related to the distance between crosslinks. B) Common hydrogel modifications in tissue engineering
including cell-adhesive ligands, enzymatically degradable crosslinks, and immobilized or sequestered
growth factors. Adapted from Zhu & Marchant, (2011).

1.6.1

Tunability

Hydrogels are highly tunable platforms in which scaffold stiffness, porosity (and thus
permeability), and swelling properties can be easily tuned by molecular weight, macromer
concentration and crosslinking density (Zhu and Marchant 2011). The creation of polymeric
networks that can swell many times their dry weight is due to crosslinking between macromers.
Crosslinks can be physical in nature, mediated by temperature, pH, or ionic stimuli, or chemical,
in which permanent covalent bonds are made between macromers. Crosslinking density itself can
be modified by adjusting the concentration and size of the macromer, (Jeon et al. 2009; Gupta and
Nicoll 2014) or density of functional crosslinking moieties. Crosslinking efficiency is affected by
molecular weight as well; longer polymer chains are more likely to form chain entanglements that

23

can aid or inhibit crosslink formations depending on the type of crosslinking occurring (Ferry
1980). The theory of rubber elasticity states that the strength of a hydrogel increases with
increasing crosslinking density, which also decreases the swelling ratio (Flory and Rehner 1943a;
1943b; Rehmann et al. 2017). Swelling ratio and crosslinking density are directly related to the
mesh size (x) (Figure 1.9) (Canal and Peppas 1989), which affects the diffusion of solutes into
and out of the hydrogel, as well as influences the movement of cells through the gel (Brazel and
Peppas 2000).
Equilibrium swelling behavior is a balance between the elastic properties of the polymer and
the water content of the hydrogel. As such, hydrogels are viscoelastic materials with mechanical
behavior that is both like an elastic solid and viscous fluid (Anseth, Bowman, and Brannon-Peppas
1996). The NP is a highly viscoelastic structure as well, in that it relaxes and behaves in a fluidlike manner under transient loading, but under dynamic loading it behaves more like a solid
(Iatridis et al. 1996). Thus, hydrogels are the ideal class of biomaterials for NP replacement, and
polymer choice is dictated only by the extent of control available over each polymer’s properties.
1.6.2

Injectability

Of particular interest for NP replacement and IVD repair applications is the delivery
mechanism. As mentioned earlier, an ideal NP replacement strategy would be deployed in an IVD
where the AF was mostly intact. As such, in order to prevent further violation of the AF and
exacerbate the degenerative cascade further, it is necessary that any intradiscal therapeutic be able
to be delivered through a fine gauge needle (Korecki, Costi, and Iatridis 2008). Initial viscosity of
a material will determine the ease of its delivery. Upon injection, it must begin crosslinking
quickly, increasing in viscosity rapidly so as not to extravasate from the injection site, which is
critical in the high-pressure disc space. If cells are being deployed within the hydrogel then an
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ideal hydrogel would also protect cells from shear-induced damage (Marquardt and Heilshorn
2016; Burdick, Mauck, and Gerecht 2016).
In situ curing polymers that form covalently crosslinked hydrogels upon injection satisfy this
description, as they have not gone through their crosslinking reaction prior to injection (Figure
1.10). Free-radical polymerization is one of the most common methods for chemical crosslinking
and produces strong and highly stable inter-chain bonds. Radical-initiated reactive groups
commonly used include acrylate (Buxton et al. 2007), methacrylate (Stalling, Akintoye, and Nicoll
2009; Erickson et al. 2009), methacrylamide (H. Shin, Olsen, and Khademhosseini 2012), and
styrene moieties (Chen et al. 2009), all of which contain a vinyl group that is the target of freeradical crosslinking (Muir and Burdick 2021). Photopolymerization, in which an initiator molecule
is cleaved by light of a certain wavelength (UV, visible light) to generate the free radical, is widely
used, however, does not lend itself to injectable applications due to the limited penetration of light
through tissue. Oxidative-reductive (redox) reactions can be used to generate free radicals in
injectable systems by separating the two initiators into separate barrels of a dual-barrel syringe and
injecting via a mixing tip. As the reaction begins upon mixing, this is a very useful system for
injectable applications. Still, the potential cytotoxicity of initiators, and in particular the leaching
of unreacted initiators, should be monitored and titrated. Ammonium persulfate (APS) with
N,N,N’,N’-tetramethylethylenediamine (TEMED) or ascorbic acid are common redox initiators
for biomedical applications (Temenoff et al. 2003). Redox initiators can also be used to initiate
“click” reactions, named thus because of the speed and specificity of the reactions. Thiol-ene
radical crosslinking is one such mechanism that uses dithiol crosslinkers. The most common of
these is norbornene, a bridged cyclic hydrocarbon with a vulnerable carbon-carbon double bond
(Rehmann et al. 2017). Michael addition crosslinking occurs between thiol-enes without the need
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for free-radical initiators. The elimination of redox initiators as a potential source of cytotoxicity
makes these excellent crosslinking systems for injectable applications, however, are limited by the
need for high macromer concentrations to produce efficient reactions. These reactions can take
from seconds to hours, depending on their reactivity, and so the system needs to be tuned to the
application (Liang et al. 2016). Tyramine crosslinking is another covalent crosslinking mechanism
that lends itself well to injectable systems, where oxidation of the phenol group of tyramine is
mediated by the enzymatic reaction between horseradish peroxidase (HRP) and H2O2 (Ren et al.
2016).

A

B

C

D

Figure 1.10 Schematic representation of various injectable in situ curing chemical crosslinking
systems.
A) Free-radical chain polymerization B) Thiol-ene radical addition C) Thiol-ene Michael addition
and D) Tyramine-based enzymatic crosslinking. Adapted from Muir & Burdick, (2021).

An alternative to chemical crosslinking systems for injectable hydrogels is physically
crosslinked systems. Physically crosslinking hydrogels are stimuli responsive, forming crosslinks
in response to changes in temperature, pH, and ionic concentration, which makes them useful for
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injection into the body where the environment has very specific cues. Thermogelling polymers are
of specific interest for the disc because of their tunable gelation. Although ionic and pH- sensitive
hydrogels have been studied in the context of the disc, since the pH and ionic quality of the IVD
is highly variable depending on degenerative stage, as opposed to temperature which is relatively
constant, they will not be explored here. Thermogelling polymers include naturally- derived
chitosan, (Alinejad et al. 2019) and cellulose derivatives including methylcellulose (MC), (Choi
et al., 2020) and hydroxypropylmethylcellulose (HPMC), (Buchtová et al. 2018), animal-derived
gelatin, (Cheng et al. 2010) and synthetic poly N-isopropylacrylamide (pNiPAAm) (Ji et al. 2009).
Thermogelling hydrogel systems exhibit a lower critical solution temperature (LCST) below which
the polymers are soluble; as temperature rises above the LCST, the polymers become increasingly
hydrophobic. Instead of coming out of solution altogether, the hydrophobic moieties form
networks which trap water within the gel (Klouda and Mikos 2008). Tuning thermogelling
polymers so that the transition from solution to gel, or sol-gel transition, occurs at or below
physiologic temperature (37°C) is ideal for injection into the human body. The reversibility of
physical crosslinks has pros and cons. Physically crosslinked hydrogels are more permissive to
cell growth and matrix deposition, as their structure can change in response to cells. The most
obvious con of physically crosslinked gels is that the crosslinks are reversible and sensitive to
deformation. Because of this, physically crosslinked gels alone would not perform well as NP
replacements. Physical crosslinking systems can, however, be combined with other systems to
form dual-polymer networks (DPN) and dual crosslinking hydrogels, where the thermoresponsive
nature of the physical gel works in conjunction with covalent crosslinks to form a stronger gel.
Shear thinning is another material behavior that is highly sought after for injectable
applications (Loebel et al. 2017). Materials that exhibit high viscosity or even gel like behavior in
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the absence of deformation in shear, but quickly decrease in viscosity with increasing shear rates,
hold great appeal for injectable systems. Such materials are less likely to cure and set within a
mixing tip or needle upon delivery, and rapidly recover to their original gelled state once the force
upon them is removed, a feature known as “self-healing” (Zhang et al. 2020; Yeo and Park 2021).
Shear-thinning gels are frequently physically crosslinked, and lack sufficient mechanical integrity
as previously mentioned. Therefore, secondary crosslinking is often applied to set the gel once it
has been injected in the location and forms the desired shape. These systems are also gaining
interest as polymer inks for 3-D printing applications.
Rheology is a critical tool in assessing the viscoelastic properties of materials, and in
particular, the injectability and gelation kinetics of crosslinking hydrogels (Chen, Wen, Janmey,
Crocker, & Yodh, 2010). Small amplitude oscillatory shear (SOAS) allows for stress and strain to
be measured under controlled oscillations, where the complex modulus G* is given by
𝐺 ∗ = 𝜎"#$ ⁄𝛾"#$

(1.1)

where smax is the maximum stress and gmax is the maximum strain. Purely elastic materials
exhibit maximum stress at maximum strain, where both are in phase (dà0), and in a purely viscous
material, the maximum stress occurs when the strain rate is greatest, and stress and strain are out
of phase by 90°. Thus, the relationship between the complex modulus and its elastic and viscous
components (G’ and G”, respectively) of a given viscoelastic material is given by the relationship
in Figure 1.11:

Figure 1.11: Geometric relationship between G* and its components G’ and G”.
(Malvern Instruments 2016)
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This fundamental concept allows us to utilize the rheometer to ascertain a large amount of
information, including the complex viscosity, h*, from its relationship with G* and the angular
frequency w:
𝜂 ∗ = 𝐺 ∗ ⁄𝜔

(1.2)

The linear viscoelastic region (LVER), or region where stress and strain are proportional, can
be determined via strain sweep. The point at which the material begins to yield, known as the yield
strain (gyield), defines where G’ becomes strain dependent, and is the upper limit of the parameters
for where most SAOS testing occurs. Strain sweeps, and the resulting gyield also determine strain
yielding/shear-thinning behavior (Chen et al., 2017; Loebel et al., 2017). Materials that exhibit
gradual yielding with increasing strain are more likely to be easily injected than those that
“rupture” by exhibiting a precipitous drop in G’ at higher strains. This rupture indicates that a large
shearing force is necessary to achieve material yielding, which likely translates to material bursting
forth from the injection needle, and very limited control. While physically crosslinked biopolymers
such as agarose and methylcellulose exhibit shear thinning, many biological polymers display
strain stiffening and rupture (Zuidema et al. 2014). Cyclic strain tests in which the apparatus is
rapidly switched between high and low strain regimes can also be performed to assess shearthinning behavior. Low viscosity or G’ measurements at high strains followed by rapid recovery,
as well as high viscosity or G’ values at low strain, indicate not only that the material is shear
thinning, but that it recovers quickly and is less likely to extravasate from the injection site once it
has exited the syringe.
Throughout these tests, the relationship between G’ and G” is indicative of whether the
material is exhibiting mostly elastic or mostly viscous behavior, respectively, as the relationship
G’>G” is traditionally considered the “gel point.” Subsequently, this point also corresponds to the
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d=45°. Rheometry can also be used to determine the kinetics of free-radical polymerization over
time (Temenoff et al. 2003; Gold et al. 2014), as well as thermoresponsiveness, both by measuring
the response to steadily increasing temperatures (usually at a ramp rate of 1-2°C/min) to determine
the temperature at which a polymer rapidly begins to aggregate into a gel (Bain et al. 2012; Nasatto
et al. 2015), or to instantaneous thermoresponsiveness by rapidly increasing the platform
temperature (usually to 37°C) and holding for a prescribed amount of time to measure the time
course of gelation behavior when introduced to physiologic temperatures (Caicco et al. 2013).

Figure 1.12: The tissue engineering paradigm: Cells, Scaffold (Tissue Architecture), and Signals
(Niche Properties).
Adapted from Moysidou, Barberio, & Owens (2021).

1.7

Tissue Engineering and Biological Repair
While acellular biomaterial approaches to IVD repair hold promise for restoring disc

hydration and mechanics, biologic therapy is an increasingly appealing alternative to end-stage
surgical treatment, as it attempts to mitigate the cause of IVDD before the effects become too
severe and spread to adjacent structures. Partial or full NP replacement seeks to rehydrate the disc
and restore hydrostatic pressure lost during nucleotomy. The goal of tissue-engineered disc
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replacements is not only to restore hydration, pressure, and overall mechanical function, but also
biological function, so that the replaced disc can maintain itself.
Tissue engineering aims to combine cells with engineered environments in an attempt to
replicate, heal, and/or replace injured or diseased tissues, and thus, is a promising strategy for
alleviating the effects of IVDD (O’Halloran and Pandit 2007; Henry et al. 2018; Hudson et al.
2013). Targeting the NP where IVDD begins, tissue engineering strategies attempt to address
degeneration before the effects spread irreversibly to the surrounding tissues of the AF, CEP, and
adjacent vertebral bodies. Depending on the severity of the disease state, various regenerative
approaches may be taken. In early degeneration, direct growth factor delivery may be sufficient to
stimulate matrix production in the native cells (Singh, Patel, and Singh 2021). Platelet-rich plasma
(PRP) is an appealing therapy utilized by clinicians because it is an autologous treatment that
requires little to no manipulation and can be produced quickly, avoiding many regulatory hurdles
of regenerative therapies, however, clinical efficacy is highly variable and there is no strong
consensus on whether the resultant effects are regenerative or palliative. (Urits, Viswanath, et al.
2019). If the native cells are not responsive, or the existing matrix is too degenerated, a nucleotomy
may be performed and the void space may be filled with cells in an engineered scaffold. Both of
these treatments depend on the remaining structural stability of the AF; if the AF is damaged and
can no longer provide mechanical support to withstand the pressure within the NP, then a whole
disc replacement will be necessary, with both NP and AF portions of the IVD engineered (Bowles
et al. 2011; Gullbrand et al. 2018). The traditional tissue engineering paradigm is a triad that
consists of cells, scaffold, and signals (Figure 1.12): the appropriately terminally differentiated
cells or stem cells with potential to differentiate to the target cell type must be delivered with a
scaffold material to provide structure and mechanical cues, while soluble factors like growth
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factors and cytokines, as well as bound factors such as integrin binding peptides can be utilized to
further direct cell behavior. The following sections will outline the three traditional components
of tissue engineering and the current state of the art of NP tissue engineering.
1.7.1

Cell Source

Cell source is one of the first questions that must be answered when tissue engineering the
NP, as the unique characteristics of the cell will dictate what type of environment is necessary to
produce a de novo healthy NP. Various animal sources of NP cells have been used in in vitro and
preclinical in vivo studies, including rat (Bowles et al., 2011; Maidhof et al., 2012; O’Halloran &
Pandit, 2007), and bovine cells (Chou and Nicoll 2009; Reza and Nicoll 2010a; 2010b; Feng et al.
2014). While these cells are useful model systems, development of translational therapeutics has
focused on allogeneic and autologous cells. Autologous or cadaveric NP cells have been
considered as an option; however, their functionality and availability is problematic. Given that
the loss of the large, vacuolated notochordal cells (NCs) and the rise of small, chondrocytic cells
in the NP is regarded as a precipitator of degeneration, autologous adult NP chondrocytes are
generally not used as a tissue replacement. Conversely, NCs are known to regulate NP matrix early
in life and are an appealing option, however, cell density in the native disc is so low that harvesting
enough cells to expand in culture and produce a clinically viable tissue-engineered construct is
difficult. NCs almost entirely disappear from the human NP by 10 years of age, which also
contributes to the problem of acquisition of cells (Chen, Yan, and Setton 2005). Still, NCs, and
NC-conditioned media have been shown to promote NP matrix elaboration in other cells in coculture, which may be useful for in vitro organ development (Korecki et al. 2010; Aguiar, Johnson,
and Oegema 1999).
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Significant developments in stem cell research make such progenitor cells an appealing choice
for NP tissue engineering. Potential sources of stem cells include induced pluripotent stem cells
(iPSCs) (Tang et al. 2018) and adult mesenchymal stromal cells (MSCs). Embryonic stem cells
(ESCs) from animal sources are available for study, however, human embryonic stem cells are
difficult to obtain and face ethical and political challenges for use (Urits, Capuco, et al. 2019).
Autologous adult MSCs have shown promise in differentiating into NP-like cells (Gou et al. 2014;
Risbud et al. 2004; Steck et al. 2005). These multipotent, non-hematopoietic progenitor cells have
proven ability to differentiate into all connective tissue lineages, and are easily harvested from a
patient, either from bone marrow (Zhang et al. 2021; Gupta and Nicoll 2014) or adipose tissue
(Zhu et al. 2019; Minogue et al. 2010), and expanded in culture.
Recently, a subset of mesenchymal stem cells within the IVD have been identified, showing
nearly identical differentiation capabilities as bone marrow-derived MSCs (all except adipocytes)
(Blanco et al. 2010; Henriksson et al. 2009). Although the population is likely too small to harvest
and use for tissue engineering, they do have the potential for direct stimulation by growth factor
delivery in the early stages of disc degeneration, as well as being target cells for cell-homing
strategies that use diffusion of growth factors to induce chemotaxis, such that the local stem cell
population will populate a cell-free scaffold themselves (Illien-Jünger et al. 2012; Sakai and Grad
2015).
Identifying the phenotype of the cells chosen for the tissue engineering construct is critical in
determining the success of the biological therapy. Many attempts have been made at identifying
NP specific gene and protein markers. The primary matrix components of the NP are similar to
those of AC, namely proteoglycans (in particular, aggrecan) and type II collagen, although the
proportions of proteoglycan to collagen (as well as total water content) differ. NP cells and AC
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cells both highly express COL2A1, ACAN, and SOX9. Minogue et al. (2010) explored gene
expression in NP and AC cells and identified a number of NP positive and NP negative (AC
positive) genes. The NP-positive genes were PAX1, FOXF1, HBB, CA12, and OVOS2; the ACpositive genes were GDF10, CYTL1, IBSP, and FBLN1. Lee et al. (2007) found that in rat NP,
annexin A3, glypican 3 (GPS3), keratin 19 (K19), pleiotrophin (PTN), and vimentin (VIM) were
expressed significantly more than in the AF and AC, while cartilage oligomeric matrix protein
(COMP) and matrix gla protein (MGP) were higher in AC than NP; they did note, however, that
there were no clear “on/off” markers to distinguish NP from AF or AC cells. Lv et al. (2014)
reviewed many different studies on phenotypic markers in multiple species and concluded that Ncadherin (CDH2) and keratin 19 (K19) are potential NP markers, as they distinguish healthy NP
from AF, AC, and degenerate NP. Although these and other genes have been described as NP
markers because they identify NPCs in non-human species, Thorpe et al. (2015) have cautioned
that KRT-19, KRT-18, CD24 and laminin genes, LAM-5 and LAM-11, do not distinguish between
NPC and AC cells in humans. Gene expression is a useful tool in determining cell differentiation
and lineage, however, protein expression has more direct functional application, as it is not only
indicative of successful transcription of the genes but results in gross biological and mechanical
changes in the tissue.
1.7.2

Growth Factor Delivery

When engineering new tissues, and particularly when using stem cells, growth factors are
often necessary to direct cells towards the appropriate phenotype. These factors may influence the
production of matrix molecules, decrease the production of catabolic enzymes, or a combination
of both effects (Yang and Li 2009). Many of the growth factors used in engineering NP tissues are
from the transforming growth factor-β (TGF-β) superfamily, including TGF-β1, TGF-β3, and bone
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morphogenetic proteins-2, -7 and -12 (BMP-2, -7, -12) (Li et al. 2017), as well as others, such as
insulin-like growth factor 1 (IGF-1) (Chon et al. 2013; Shim et al. 2016), and
growth/differentiation factor-5 (GDF-5) (Yang and Li 2009; O’Halloran and Pandit 2007; S Chen
et al. 2019). In particular, numerous studies have utilized TGF-β1 and TGF-β3 to differentiate
stem cells towards a chondrogenic and NP-like phenotype in vitro (Steck et al. 2005; Cox et al.
2014; Gupta, Cooper, and Nicoll 2011). Studies have shown that short term TGF-β3 treatment of
encapsulated bone-marrow derived MSCs was sufficient to promote long-term differentiation and
tissue maturation (Steck et al. 2005; Cox et al. 2014; Gupta, Cooper, and Nicoll 2011). Long-term
efficacy of growth factor stimulation and delivery is limited, however, due to their short half-lives
(Wang et al. 2017). Growth factor stimulation has been shown to be critical for the differentiation
of encapsulated hMSCs; in the absence of growth factor stimulation, cells fail to clearly
differentiate and synthesize new matrix (Madry et al. 2014; Johnstone et al. 2013; Gupta, Cooper,
and Nicoll 2011). Various delivery vehicles have been developed to protect and prolong the
bioavailability and bioactivity of growth factors for tissue engineering, with a particular focus on
in vivo translation.
In vivo, exogenous growth factor supplementation is not feasible, and so growth factor
delivery mechanisms must be utilized to supply growth factors with the injectable scaffold material
and sustain their bioavailability long enough to direct stem cell differentiation. Prolonged growth
factor delivery can be difficult to control and expensive to maintain. Direct loading of growth
factors into hydrogels usually results in a burst release due to the rapid influx of water into the
hydrogel pushing out the payload (Lin and Metters 2006; Silva et al. 2009). Sequestration or
delivery of growth factor remains an area that many are attempting to address through such
methods as modification of the scaffold material via covalent tethering (Mann, Schmedlen, and
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West 2001; Schneider et al. 2019; McCall, Luoma, and Anseth 2012), encapsulated microparticles
(Holland, Tabata, and Mikos 2003; Bian et al. 2011), and affinity-based sequestration (Figure
1.13) (Benoit and Anseth 2005; Tae et al. 2006; Bian et al. 2011; Lee, Silva, and Mooney 2011).
Covalent immobilization of growth factors or growth factor mimics can lead to sustained signaling,
but can be susceptible to hinderance by steric factors, or conversely can provide permanent
stimulation, which is not always desirable (Mann, Schmedlen, and West 2001). Secondary carriers
such as microparticles have also been used in growth factor delivery, however, this approach
requires multiple steps for particle and hydrogel preparation, and presents a less direct route for
delivery since the factor must be released from the microparticles to reach encapsulated cells,
potentially delaying stimulation (Bian et al. 2011).

Figure 1.13: Schematic representation of growth factor delivery mechanisms from hydrogels.
(Blue squares represent growth factors). Adapted from Censi et al. (2012).
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Affinity-based growth factor sequestration is a promising method that utilizes affinity
between molecules to attract and reversibly bind growth factors. These affinity molecules can be
ligand mimetic peptides, guest-host interactions (cyclodextrin), or more fundamental
intermolecular attractions like Van der Waals forces, hydrogen bonding, electrostatic and
hydrophobic interactions (Wang & Von Recum, 2011). Electrostatic interactions are one such
affinity sequestration mechanism of particular interest because it mimics the natural behavior of
the native ECM. Specifically, negatively charged sulfates on GAGs, such as heparin and
chondroitin sulfate, are known to act as depots for charged growth factors, maintaining their
availability and prolonging their activity, with some growth factors showing greater resistance to
proteolysis and thermal denaturation when bound to heparin or heparan sulfate (McCall, Lin, and
Anseth 2011; Soares Da Costa, Reis, and Pashkuleva 2017). Heparin-based growth factor delivery
systems have been investigated due to the affinity of many growth factors such as BMP, bFGF,
and TGF-β to heparin, thus enabling sustained release of the encapsulated growth factors (Jeon et
al. 2011; Lei, Trevino, and Temenoff 2016; Lei et al. 2014; Nie et al. 2007; Liang and Kiick 2014;
Hachim et al. 2019).
Scaffolds that mimic the sulfation of native matrix GAGs by artificially incorporating sulfate
groups have also been investigated (Purcell et al. 2014; Feng et al. 2017; Hintze et al. 2012; Yan
et al. 2018; Portocarrero Huang et al. 2017; Waghmare et al. 2018). Sulfated alginate gels have
shown to sequester heparin-binding proteins bFGF, VEGR, IGF and TGF-β1 (Freeman, Kedem,
and Cohen 2008; Re’em et al. 2012). Many of these artificially sulfated polymers have been
referred to as “GAG mimetics” as they aim to mimic highly sulfated GAG-rich matrices in a
controllable fashion (Arslan, Guler, and Tekinay 2016; Sivan et al. 2014). These studies utilize
SO3-dimethyl formamide complexes, pentosan sulfates, carbodiimide chemistry with sulfuric acid,
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and other mechanisms for covalently sulfating the base polymer (Hintze et al. 2012; Frith et al.
2013; Freeman, Kedem, and Cohen 2008).
1.7.3

Biomaterials for NP Tissue Engineering

Biomaterials under consideration for tissue engineering of the NP must satisfy the same
requirements as acellular NP replacement biomaterials (injectability, in situ gelling, and swelling
and mechanical properties matching the healthy NP) as described earlier in section 1.6. In addition,
there are a number of considerations specific to carrying and supporting cell differentiation and
tissue growth (Huang, Hu, Li, & Luk, 2018). Firstly, cytocompatibility of the material must extend
beyond not releasing cytotoxic factors (the response to which is noticeable within 24-72 hours)
but should promote cell survival and differentiation. Proliferation is often seen as a marker of cell
health, however, studies have shown that proliferative phenotypes are different than “biosynthetic”
phenotypes that lay down matrix, so increasing cell number may not be indicative of biomaterial
success (Strehl et al. 2002). Secondly, ideally the scaffold should break down at a rate concurrent
with matrix deposition by the cells, such that mechanical integrity of the construct is not lost, but
void space is created within the gel to be permissive for neomatrix elaboration (Bryant and Anseth
2003; Chung et al. 2009).
Integrin binding moieties like RGD (fibronectin derived) or direct conjugation of cell
attachment matrix proteins (like laminin) have been utilized to harness the cell’s responsiveness
to its environment (Bridgen et al. 2017; Francisco et al. 2013). Immature NP cells preserve their
phenotype and matrix-production on soft gels (Hwang, Chen, et al. 2014). Similarly, studies with
both NPCs and hMSCs in chemically crosslinked carboxymethylcellulose (CMC) yield better
results in NP gene expression and matrix elaboration on softer substrates, even in the absence of
any cell-binding sites (Reza and Nicoll 2010a; Gupta and Nicoll 2014; Lin et al. 2016). Hyaluronic
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acid and type II collagen-based hydrogels have been studied extensively for NP tissue engineering,
as they are found natively in the NP, and provide an excellent mimic for the native tissue that
promotes NP-like differentiation (Calderon et al. 2010; Cloyd et al. 2007). However, because they
are animal derived and specifically found in the NP, these materials are susceptible to enzymatic
degradation, which is upregulated in the degenerative disc. Hydrogels composed of alginate, a
natural polysaccharide derived from kelp, have also shown the ability to support NP-like matrix
elaboration (Chou and Nicoll 2009; Bron et al. 2009). Nevertheless, these ionically crosslinked
gels are not mechanically stable enough for long-term culture, and certainly less so for in vivo
application. Synthetic materials have also been investigated for NP tissue engineering, although
less so than naturally derived substrates. Synthetic hydrogels that are designed with hydrolytically
degradable portions in particular, like poly(lactic-co-glycolic acid) (PLGA) have shown promise
as they are permissive to NP-like matrix elaboration, although they are otherwise “bioinert” in that
they do not directly interact with encapsulated cells (Fraylich et al. 2010).
As stated in earlier sections, injectability is a critical factor for both acellular biomaterial and
cell-based NP replacement materials. Injectability in the IVD possesses a unique challenge, not
only because delivery must be through a fine gauge needle, but because the IVD and NP void
space are naturally high-pressure regions, and the void space created by nucleotomy is irregular,
all of which puts the injectable at risk for extravasation. This not only directly leads to failure of
the NP replacement but can have deleterious effects to neighboring tissues in vivo. It is critical that
“injectable” systems that pass injectability tests in the laboratory be validated, either in vivo or in
ex vivo motion segment models. Work in our lab has shown very promising results for NP-like
differentiation and matrix elaboration in soft, CMC-based hydrogels (Reza and Nicoll 2010b;
Gupta, Cooper, and Nicoll 2011; Gupta and Nicoll 2014; Lin et al. 2016). Recently, we were able
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to transition the photocrosslinked CMC hydrogel system to one that polymerizes in situ without
the need for ultraviolet light exposure using a redox-initiated crosslinking system with
APS/TEMED in dual-barrel syringes (Varma, DiNicolas, and Nicoll 2018). These scaffolds
showed robust and uniform distribution of NP matrix components Col II and sGAGs. However,
preliminary ex vivo motion segment studies showed that despite redox-initiated polymerization
and rheological studies that indicated rapid gelation, the viscosity of the gel did not increase
enough to resist extravasation from the disc upon injection. CMC was mixed with MC in order to
combine the high swelling capacity of CMC and the intrinsic thermogelling capacity of MC to
form an in situ gelling acellular NP replacement that restored disc height and range of motion
(Varma et al. 2018). However, the effective macromer concentration of this system is 6%, which
is far from the low macromer concentrations that are most permissive to cell differentiation (1.52%). Thus, future work aims to shift the development of this cellulose-based hydrogel system,
such that it maintains the ability to support cell differentiation and matrix production, while also
providing translational potential of an in situ forming hydrogel.
1.7.4

Cellulosic Biomaterials

Cellulose is a naturally occurring polysaccharide and is the most abundant polymer on earth
(Klemm et al. 2005). It is renewable and biodegradable, making it an ideal biomaterial in the age
of sustainability. It is also easily chemically modified and is highly tunable, making it an ideal
material for biomedical applications (Fox et al. 2011; Kamide 1977). Cellulose is primarily derived
from the cell walls of plants but can also be synthesized by bacteria and tunicates (Klemm et al.
2005; Gorgieva and Trček 2019). Consisting of repeating β(1,4) linked D-glucose units, each
glucan ring has 3 hydroxyl groups, which allows for strong hydrogen bonding between cellulose
chains. The hydrogen bonding makes cellulose resistant to dissolution in water and many other
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organic solvents. However, cellulose can be solubilized in ionic solutions and processed by means
such as casting, molding, or electrospinning. Degree of polymerization (DP), or the number of
repeating monomeric units, is highly dependent on source, and can affect the mechanics and
viscosity of the polymer solution (Klemm et al. 2005).
The three hydroxyl groups on each glucan unit can easily be substituted with functional
groups, changing the solubility of the polymer, and making it suitable for a variety of applications
in biomedicine. Esterification of the hydroxyl groups is a common modification that results in a
number of cellulose derivatives that have widely been used as biomaterials (Figure 1.14) (Fox et
al. 2011). Methylcellulose (MC) is the simplest of these derivatives, in which hydroxyl groups are
replaced by methoxy groups (Desbrières, Hirrien, and Ross-Murphy 2000; Nasatto et al. 2015).
These methoxy groups create hydrophobic regions within the cellulose polymer while still
rendering it water soluble (Nasatto et al. 2015; Haque and Morris 1993). The result is a
thermosensitive polymer that can form reversable, physically crosslinked hydrogels upon heating.
The addition of ionic salts and other components in solution can be used to tune the thermogelation
temperature of MC, making it useful for injectable systems that go from lower ambient
temperatures to physiologic temperatures (Caicco et al. 2013; Gupta, Tator, and Shoichet 2006;
Zheng

et

al.

2004).

Hydroxypropyl

methylcellulose

(HPMC)

displays

similar

thermoresponsiveness that varies depending on the percentage of methoxyl and hydroxypropyl
substitutions (Joshi 2011). CMC is another cellulose ether in which hydroxyl groups are replaced
by highly negatively charged carboxylmethyl groups (Ogushi, Sakai, and Kawakami 2007; Reeves
et al. 2010). The increased negative charge makes CMC highly hydrophilic, and an excellent
material for applications in which a high affinity for water is critical. CMC is highly sensitive to
pH and ionic concentration, which results in tunable swelling behavior. All these cellulose ethers
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are commonly used in the pharmaceutical and food industries, are biocompatible and are FDA
approved for several biological applications. Cellulose sulfates (CS) have also been investigated,
both for their highly anionic character, like CMC, as well as their similarity to sulfated
glycosaminoglycans found in many animal tissues ( Wang et al. 2007; Zhang, Lin, and Yao 2015;
Portocarrero Huang et al. 2018; Portocarrero Huang et al. 2017)
Cellulose microparticles are another form of cellulose that have also recently gained interest
for biomaterial applications. They include microfibrillated and nanofibrillated cellulose (MFC and
NFC, respectively), and cellulose nanocrystals (CNC). MFC and NFC are cellulose microfibers
formed by defibrillation of plant cellulose and are noted to possess high stiffness and strength
(Borges et al. 2011; Eyholzer et al. 2011). CNC is formed via acid hydrolysis of naturally occurring
crystalline cellulose fibers (Bhat et al. 2019). The resulting material consists of rod-like crystals
with unique rheologic properties. CNC is comprised of an isotropic suspension that then forms a
liquid crystal structure depending on concentration, and is highly dependent on temperature, ionic
strength, and pH of the solution (Qiao et al. 2016). Micro- and nano-celluloses can be used on their
own or can be incorporated into hydrogels and other biomaterial matrices in order to increase their
physical properties (McKee et al. 2014; Stevanic et al. 2012; Haghpanah et al. 2013; Dai et al.
2019; Markstedt et al. 2015; Bhat et al. 2019).
Cellulose-derived biomaterials have been used for a variety of applications, such as soft tissue
fillers ( Varma et al. 2014; Gold et al. 2015; 2014), ophthalmic lubricants, and hemostats (Lewis
et al., 2013). In addition to its tunability, cellulose is not enzymatically degradable by the human
body, as humans do not naturally produce cellulose or the enzyme that degrades it (i.e., cellulase).
This creates the potential for continuous structural support but may be undesirable in the case of
tissue engineering solutions where the scaffold should eventually degrade at the approximate rate

42

of new tissue development. The introduction of functional groups can tune cellulosic susceptibility
to hydrolytic degradation. Bacterial cellulose (BC) has become increasingly popular for various
biomedical applications. Cellulose fibers formed by bacteria, particularly those formed by the
genus Acetobacter, have high appeal due to their superior purity (they are not associated with other
substances such as hemicellulose or lignin which are present in plant sources) and are able to
achieve a much higher DP than plant cellulose, resulting in greater crystallinity as well as increased
mechanical properties (Rajwade, Paknikar, and Kumbhar 2015).

Figure 1.14: A) Cellulose and B) its ether derivatives.
Available locations for ether modifications highlighted in green. Adapted from Kabir et al. (2018).

The variety of sources, chemical and physical modifications, and micro- and nano- structures
of cellulose make it an ideal material for a wide range of biomedical uses, including for IVD repair
(Klemm et al. 2005; Courtenay, Sharma, and Scott 2018).
1.7.4.1 Cellulosics for Disc Repair – Acellular Biomaterials
Several forms of cellulose are being used to develop cell-free, structural reinforcement to the
IVD, especially for early stages of the disease and post microdiscectomy. Acellular repair or
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replacement of IVD tissue is a promising approach that faces much fewer regulatory hurdles than
cell-based tissue engineering. These strategies focus on the mechanical strength of the material,
their durability over repeated cycles of physiological loading and resistance to herniation during
complex loading.
Borges et al. (2010, 2011) developed composite photocrosslinked hydrogels containing
Tween 20 trimethacrylate, N-vinyl-2-pyrrolidone, and nanofibrillated cellulose (NFC) and
assessed the gelling behavior, compressive mechanical properties, and swelling behavior along
with the morphology and biocompatibility. Here, NFC was chosen as a component of the
composite hydrogel due to its high water retention value as well as its previous use as a reinforcing
additive in other polymer matrices. Inclusion of 1.6 wt% of NFC led to a 30-fold increase in the
compressive strength of the hydrogels. However, despite NFC having a high water-retention value,
it actually resulted in a lower swelling ratio compared to hydrogels without NFC included. To
address this, the same group created carboxymethylated NFC (c-NFC), introducing negatively
charged carboxymethyl groups to increase the hydrophilicity of the composite hydrogel.
Increasing degree of carboxymethylation resulted in shear thinning behavior by the hydrogel
mixture, which is promising for injectable applications. Swelling ratio increased within each
concentration of NFC added, however, none were able to achieve the swelling ratio of the
hydrogels without c-NFC. Similarly, static compression showed that while the addition of NFC
increased compressive modulus of the hydrogels, carboxymethylation reduced the modulus within
a respective % NFC, likely due to the same loosening of the polymer network. A dynamic
compression protocol comprised of cyclic compression between 0.5-1 kPa using a testing protocol
mimicking a 16-hour workday. Here, gels with NFC demonstrated highest stiffness and percent
recovery post testing (Eyholzer et al. 2011).
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More recently, similar implant strengthening behavior of NFC was also delineated in an ex
vivo bovine motion segment model using polyethylene glycol dimethacrylate (PEGDMA)
hydrogels (Khoushabi et al. 2015; Schmocker et al. 2016; Karami et al. 2018). Photopolymerized
PEGDMA hydrogels were reinforced with NFC, increasing the stiffness 2-3.5-fold without
compromising the toughness. The high crystallinity and aspect ratio of NFCs provided mechanical
reinforcement to the hydrogels while lowering gelation time. Additionally, ex vivo biomechanical
assessment of NFC-chitosan hydrogels implanted in porcine discs demonstrated disc height
restoration along with relaxation parameters similar to native IVD (Doench et al. 2018). Currently,
these NFC-chitosan gels form over an hour, which limits their ability to gel in situ for minimally
invasive IVD procedures. Another interesting nano-sized form of cellulose consists of cellulose
nanocrystals, which were recently tested in ionically crosslinked gellan gums for AF repair.
Similar to NFCs, the nanocrystals increased hydrogel stiffness and complex modulus while also
aiding the gelation process. However, the gelation kinetics of this platform is slow, requiring close
to 10 minutes to obtain fully formed hydrogels. Further, degradation studies indicated poor
stability of the gels, with 15% mass loss in 30 days of incubation in PBS (Pereira et al. 2018).
CMC, a cellulose ester with high water absorbing capacity due to the substitution of anionic
carboxyl groups for some of the hydroxyls on the cellulose backbone has been methacrylated to
allow for free-radical crosslinking of the polymer chains resulting in hydrogels with tunable
material properties (Varma et al. 2014; Gupta, Cooper, and Nicoll 2011). Recently, the Nicoll lab
has combined methacrylated CMC with thermosensitive MC to obtain thermogelling, injectable,
redox-polymerized hydrogels capable of forming rapidly (within 4 min.) in situ, with swelling and
compressive mechanical properties akin to native NP tissue (Varma et al. 2018). Cyclic
compressive loading of bovine motion segments injected with CMC/MC hydrogels restored a
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range of compressive biomechanical parameters to healthy values, including the disc height, range
of motion and neutral zone parameters. Additionally, fatigue testing of this formulation in bovine
motion segments revealed that the CMC/MC hydrogel improved fatigue endurance of the discs
compared to the injured condition, but performed similar to the nucleotomy control group, a
clinical standard for IVD herniation. Although, the implanted and nucleotomy groups presented
similar herniation risks during the failure test, a majority of the failure parameters (failure strength,
subsidence to failure and stiffness) were similar between the implanted and intact discs (Lin et al.
2019).
1.7.4.2 Cellulosics for Disc Repair – Cell-based Strategies and Tissue Engineering
While biomaterial-based acellular replacements may be able to relieve pain and partially
restore mechanical functionality of the spine, lack of cells limits their use for biological repair of
disc tissue. Therefore, in the long run, a cell-based therapy may serve as a better solution for disc
degeneration (O’Halloran and Pandit 2007; Yang and Li 2009; Hudson et al. 2013). Roughley et
al. (2006) explored a composite hydrogel containing chitosan, glycerophosphate, and
hydroxyethyl cellulose (HEC) for its potential as an NP tissue engineering scaffold. These
hydrogels with encapsulated disc cells showed deposition and retention of GAGs. To the best of
our knowledge, we are the only group to have successfully demonstrated the use of cellulose as
the primary scaffold material for NP tissue engineering. Reza and Nicoll (2010a) demonstrated
that photocrosslinked carboxymethylcellulose hydrogels can support NP-like matrix elaboration
by encapsulated bovine NP cells, thus establishing CMC as a promising biomaterial for NP tissue
engineering. Gupta et al. (2011) further explored the utility of photocrosslinked CMC hydrogels
for the encapsulation of human mesenchymal stem cells (hMSCs). These cells showed NP-like
differentiation under TGF-b3 treatment, as determined by assessment of gene expression and
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relevant matrix macromolecular deposition. Furthermore, the resulting tissue engineered
constructs possessed compressive mechanical properties similar to that of the human NP. That
study was a critical step forward as hMSCs are a more clinically relevant cell source compared to
either autologous or allogeneic NP cells. In subsequent studies, our group evaluated the impact of
photocrosslinked CMC scaffold composition and TGF-b3 exposure duration on the NP-like
differentiation of encapsulated hMSCs, further elucidating scaffold microenvironmental effects on
hMSCs, leading to improved CMC hydrogel systems (Gupta and Nicoll 2015; Lin et al. 2016;
Gupta and Nicoll 2014). As UV light has limited tissue penetration, photocrosslinking restricts
clinically relevant, minimally-invasive delivery of CMC hydrogels. Thus, the Nicoll group has
recently been exploring redox-initiated crosslinking in CMC hydrogels to achieve in situ gelation
with an injectable material, moving closer to clinical translation. (Varma, DiNicolas, and Nicoll
2018) successfully demonstrated that redox-polymerized CMC hydrogels support NP-like
differentiation of encapsulated hMSCs, leading to relevant matrix deposition and functional
mechanics in vitro.
Successful tissue engineering of whole IVDs will be a big step forward in the spine field,
especially for patients who present late stage IVDD requiring full discectomy. The angle-ply
architecture of the AF and integration of the inner AF to the NP are largely responsible for
maintaining the disc pressure, height and preventing herniation of the NP in healthy discs,
however, this complex structure is challenging to replicate in tissue-engineered constructs. Yang
et al. (2018) presented an interesting approach to tissue engineer whole IVDs by micropatterning
bacterial cellulose to re-create the angle-ply structure of the AF, further rolling the cellulosic sheets
embedded with AF cells, and combining a central collagen gel to create disc-shaped organs.
Integration of these tissue-engineered units with native tissue was evaluated in vivo in rat tails. The
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resulting 3-month data demonstrated successful integration and inter-lamellar neo-tissue formation
along with disc height and mechanical strength similar to native, healthy discs. This study utilized
micropatterning to achieve aligned cells and matrix components - a novel, scalable approach to
obtain tissue-engineered whole IVDs. Although successfully demonstrated in animal studies, the
isolation and use of healthy human AF and NP cells poses several challenges, which can be
countered by using adipose or mesenchymal stem cells. In addition, this strategy is also dependent
on successful delivery of growth factors, either via scaffolds or gene-delivery. Growth factors,
such as GDF-5, TGF-b1, are some of the most studied proteins for NP differentiation and identified
as critical to sustain the differentiated state of stem cells in the NP. Henry et al. (2017)
demonstrated the use of pullulan microbeads to enable sustained release of these growth factors in
injectable silanized hydroxypropylmethylcellulose (HPMC) hydrogels. Further investigation of
the microbead system in an ex vivo degenerative disc model showed that sequential release of the
chemokine CCL-5, followed by TGF-b1 and GDF-5, could recruit MSCs into the NP and induce
matrix elaboration, although they have not yet reported data on tissue elaboration within the HPMC
hydrogels.
Recently, an injectable hyaluronic acid-methylcellulose (HAMC) hydrogel carrier with
Wharton’s jelly-derived MSCs (WJ-MSCs) was reported for repair of degenerate discs in a rat
model (Choi et al., 2020). This hydrogel has been previously used for various neurological repair
strategies, but this is the first report of its use in orthopedic tissues (Gupta, Tator, and Shoichet
2006; Caicco et al. 2013). The hydrogel promoted retention and survival of the WJ-MSCs, and
together showed superior matrix elaboration, restoration of disc hydration, and down regulation of
catabolic enzymes that frequently matched that of the uninjured control. It should be noted,
however, that the rat-tail model is extremely small, and retention within a disc of that size does not
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necessarily translate to retention of cells or elaboration within larger species (i.e., human).
Furthermore, mechanical properties were not reported, and from previous studies of physically
crosslinked gels, it can be surmised that the HAMC hydrogel system would not likely contribute
to the restoration of disc height or mechanics.
1.7.5

Design Criteria and Functional Outcomes

The goal of NP tissue engineering is to restore the mechanical function of the degenerate disc
to healthy levels and promote the ability of the incorporated cells to actively maintain the healthy
tissue. In addition, delivery of a tissue-engineered therapeutic for NP repair must minimize any
disruption to the neighboring structures to limit further damage and disease progression. As such,
the endpoints of the tissue-engineered construct should be clearly defined and aim to achieve
characteristics as close to the native, healthy disc as possible.
As the NP and IVD’s function is purely mechanical, a tissue-engineered NP replacement must
attempt to meet the mechanical specifications of the NP (Nerurkar, Elliott, and Mauck 2011).
Several studies have been conducted on the native tissue mechanics of the healthy IVD, as a
composite structure, as well as the individual portions of the AF and NP. Table 1.1 below shows
a summary of the mechanical benchmarks for the NP relevant for NP tissue engineering.
Additionally, swelling behavior is a critical component of NP material behavior. Though to the
best of our knowledge the equilibrium weight swelling ratio (Qw) of healthy human NP tissue has
not been reported in the literature, our laboratory has previously measured Qw of healthy bovine
NP tissue to be ~19 (Reza and Nicoll 2010b).
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Table 1.1: Summary of native tissue mechanics benchmarks of the NP.
Modified from Nerurkar et al. (2011)
Testing Modality
Benchmark
Swelling Stress Psw
Confined Compression
Aggregate Modulus HAeff
(Johannessen and Elliott 2005)
Permeability ko
Equilibrium Young’s modulus Ey
Unconfined Compression
Poisson’s ratio
(Cloyd et al. 2007)
Percent relaxation
Complex shear modulus |G*|
Torsional shear
(Iatridis et al. 1997)
Phase shift δ

Native Value
0.138 MPa
1.01 ± 0.43 MPa
0.9x10-15 m4/Ns
5 kPa
0.62
~65%
7.4-19.8 kPa
23º-30º

The similarities between AC and the IVD are many, particularly in the make-up of the matrix.
The cells of the mature IVD are so similar to articular chondrocytes that they are often referred to
as NP chondrocytes. Still, the IVD and AC are two distinct tissues that have key differences to be
mindful of while tissue engineering either one of them. The function of the IVD as a whole is to
resist compression and allow motion; separately, the NP resists compression while the AF resists
tension. Cartilage resists compression but also provides lubrication for articulating joints (Chen et
al. 2017). Both AC and NP are characterized as having high proteoglycan content, particularly of
aggrecan, as well as collagen type II. A critical difference lies in the ratio of these molecules, as
the glycosaminoglycan to collagen ratio is 2:1 in cartilage, and 27:1 in the NP
(GAG:Hydroxyproline) (Mwale et al. 2004; Yang and Li 2009). Absolute values of GAG and
collagen in the NP are approximately 250 µg/mg dry weight and 525 µg/mg dry weight,
respectively (Antoniou et al. 1996; Mwale et al. 2004). Type II collagen outnumbers type I in the
NP 60:1 (Antoniou et al. 1996). The relative proportions of these matrix components are what
distinguish NPCs from AC cells, however, it is not necessarily accurate to apply this proportion to
gene expression (Mwale et al. 2004; Risbud et al. 2015).
In addition to the functional outcomes of mechanics and biochemistry/matrix elaboration,
clinical translation must be considered. Primary considerations include the material be sterilizable,
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cytocompatible, injectable, and retained in situ upon injection. The ideal NP replacement delivered
minimally invasively, to limit disruption of the AF. Low initial viscosity can allow for injection
through fine gauge needles (Boyd and Carter 2006). Injectable dermal fillers, which similarly
require delivery through a fine gauge needle (27-30 ga) have been reported to range in initial
viscosity from 58-1199 Pa·s (Falcone and Berg 2008). In addition, because the center of the IVD
is a high-pressure space, the injectable material must rapidly increase in viscosity and shear
modulus as it cures in situ in order to resist extravasation from the void space. Previous work from
our lab using a CMC-MC DPN system reported initial viscosity (within 30 seconds of injection)
to be 440.7 Pa·s, followed by a rapid 10-fold increase in viscosity by gelation completion (Varma
et al. 2018). Previous work with CMC alone achieved a final gelation viscosity of ~160 Pa·s,
though this was found not to be retained within the disc when injected in an ex vivo bovine disc
model. Thus, while rheological analysis can be used to quantify the viscosity and shear modulus,
secondary validation in a constrained space, or better yet, an in vivo or ex vivo nucleotomy model
is useful for qualitatively confirming gelation and retention (Frith et al. 2013; Varma et al. 2018).
Gelation time should also be taken into consideration, such that the physician has enough time to
work with the pre-gelled material and fill void spaces, but short enough that the material does not
extravasate and the procedure time is not prolonged. The current ISO standard for injectable
biomaterials is 4-15 minutes (ISO Standard 5833:2002).
1.8

Motivation and Research Overview
Tissue-engineered NP replacements are a promising solution that can address the immediate

mechanical needs of a damaged disc; however, clinical translation is hindered by a number of
factors. As the goal of tissue engineering repair is to minimize further injury to the degenerated or
herniated disc, delivery of the constructs must remain minimally invasive. Injectability, in situ
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formation and retention are necessary for any acellular or cell-laden biomaterial approach. CMC
has been methacrylated to form stable, chemically-crosslinked hydrogels that support growth of
NP cells (Reza and Nicoll 2010b; 2010a) and the differentiation of hMSCs towards an NP-like
phenotype when treated with TGF-β3 (Gupta, Cooper, and Nicoll 2011; Gupta and Nicoll 2014;
Lin et al. 2016). However, recent work has demonstrated that even when utilizing redox-initiated
crosslinking methods, methacrylated CMC does not gel in situ in the disc space due to diffusion
away from the injection site (Varma et al. 2018). Recently a dual-polymer network (DPN)
hydrogel consisting of methacrylated CMC and MC was investigated as a potential acellular NP
replacement. MC afforded the construct additional thermogelling capacity, which allowed for in
situ retention and restoration of disc height and mechanics, however, the effective polymer
concentration was too high to support encapsulated cell viability. To reduce the effective
macromer concentration while maintaining injectability and intradiscal retention, the overall
objective of this thesis was to identify a lower macromer concentration of a single polymer network
consisting of MC that would be retained in situ while serving as a potential cell scaffold. MC
hydrogels have been well characterized for their mechanical and material properties once
chemically crosslinked and for rheological properties during redox-initiated gelation (Gold et al.
2014; 2015), but the influence of this chemical modification on the intrinsic thermogelation of MC
is unclear. Therefore, the first objective of this thesis was to investigate the effect of methacrylation
on MC thermogelation and its role in the rheologic properties of a dual-crosslinked MC hydrogel
network. Although methylcellulose is a water-soluble cellulose derivative, its thermosensitive
nature is derived from the presence of hydrophobic methoxy groups on its backbone, which also
results in a lower swelling capacity than CMC. Incorporation of negatively charged sulfonate
groups to the polysaccharide backbone of MC would allow the polymer to mimic the charged
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proteoglycan-rich matrix of the NP, which can enhance the water uptake and swelling capacity
and potentially promote differentiation of stem cells towards an NP-like phenotype. Thus, the
second objective of this thesis was to develop a sulfonated MC hydrogel and characterize its
material properties relevant to NP replacement. Furthermore, matrix sulfation has been shown to
promote sequestration and presentation of growth factors. Clinical translation of a potential
injectable, cell-based scaffold material requires the ability to retain and deliver TGF-b3 (Purcell
et al. 2014; Lei, Trevino, and Temenoff 2016; Merceron et al. 2012). Accordingly, we also aimed
to characterize the sustained release or sequestration of encapsulated TGF-b3 from within these
scaffolds. Multiple studies have now shown CMC hydrogels successfully support NP-like
differentiation and matrix elaboration of hMSCs (Varma, DiNicolas, and Nicoll 2018; Lin et al.
2016; Gupta and Nicoll 2014; Gupta, Cooper, and Nicoll 2011); however, methacrylated MC
hydrogels have not been investigated as scaffolds for hMSCs. Thus, the final objective was to
characterize hMSC survival, differentiation, and matrix elaboration within dual-crosslinked MC
hydrogels. As matrix sulfation has been shown to be critical to the development of healthy skeletal
tissues, the effect of added sulfonation to the matrix was also investigated (Cho et al. 2004; Mertz
et al. 2012; Cortes, Baria, and Schwartz 2009; Klüppel et al. 2005).
The tissue engineering paradigm centers on three factors: scaffolds, signals, and cells;
previous studies have combined these in vitro using exogenous delivery of growth factors via cell
culture media. A clinically translatable tissue engineering solution would need to deliver all three
together, as exogenous growth factor is not clinically feasible. In addition, previous work in our
lab has shown promise for robust acellular in situ gelling biomaterials that aim to restore disc
mechanics, and for soft, cell-laden constructs that promote hMSC differentiation, but not materials
that achieve both desirable outcomes. As such, the global hypothesis of this thesis is that an MC-

53

based hydrogel system can be utilized as a thermogelling, injectable and in situ gelling system
capable of serving as a clinically translatable method of tissue engineering NP repair.
Specifically, chemical modifications of MC via controlled methacrylation percentage and
sulfonation may be employed to direct injectability and sequestration of soluble factors to
support hMSC differentiation towards an NP-like phenotype.
The specific aims to test this hypothesis are as follows:
Specific Aim 1: Investigate the influence of the degree of methacrylation modification
on thermogelation and rheological properties of MC.
MC polymer solutions will be modified with methacrylate groups resulting in varying
methacrylation percentages, and the rheological properties of methacrylated MC without redoxinitiated chemical crosslinking (thermogelation onset temperature, storage and loss modulus,
complex viscosity, phase angle, and shear thinning behavior) will be assessed in relation to varying
temperature, shear rate, and time. Storage and loss modulus upon completion of redox-initiated
chemical crosslinking and time to completion will also be investigated after gelation at room
temperature (20ºC) and physiologic temperature (37ºC) to assess the role of the thermoresponsive
behavior in chemically crosslinked hydrogel behavior, and to determine if gelation at physiologic
temperature results in a dual-crosslinked hydrogel.
Specific Aim 2: Develop sulfonated MC hydrogels for injectable NP replacement with
tunable swelling and mechanical properties, as well as a means for retaining incorporated
TGF-b3 to serve as a clinically relevant, tissue engineering scaffold.
Negatively charged monomers, 2-sulfoethyl methacrylate (2SEM), will be covalently
incorporated into MC hydrogels during free-radical polymerization. The effects of 2SEM
incorporation on bulk material properties (equilibrium swelling, mechanics) and long-term
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stability of acellular hydrogels will be assessed. Injectability will be evaluated by investigating
thermogelation and redox-initiated gelation of sulfonated gels via rheometry, and in situ gelation
will be assessed via injection into an ex vivo nucleotomized bovine motion segment model. The
electrostatic interaction of sulfonated MC hydrogels with proteins will be characterized by
quantifying serum protein adsorption, and more specifically, its ability to sequester incorporated
TGF-b3 over the course of two weeks via electrostatic affinity will be interrogated.
Specific Aim 3: Investigate the ability of redox-polymerized MC hydrogels (with and
without the addition of sulfonates) to support human mesenchymal stromal cell (hMSC)
differentiation towards an NP-like phenotype with TGF-b3 supplementation in cell culture
media or direct incorporation into hydrogel constructs.
Human MSCs will be encapsulated within MC hydrogels with and without sulfonates, and
survival and differentiation will be assessed in vitro. TGF-β3 will either be incorporated directly
into the hydrogels or supplemented exogenously via cell culture media to assess the impact of the
hydrogel sulfonation on the bioavailability of TGF-β3 to encapsulated hMSCs. Human MSC
viability and differentiation will be determined based on DNA content, ECM content (sGAGs and
Collagen type II) and distribution and construct mechanical properties over the duration of the
culture period.
Successful completion of the above Specific Aims will result in the development of a fully
self-contained, injectable system for tissue engineering repair of the injured or degenerate NP. This
thesis work will provide greater insight into the influence of chemical modifications (i.e.,
methacrylation, sulfonation) on the thermoresponsive behavior of MC and functional network
formation. Moreover, it will establish the feasibility of chemically-crosslinked MC hydrogels as
cell-instructive scaffolds for minimally invasive, clinically-relevant, tissue engineering therapies.
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1.9

Overview of Present Investigation
The global objective of this thesis is to engineer an injectable MC-based hydrogel system as

a functional NP replacement for both cell-based and acellular therapies for IVDD. Previous studies
have shown successful NP-like differentiation of encapsulated hMSCs but were unsuccessful in
forming gels directly in the disc, and the combination acellular cellulosic gel developed
subsequently (CMC-MC) was not permissive for hMSC encapsulation and differentiation. It was
found that the thermogelling capacity of MC combined with redox-initiated covalent crosslinking
is necessary for in situ gel formation. Even though we have seen that the thermogelling behavior
is preserved in methacrylated MC, the effect of methacrylate modification and percent
modification on the thermoresponsive behavior of MC has not been investigated. Additionally, we
have observed previously that methacrylation percentage surprisingly did not have a strong effect
on swelling and network properties (i.e., mesh size, crosslinking density) of MC, contradictory to
most polymer studies (including CMC), which showed increasing the availability of potential
crosslinking sites leads to increased crosslink formation and modified physical properties. This
motivated the more in depth rheometric investigation of MC at varying methacrylation
percentages. Thus, thermogelation onset temperature, thermoresponsive gelation and shear
thinning behavior at physiologic temperature, and redox-initiated crosslinking kinetics were
investigated for various methacrylation percentages and are presented in Chapter 2. This study
demonstrated that the addition of methacrylate groups lowers the thermogelation onset temperature
and increases the thermoresponsiveness of MC hydrogels, potentially affecting the injectability
and handling of MC solutions, but did not have a major additive effect on the complex modulus
of redox-polymerized gels at room temperature or physiologic temperature.
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Previous studies comparing CMC hydrogels to MC hydrogels favored CMC hydrogels
because of the higher swelling capacity afforded by the negatively charged carboxyl groups. An
additional translational challenge has been delivery of TGF-b3 within the hydrogel system. As
such, Chapter 3 aimed to address both issues by incorporating sulfonates into the MC hydrogel
system, with the goal of creating an in situ gelling GAG mimetic that increased MC swelling
capacity and sequestered incorporated TGF-b3 for delivery in a single hydrogel system. Sulfonated
MC hydrogels were investigated for injectability, swelling, mechanical behavior, long-term
stability, and cytocompatibility in a factorial design comparing three macromer concentrations
(2%, 3%, and 4%) and four sulfonate concentrations (0 mM, 1 mM, 5 mM, and 10 mM). Sulfonate
incorporation did not increase the water capacity of MC hydrogels but did sequester TGF-b3 in a
tunable fashion. In addition, ex vivo bovine motion segment models for injection and retention
showed that a minimum of 3% MC crosslinked with 10 mM APS and TEMED each was necessary
to form hydrogels in situ. Therefore, this formulation was used to investigate bioactivity and
capacity to support hMSC differentiation in Chapter 4.
The results of Chapter 3 demonstrated the successful creation of an in situ gelling, sulfonated
MC that sequestered TGF-b3 in a tunable fashion. We selected 5 mM sulfonate concentration, as
this afforded no significant difference in sequestration from 10 mM, both of which displayed the
strongest sequestration of encapsulated TGF-b3 over 2 weeks. Bone marrow-derived MSCs were
encapsulated in redox-polymerized MC hydrogels with and without sulfonates, and TGF-b3
delivery was administered either within the hydrogel or through media supplementation, and
growth factor-free conditions served as controls. Over 6 weeks of culture, the MSC-laden
constructs showed moderate matrix deposition, with clear superiority in the groups that were both
sulfonated and received TGF-b3 stimulation, regardless of delivery route. However, the measured
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values of ECM content did not approach reported native NP levels. Mechanical and swelling
properties did not change over time, indicating that MC remained resistant to hydrolytic
degradation as previous studies had shown. Cell viability decreased over time in all groups except
those with both sulfonate and TGF-b3 supplementation, indicating a potentially synergistic effect.
Overall, the study showed that sulfonation and encapsulated TGF-b3 delivery hold promise for
cellulose-based hydrogels for NP tissue engineering, but that the low swelling capacity and lack
of scaffold breakdown may have prevented robust matrix elaboration and cell survival, and that
further optimization is necessary to develop an in situ gelling cellulosic hydrogel that can repair
and replace the degenerating NP.
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Chapter 2: Rheological Analysis of the Effect of Methacrylation on
the Thermoresponsive Gelation of Methylcellulose in Aqueous
Solutions
The following chapter was presented in part at the American Chemical Society National
Meeting and Exposition (2020):

Haq-Siddiqi N.A., Nicoll, S.B. (2020). Effect of methacrylation on the thermoresponsive solgel transition of methylcellulose. (Poster Presentation) Paper No. CELL 71, American Chemical
Society

Spring

2020

National

Meeting

doi.org/10.1021/scimeetings.0c05990
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and

Exposition,

Philadelphia,

PA.

2.1

Introduction
Hydrogels are a broad class of biomaterials composed of highly hydrated polymer networks.

These materials have a wide array of biomedical applications, due to their tunability and water
content, from cell-laden tissue engineering scaffolds to cell-free prostheses and fillers (Peppas et
al. 2006; Sivashanmugam et al. 2015; Raucci et al. 2020). In situ forming injectable hydrogels are
increasingly necessary for a number of minimally invasive biomedical interventions, including
soft tissue fillers (Gold et al. 2015; Varma et al. 2014; Li et al. 2019; Falcone and Berg 2008),
orthopedic implants (Raucci et al. 2020; Lin et al. 2021), and drug delivery depots (Mathew et al.
2018). These biomaterials must have a low starting viscosity in order to be easily injected through
small gauge needles but must also exhibit an increase in viscosity upon injection in order to not
lose mechanical integrity or extravasate from the injection site. Physical, ionic, and covalent
crosslinking of polymeric biomaterials are all means by which an injectable material can form a
gel in situ in order to be retained at the site of injection. Physical crosslinking of polymers is
frequently mediated by environmental changes like temperature and pH. This is very useful in
biological applications, where the introduction of physiological temperature (37°C) or pH (7.4)
can direct the formation of gels. Physical crosslinks driven by environmental changes are also
reversible, as they are dependent on specific environmental stimuli, which may fluctuate.
Methylcellulose (MC) is one such polymer that exhibits temperature-dependent physical
crosslinking to produce thermoreversible hydrogels. MC is a water-soluble derivative of cellulose,
a naturally occurring plant-derived polysaccharide and the most abundant natural polymer on earth
(Klemm et al. 2005). Cellulose is a linear polymer made up of repeating β(1,4) linked D-glucose
units with three hydroxyl groups on each glucan ring, which allows for strong inter- and intrachain hydrogen bonding, resulting in a rigid crystalline structure and resistance to water solubility.
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Substitution of the hydroxyl groups on cellulose by methoxy groups in MC disrupts the crystalline
structure, thereby improving its affinity for water and enabling it to be dissolved in aqueous
solutions (Nasatto et al. 2015). The methoxy groups themselves are hydrophobic, and thus, while
the polymer chain is made water-soluble, the methoxy groups form aggregations as temperature
increases, resulting in a reversible, physically crosslinked hydrogel. Unmodified MC has been
reported to show a thermogelation onset temperature ranging from 50°C to 70°C, depending on
degree of substitution (DS) of cellulose hydroxyls by methoxy groups and weight % concentration
(Haque and Morris 1993; Lin Li 2002). The ability to form hydrophobic aggregates in response to
increasing temperature is dictated by the concentration of hydrophobic moieties. A DS of 1.7-1.9
out of 3 possible substitutions of methoxy groups for hydroxyls on cellulose has been shown to be
optimal for solubility and thermoresponsiveness; higher or lower than this limits the water
solubility of MC (Sarkar 1979). Other additions to MC such as hydrophobic stearyl groups and
hydrophilic carboxyl, amino, and acylamino modifications have been used to decrease and
increase the thermogelation temperature, respectively (Wu et al. 2021; Lee, Cho, and Park 2005;
Li et al. 2012).
Although MC readily forms thermoreversible hydrogels, the mechanical properties of the gels
are generally not sufficient to withstand the forces experienced in many biomedical applications
(i.e., movement, touch, load-bearing joints). As such, MC is frequently used as an additive in dual
polymer networks to provide thermogelling capacity, but not on its own as a primary scaffold
material (Gupta, Tator, and Shoichet 2006; Payne et al. 2017; Choi et al. 2020; Oğuz and Ege
2018; Jung, Kim, and Ho Park 2019; Mihardja et al. 2013). In order to enhance the mechanical
properties of MC, we previously coupled methacrylate groups to the MC backbone to allow for
free-radical

crosslinking

and

the

formation
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of

mechanically

stable

hydrogels

via

photopolymerization (Stalling, Akintoye, and Nicoll 2009). The injectability of methacrylated MC
(Ma-MC) hydrogels was later achieved by introducing redox initiators to form covalently
crosslinked hydrogels in situ (Gold et al. 2014; 2015). In that prior work, Ma-MC hydrogels were
formed in vitro using redox-initiated, free radical polymerization at room temperature, but the
influence of temperature on Ma-MC gelation, was not explored. Methacrylate groups are strongly
hydrophobic and have been shown to decrease the cloud point temperature of the cellulose
derivative, hydroxypropyl cellulose, in a manner proportional to the degree of methacrylate
substitution (Marsano, Bianchi, et al. 2000). Thus, it was hypothesized that methacrylation would
augment the hydrophobically-driven physical crosslinking of MC, thereby lowering the
thermogelation onset temperature and enhancing the chemical crosslinking of methacrylate
moieties, leading to more robust, dual-crosslinked hydrogels.
Numerous studies have also shown that the solvent constitution of the MC solution (i.e., water
versus saline) can alter the thermogelation temperature of MC (Zheng et al. 2004; Xu, Li, et al.
2004; Xu, Wang, et al. 2004). Ionic solutes in aqueous MC solutions can modify both the
temperature and strength of thermogelation by altering the water solubility of the polymer in
“salting-out” or “salting-in” effects, depending on the ion(s), in accordance with the Hofmeister
series (Xu, Wang, et al. 2004; Hofmeister 1888). The effect is tunable and can be seen to vary
depending on the mixture and concentration of ions, including those in physiologically relevant
solutions (Xu, Li, et al. 2004; Zheng et al. 2004). This is particularly relevant for MC hydrogels
containing cellulose nanocrystals, which require specific solvents (i.e., water) for complete
resuspension and dispersion in MC solutions (Hynninen et al. 2018). Therefore, in this study the
effect of methacrylate pendant groups on the thermoresponsive behavior of MC in water and saline
solutions, and the effect of gelation temperature on redox-initiated polymerization were
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characterized. This investigation has important implications for surgical implementation of the
injectable biomaterial, interrogating how the rate of thermogelation and strength of physical
crosslinks formed at physiologic temperature impact the efficiency of redox-initiated chemical
crosslinking.
2.2

Materials and Methods

2.2.1

Macromer Preparation

Methylcellulose was methacrylated by esterification of hydroxyl groups with methacrylic
anhydride (Sigma-Aldrich) according to previously described protocols (Figure 2.1) (Gold et al.
2014; Stalling, Akintoye, and Nicoll 2009; Varma et al. 2018). Briefly, 15kDa (15 cP viscosity at
2 wt%, 20°C) and 41kDa (400 cP viscosity at 2 wt%, 20°C) MC powder (Sigma-Aldrich, degree
of substitution of methoxy groups 1.8) was mixed 1:1 and then added to deionized H2O (diH2O)
at 1% (w/v) at 80°C until it was evenly disbursed, after which the temperature was lowered to 4°C
and allowed to continue to dissolve fully for ~24 hours. The mixture of low and medium viscosity
MC was used for optimal viscosity and handling, as previously described for injectable tissue
replacement applications (Varma et al. 2018; Lin et al. 2019). The solution was then reacted with
methacrylic anhydride with a molar excess of 20 at 4°C with periodic adjustments of pH between
8-9 for 48 hours. The reaction product was purified by dialysis (Spectra/Por, MWCO 6-8 kDa)
over 3 days to remove unreacted methacrylic anhydride. Purified solution was lyophilized and
stored at -20°C. Unmodified MC was treated in the same method as Ma-MC, by dissolving 1:1
low-medium viscosity MC and dialyzed and lyophilized but without reacting with methacrylic
anhydride.
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2.2.2

Nuclear Magnetic Resonance

Polymer samples were acid hydrolyzed as previously described for 1H NMR analysis (500
MHz, Varian Mercury 500) (Stalling, Akintoye, and Nicoll 2009; Reza and Nicoll 2010a). Percent
methacrylation was determined via relative integrations of methacrylate protons to carbohydrate
protons:
%&!"#$%& ⁄'!"#$%& )

% 𝑚𝑒𝑡ℎ𝑎𝑐𝑟𝑦𝑙𝑎𝑡𝑖𝑜𝑛 =

(&!' ⁄'!' )

× 100

𝐷𝑆, = % 𝑚𝑒𝑡ℎ𝑎𝑐𝑟𝑦𝑙𝑎𝑡𝑖𝑜𝑛 × 3

(2.1)
(2.2)

where AMethyl is the peak area of the protons (PMethyl = 3) in the methyl of the methacrylate group
and AMC is the peak area of the protons (PMC = 14) on the disaccharide subunit of MC, and degree
of methacrylate substitution (DSM) was determined based on a maximum DS of 3 (Gold et al.
2015).
2.2.3

Rheology

Methacrylated methylcellulose and unmodified methylcellulose (uMC) were dissolved in
either diH2O or Dulbecco’s Phosphate Buffered Saline (DPBS) at 3% w/v and stored at 4ºC until
use. All rheometric analyses were performed on an AR2000ex Rheometer (TA Instruments) with
a cone and plate geometry (2º, 20mm) under oscillatory conditions. Preliminary strain and
frequency sweep measurements on non-gelled methacrylated MC polymer solutions established
the optimal test parameters (1% strain, 1 Hz) based on the linear viscoelastic region (Gold et al.
2015; Varma et al. 2018). A solvent trap apparatus with diH2O was used to prevent sample
dehydration. Results were analyzed using the TA Data Analysis software (Advantage v.5.4.0).
Shear storage modulus (G’), shear loss modulus (G”), and phase angle (d) were measured against
temperature, time, and strain % (g) (Kim et al. 2016; Gold et al. 2015; 2014).
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Methacrylic Anhydride

Methylcellulose

Methacrylated Methylcellulose

48 h
4°C & pH 8

R1

R2
9.54% Methacrylation
(mMC9)

5.84% Methacrylation
(mMC5)

2.44% Methacrylation
(mMC2)

Unmodified MC
(uMC)

Figure 2.1: Reaction scheme of the esterification of methylcellulose with methacrylic anhydride,
and subsequent 1H- NMR spectra.

2.2.3.1 Determination of Thermogelation Onset Temperature
A temperature ramp was performed from 4ºC to 80ºC with a ramp rate of 1ºC/min to determine
the temperature of thermogelation onset. Onset temperature was measured using three different
methods (Figure 2.2) to account for the variation in methodology reflected in the literature (Li

65

2002; Arvidson et al. 2013; Knarr and Bayer 2014). Method 1 employed the most commonly used
definition of gelation onset as the point at which G’>G”, indicating the elastic component of the
complex modulus was dominant over the viscous component (Desbrières, Hirrien, and RossMurphy 2000; Winter and Chambon 1986; Payne et al. 2017; Caicco et al. 2013; Oğuz and Ege
2018). Method 2 defined thermogelation as the point at which the rate of increase in G’ was greater
than 2% for 4 or more consecutive points, used to determine the inflection point of G’ which
corresponds to a rapid increase in stiffness (Xu and Li 2005; Haque and Morris 1993; Tate et al.
2001; Xu, Li, et al. 2004; Almeida, Rakesh, and Zhao 2018). The final method defined
thermogelation onset by the local maximum of the first derivative of log(G’) with respect to
temperature, corresponding to the steepest slope in the curve of G’, indicating rapid gel formation
(Zheng et al. 2004; Li et al. 2002; Wang and Li 2005).
2.2.3.2

Strain Sweep and Timed Temperature Hold at Physiologic Temperature

The response to instantaneous increase in temperature, as is experienced during injection into
the body, was determined via time sweep at physiologic temperature, 37ºC. Polymer solution was
equilibrated at 4ºC for 5 minutes, after which the temperature was immediately raised to 37ºC and
held for 15 minutes (1 Hz, 1% strain). Logarithmic strain sweeps from 0% to 100% were performed
at 4ºC and 37ºC, before and after the timed temperature hold, respectively.
2.2.3.3

Strain Recovery

Recovery of the MC formulations after cyclic deformation was investigated by applying strain
and cyclically switching from low strain (0.2%) to high strain (500%) for 2 minutes each over the
course of 14 minutes, at 37ºC and 1 Hz throughout the experiment (Chen et al. 2017; Loebel et al.
2017).
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A

B

Figure 2.2: Methods of determining thermogelation temperature via rheometric analysis.
A) Log plot and B) standard plot of the same data set (G’ and G”) with three commonly used
methods for defining thermogelation onset marked accordingly. Method 1 uses the Winter-Chambon
criteria of G’>G” and equates the formation of a gel with thermogelation. Method 2 selects the point of
sharp increase in G’ (corresponding to an increase in G’ of greater than 2% for 4 consecutive points over
30 seconds). Method 3 displays the derivative of logG’ with respect to T, exhibiting a clear maximum at
the inflection point of logG’, where increase in G’ is at its maximum.

2.2.3.4 Thermogelation Effect on Redox-Initiated Crosslinking of Methacrylated MC
The influence of temperature during redox-initiated crosslinking of injectable MC hydrogels
was measured via time sweep. MC solutions were dissolved as previously described in in dualbarrel syringes, at a final concentration of 3% w/v (Gold et al. 2014). Redox initiators ammonium
persulfate (APS) (Sigma) and N,N,N,N-tetramethylethylenediamine (TEMED) (Sigma) were each
added in opposing sides of the dual-barrel syringe (Pac-Dent) at 10 mM final concentration for
free-radical polymerization. Mixing tips (1:1) were used to mix polymer precursors during ejection
onto the pre-warmed (20ºC or 37ºC) peltier plate. T=0 was defined as the point at which 10 mM
TEMED was added to the MC/10 mM APS solution. Gelation onset, determined by oscillation
time sweep, was identified at the point at which G’>G”. Gelation completion was established as
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the first time at which four consecutive data points exhibited less than a 2% change in the growth
of G’ (Gold et al. 2014; Temenoff et al. 2003).
2.2.4

Statistical Analysis

All analyses were performed in triplicate unless otherwise noted. Data are represented as mean
± standard deviation. A two-way ANOVA was used to determine the effect of methacrylation
percentage and solvent on thermogelation onset temperature, and the effect of methacrylation
percentage and temperature on the properties of redox-polymerized gels. A three-way ANOVA
was used to determine the effect of methacrylation percentage, solvent, and temperature on
rheological properties of thermally crosslinked gels. Significance was set at p<0.05.
2.3

Results

2.3.1
1

Structural Characterization
H-NMR confirmed the methacrylation of MC via the presence of methylene and methyl

protons of the methacrylate at d ≈ 6.1 and 5.7 ppm and d ≈1.9 ppm respectively, which are not
present on the unmodified MC (Figure 2.1). The broad stretch from ~2.8-4.6 ppm corresponding
to protons on the disaccharide MC subunit was integrated with respect to the methyl peak, and
relative methacrylation calculated based on the relative ratio of methyl protons (3) to disaccharide
protons (14).
Table 2.1: Methacrylation percentage and degree of methacrylate substitution
% Methacrylation
Degree of Substitution by Methacrylates
uMC
0%
0
mMC2
2.44%
0.07
mMC5
5.84%
0.18
mMC9
9.54%
0.29

2.3.2

Determination of Thermogelation Onset Temperature

Thermogelation curves of MC of varying methacrylation percentage from 4ºC to 80ºC
(Figure 2.3A) showed a wide range of moduli (G’, G”) as well as rates of increase (Figure 2.3C).
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The effect of methacrylation percentage on thermogelation onset temperature was significant
across all three methods of calculation, with gelation onset temperature decreasing with increasing
methacrylation percentage (Figure 2.3B). The effect of the solvent on thermogelation was only
statistically significant when measured by the first derivative of log(G’) or by the sharp increase
of G’; for thermogelation onset temperature measured by G’>G”, the effect of the solvent was not
considered significant. For mMC9, G’ was greater than G” from the onset of the experiment, and
therefore, onset temperature was calculated as 0ºC.
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Figure 2.3: Temperature-dependent gelation of MC formulations with increasing temperatures.
A) Representative temperature ramp curves of various Ma-MC (and unmodified MC) formulations
in H2O and PBS. B) Gelation onset temperatures as determined by differing mathematical criteria. C)
Determination of thermogelation rate and comparison of slopes. # — Significant difference between
solvents. * — Significantly different from all other methacrylation % within the same solvent. a,b,c,d,e,f
— Significantly different from other methacrylation % within the same solvent. Significance set at p <
0.05.
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2.3.3

Thermoresponsive Gelation at Physiologic Temperature

Strain sweeps were conducted at 4ºC and 37ºC to simulate the behavior of the polymer
solutions at refrigerated storage temperature and physiologic temperature, respectively.
Representative curves of each group are shown in Figure 2.4 for polymer solutions in H2O and
Figure 2.5 for polymer solutions in PBS. Quantitative values for each group were taken at 1%
strain (Figure 2.6). Strain sweeps at 4ºC showed that G” was consistently greater than G’ for
almost all methacrylation percentages, indicating the polymer solutions were more viscous than
elastic. Only mMC9 showed G’ as slightly greater than G’ until the yield strain was reached. This
was corroborated by the phase angle (d) which was near 90º for most groups at 4ºC, characteristic
of viscous fluid-like behavior, while mMC9 had a phase angle less than 45° in both solvents. At
37ºC, all groups had achieved “gelation” in that G’>G” from the onset of the strain sweep. Only
mMC9 exhibited G’ and |h*| significantly greater than groups of lower methacrylation percentage
at 4ºC (Figures 2.6A, B). At physiologic temperature, all groups underwent thermogelation as
shown by d less than 45º indicating more elastic than viscous behavior (Figure 2.6C). All samples
displayed d significantly lower than those at 4ºC. Despite this, uMC and mMC2 showed no
significant change in G’ or |h*| in either solvent, while mMC5 and mMC9 displayed significantly
higher G’ and |h*|, with solutions in PBS resulting in even stiffer/more viscous gels.
Physical crosslinks are reversible and can break under deformation and then reform when the
force is released. This can be observed by the decrease in G’ with increasing g (Figures 2.4 and
2.5). Yield strain (gyield) is typically described as the strain at which G’ becomes less than G”,
indicating the strain-dependent gel-sol transition (Shih, Shih, and Aksay 1999). Unmodified MC
mMC2 and mMC5 did not display yield according to this definition, although a decrease in G’ can
be observed between 1 and 10% strain. Yield strains were observed for uMC and mMC2 (H2O and
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PBS) at 37ºC (Figures 2.4 and 2.5, Table 2.2). mMC5 and mMC9 displayed strain stiffening
behavior rather than thinning as shown by an increase in both G’ and G”, which for mMC9 resulted
in rupture of the gel at high g, as shown by a sharp drop in both G’ and G” (Figures 2.4 and 2.5).
Table 2.2: Yield strain (gyield) from strain sweeps performed at 4°C and 37°C (1 Hz)
Yield Strain
4ºC gyield (%)
37ºC gyield (%)
H2O
—
15.25 ± 21.50
uMC
PBS
—
12.88 ± 6.38
H2O
—
18.64 ± 15.24
mMC2
PBS
—
14.84 ± 15.43
H2O
0.097 ± 0.12a
—
mMC5
PBS
—
—
H2O
5.51 ± 3.48a
—
mMC9
PBS
6.26 ± 0.82
—
a
– Significantly different from other yield strain within the same solvent. Significance set at p < 0.05.

Between strain sweeps, temperature was increased from 4ºC to 37ºC rapidly and held for 15
minutes to simulate the temperature change upon injection. Onset of gelation here was defined as
the time at which G’>G” (sol-gel transition) and completion of the thermogelling process at 37ºC
was defined as the point at which G’ increased by less than 2% for 4 or more consecutive points,
corresponding to a plateauing of the increase in G’. Thermogelation onset time ranged from 0:13
± 0:05 to 0:45 ± 0:22 minutes; thermogelation completion was achieved between 2:40 ± 0:20 and
6:09 ± 1:12 minutes (Table 2.3).
Table 2.3: Onset and completion times of thermogelation at 37°C (1%, 1 Hz).
Thermogelation Onset Time (min)
Thermogelation Completion Time
H2O
00:19 ± 00:22
03:25 ± 01:08
uMC
PBS
00:43 ± 00:04
02:55 ± 00:39
H2O
00:40 ± 00:42
03:12 ± 01:08
mMC2
PBS
00:36 ± 00:28
02:42 ± 01:26
H2O
00:28 ± 00:15
02:40 ± 00:20#
mMC5
PBS
00:45 ± 00:22
06:09 ± 01:12*
H2O
00:13 ± 00:05
03:00 ± 00:10
mMC9
PBS
00:17 ± 00:04
02:50 ± 00:04
*
- Significant difference from all other methacrylate percentages. # - Significant difference from PBS
with the same methacrylation % and temperature. Significance set at p < 0.05.
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Figure 2.4: Temperature-dependent gelation and strain behavior of MC formulations in H2O.
MC formulations were equilibrated at 4°C and then underwent a strain sweep, followed by an
immediate ramp up to 37°C that was held for 15 minutes, after which a subsequent strain sweep at 37°C
was conducted, displaying time, temperature, and deformation-dependent mechanical behavior of
physically crosslinked MC gels.
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Figure 2.5: Temperature-dependent gelation and strain behavior of MC formulations in PBS.
MC formulations were equilibrated at 4°C and then underwent a strain sweep, followed by an
immediate ramp up to 37°C that was held for 15 minutes, after which a subsequent strain sweep at 37°C
was conducted, displaying time, temperature, and deformation-dependent mechanical behavior of
physically crosslinked MC gels.
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Figure 2.6: Behavior of thermogelling MC solutions at storage and physiologic temperatures (1%
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2.3.4

Strain Recovery

The rapid breaking and recovery of physical crosslinks was demonstrated via cyclic strain
time sweep. Application of extremely high strain (500%) resulted in fluid-like behavior where
G’<G” and immediate removal of the high strain (strain % of ~0.2%) returned the MC solution to
a “gel” with G’>G” (Figure 2.7). Recovery at low strain included characteristic thixotropic
behavior, wherein a gradual increase in G’ is attributed to the time-dependent reordering of
hydrophobic aggregate crosslinks within the MC chains. The recovery profile for mMC9 in H2O
is shown in Figure 2.7 as a representative profile; all other groups showed similar results.
Strain Recovery (mMC9, H2O)
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Figure 2.7: Representative graph of gel recovery under cyclic strain.

2.3.5

Effect of Temperature on Redox-Initiated Crosslinking of Methacrylated MC

Gelation of methacrylated MC hydrogels with redox initiators APS and TEMED was
performed at 20ºC and 37ºC to compare the gelation kinetics and modulus of thermosensitive,
chemically crosslinked gels. Characteristic gelation curves (Figure 2.8A) showed a toe region
where chemical crosslinking and polymerization was not dominant within the gel system at 20ºC
that lasted an average of 3:39 ± 0:36 minutes across all methacrylated groups (not significantly
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different). This lag time was eliminated when gelation occurred at 37ºC. Gelation initiation time
was significantly different across all methacrylation percentages at 20ºC (Figure 2.8B), with
gelation onset occurring more rapidly with increasing methacrylation, ranging from 0:34 ± 00:06
to 04:37 ± 00:32 minutes for all methacrylated groups. With mMC9, gelation onset was nearly
instantaneous even at 20ºC, however, there was still a toe region. There was no significant
difference between gelation onset time for all groups at 37ºC, with G’>G” occurring at or prior to
the first recorded point, ranging from 26 ± 4 seconds to 42 ± 14 seconds. Unmethacrylated MC
was mixed with redox initiators and prepared exactly as the methacrylated MC to investigate any
effect the redox initiators might have on gelation characteristics of the unmodified polymer.
Unmodified MC did not achieve consistent gelation initiation at 20ºC, as G’ became equal to G”
at a few points but never crossed over. Gelation completion, defined as the point at which G’
increased by less than 2% for 4 or more consecutive points (Figure 2.8A, dotted red line) and
coinciding with a plateauing of the gelation reaction, was significantly different between 20ºC and
37ºC for all methacrylated MC, with an average difference of 5:33 ± 00:51 minutes between
temperatures.
Initial G’ ranged from 0.773 ± 0.271 to 16.416 ± 4.786 Pa and was significantly influenced
by both methacrylation percentage and temperature. Upon gelation completion, G’ was two orders
of magnitude greater in the methacrylated MC gels (1,046.63 ± 139.84 to 3,722.67 ± 474.21 Pa)
than uMC (0.842 ± 0.093 to 8.383 ± 6.169 Pa), due to the formation of chemical crosslinks by the
redox initiation of methacrylate crosslinking. Viscosity behaved similarly, with initial |h*| for
mMC9 higher than all other groups, although values were on the same order of magnitude for all
samples (under 5 Pa•s), and |h*| at completion ranging from 166.60 ± 22.30 to 592.5 ± 75.54 Pa•s.
G’ and |h*| were higher in all gels formed at 37ºC than those formed at 20ºC except for mMC9.
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Although gelation completion had been achieved as defined previously by the plateauing of G’,
gels continued to stiffen as the final remnants of free radicals and methacrylates reacted to form
crosslinks, and by the true end of the reaction, each methacrylated MC group was significantly
stiffer than at “completion.” Gels from mMC2 and mMC5 formed at 20ºC were no longer
significantly softer than those formed at 37ºC, as the reactions had essentially “caught up” with
those at 37ºC. However, while mMC9 gels also continued to increase in G’, the increase at 20ºC
was significantly higher than at 37ºC (Figure 2.9). The phase angles for all chemically crosslinked
gels were less than 1 (0.341º ± 0.065 to 0.856º ± 0.033) indicating the formation of strongly
crosslinked elastic solids, while uMC reached a d of 65.553º ± 8.095 at 20ºC and 20.190º ± 8.072
at 37ºC, consistent with a viscous fluid at room temperature and a weak elastic gel at physiologic
temperature.

77

G"

G’,G” (Pa)

100

10-1
5

10

15

104

103

103

103

102
101

100
10-1

0

5

10

10

5

10

15

0

20

mMC5 37°C

105

104

103

103

102
101

102
101

100

10-1

10-1

10-1

10

15

20

0

5

10

Time (min)

15

20

0

5

Time (min)

15

20

Initial |η*|

4

20°C

10

Time (min)

Initial G’

30

#

20

101

100

5

15

102

100

0

10

mMC9 37°C

105

104

20

5

Time (min)

103

*

#

37°C

*

*

25
#

20
#

*

3

*

4

|η*| (Pa•s)

6

G’ (Pa)

Time (min)

15

Time (min)

104

Gelation Onset Time

30

0

20

mMC2 37°C

Time (min)

B

15

G’,G” (Pa)

G’,G” (Pa)

G’,G” (Pa)

10-1

101

10-1

105

100

102

10-1

Time (min)

101

5

101
100

uMC 37°C

0

102

100

20

mMC9 20°C

105

104

Time (min)

102

mMC5 20°C

105

104

G’,G” (Pa)

G’,G” (Pa)

101

0

mMC2 20°C

105

G'

G’,G” (Pa)

uMC 20°C

102

G’,G” (Pa)

A

*

*

2

10

1
2

*
0

0

0
mMC2

mMC5

uMC

mMC9

Gelation Completion Time

15

#

mMC2

mMC5

G’ at Completion

6,000

G’ (Pa)

Time (min)

2,000

*
15
10

mMC9

uMC

mMC2

mMC5

mMC9

*

200

2

0

mMC5

*

*
*

#

400

*

4

*

5

0

#

600

*

*

*

mMC2

mMC9

#

800

*
*

#

*

uMC

mMC5

|η*| at Completion

1,000

#

4,000

5

mMC2

#

#
#

10

uMC

mMC9

|η*| (Pa•s)

uMC

*

0
uMC

mMC2

mMC5

mMC9

Figure 2.8: Free-radical polymerization of MC formulations with redox initiators APS and
TEMED (10 mM each) in PBS at room temperature (20ºC) versus physiologic temperature (37ºC).
A) Representative gelation curves over 20 minutes. B) Values measured from gelation curves for
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2.4

Discussion
Thermogelling hydrogels have immense utility in biomedical applications, as they take

advantage of the difference between ambient temperatures and physiologic temperatures to form
gels in situ, allowing minimally invasive delivery of therapeutics, drug depots and cell-laden
scaffolds. In order to achieve robust mechanical properties that withstand physiological stresses
and strains in situ, high macromer concentrations may be necessary, however, rendering
injectability more difficult, as increased macromer concentration even at low temperatures is often
accompanied by high viscosity. We have previously shown that MC, a thermogelling derivative
of cellulose, can be chemically modified with methacrylate groups to enable the formation of
stable, chemically crosslinked hydrogels via photopolymerization (Stalling, Akintoye, and Nicoll
2009). The use of redox initiators in a dual-barrel syringe system further enables injectability of
these chemically crosslinking gels, which have been characterized extensively for their material
properties including swelling, compressive mechanics, long-term stability, and cytocompatibility
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(Gold et al. 2014; 2015). Here, we investigated the influence of hydrophobic methacrylate
substitutions on the thermogelation of MC via rheometric analysis. It was found that the
combination of thermally mediated physical crosslinks and redox-initiated chemical crosslinks
influences the rate and efficiency of gel formation as well as the final gel strength in relation to the
percent methacrylation of MC. This has implications for ease of use in surgical implementation,
as well as tuning hydrogel formulations for a variety of indications.
Physiologic applications for thermogelling polymers require a threshold of 37ºC for onset of
gelation, above which a polymer solution is generally considered less than ideal for biomedical
applications, because it implies that the change in temperature upon injection would not elicit a
gelation response. There is, however, no consensus in the literature for determining the
temperature of thermogelation. Rheology has widely been used as a tool to measure the gelation
properties of MC. While other analytical methods like differential scanning calorimetry (Haque
and Morris 1993; Li et al. 2002) and turbidimetry (Arvidson et al. 2013; Zheng et al. 2004) have
also successfully been used to measure thermogelation onset temperature, rheology provides data
relevant to the physical behavior of the material, such as shear modulus, phase angle, and viscosity,
which are of particular interest in the characterization of an injectable material for clinical
applications. Within the available rheometric studies of thermogelling materials, numerous
definitions of thermogelation onset temperature have been used, making comparison across studies
difficult. The most common and traditional definition for gelation is point at which G’ becomes
greater than G”, indicating the elastic component of the modulus dominating over the viscous
component (Desbrières, Hirrien, and Ross-Murphy 2000; Winter and Chambon 1986; Payne et al.
2017; Caicco et al. 2013; Oğuz and Ege 2018; Almdal et al. 1993). This method works reasonably
well where the difference between G’ and G” grows rapidly, however, frequently there is no
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physical significance as both G’ and G” remain within an order of magnitude of each other for a
considerable range of temperature increase beyond that point, and the rapid increase in G’
indicative of molecular aggregation has not yet been reached (Figure 2.3B). This is particularly
evident at lower concentrations of MC. The temperature at which G’ exhibits a sharp increase has
also frequently been used as the definition of thermogelation onset, although there is no consensus
on a numerical method to identify it (Knarr and Bayer 2014; Xu and Li 2005; Haque and Morris
1993; Tate et al. 2001; Xu, Li, et al. 2004; Almeida, Rakesh, and Zhao 2018). Here, we have
proposed a method of defining the rapid increase in G’ by identifying the point at which G’
consistently increases by greater than 2% for 4 or more consecutive points (at a sampling rate of
6.5 s), thus resulting in a more physically relevant increase in G’. Zheng et al. (2004) have
previously showed that the first derivative of LogG’ with respect to temperature, T, is a reliable
mathematical method for rheologically determining the sol-gel transition of thermally gelling MC,
as it represents the highest rate of increase in G’. This has also been shown to correspond with the
endothermic peak in calorimetric measurements of MC thermogelation and the cloud point
measured by turbidimetry (Li 2002; Wang and Li 2005).
Temperature ramps of MC samples showed that “thermogelation onset temperature”
decreased with increasing methacrylation percentage across all methods of determination. The
derivative of LogG’ gave the most consistent results both with respect to the effect of saline
solution and the effect of methacrylation percentage on reduction of thermogelation temperature.
It was observed that due to the initial decrease in G’ at increasing temperatures of unmodified MC,
the >2% increase in G’ occurred at a much lower temperature than dLogG’. This initial decrease
in G’ with increasing temperature is characteristic of most liquids, and the disappearance of that
behavior from methacrylated MC samples is indicative of the increased intermolecular aggregation
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between macromolecular chains in the presence of methacrylate groups even at low temperatures.
The crossover point where G’ > G”, which is most commonly used as an indicator of gelation, was
shown to have the greatest variability between groups. Indeed, mMC9 and occasionally mMC5 in
PBS never displayed such a crossover, as G’ began higher than G” even at 4ºC. As the polymer
solution was able to flow and be extruded through a micropipette, the material had not formed a
strong gel despite meeting the technical definition of having achieved sol-gel transition, thus
supporting the conclusion that G’>G” is not a fully accurate physically descriptive criterion for
identifying thermoresponsive aggregation, particularly at low concentrations. Here, it can be
observed that between the three criteria, a given sample may or may not meet the threshold for
thermogelation at physiologic temperature: if dLogG’/dT is used, none of the samples achieve
thermogelation at 37ºC, however, the other criteria show that the thermal response does begin at
or below 37ºC. The Winter-Chambon criterion describes the point at which the elastic component
of the shear modulus becomes dominant over the viscous component, thus behaving in a more
“gel-like” manner. Nevertheless, this does not necessarily correlate with the thermal response of
the material, as some formulations displayed gel-like behavior at the lowest temperature recorded,
indicative of strong inter-chain bonds, but the rapid response of G’ to increasing temperatures did
not occur until later in the temperature sweep. As such, the thermoresponsive behavior of polymer
solutions and particularly thermogelation onset should be clearly regarded as distinct from the
Winter-Chambon criteria for the shift to more gel-like behavior of viscoelastic materials.
To examine the thermoresponsive behavior of MC in a physiologically relevant test, MC was
equilibrated at 4ºC and then the temperature was rapidly raised to 37ºC and held constant for 15
minutes, simulating the rapid increase in temperature from refrigerated storage to injection in vivo
and its development over time. Despite the fact that not all groups achieved a thermogelation onset
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temperature of 37ºC or less (according to any of the aforementioned definitions), all MC
formulations underwent some thermogelation when the temperature was raised to 37ºC (Figure
2.3). This indicates that the temperature-dependent gelation response of MC is not binary, in that
the solution can display thermoresponsive behavior below the “thermogelation onset temperature”.
All groups started at 4ºC with G’<G” and rapidly increased in G’, undergoing sol-gel transition
before plateauing. Thermogelation at 37ºC did not result in strong gels, however; across all groups,
G’ increased by only one order of magnitude, with the maximum storage modulus achieved by
mMC9 in PBS at 146.27 ± 8.29 Pa (Figures 2.4-2.6). These values are on the order of other
reported MC thermogels at 37ºC including those of higher macromer percentage, further exhibiting
that increasing methacrylate percentage increases hydrophobic interactions, thereby strengthening
the gels (Shin et al. 2020; Jung, Kim, and Ho Park 2019; Gupta, Tator, and Shoichet 2006; Caicco
et al. 2013; Stabenfeldt, Garcia, and LaPlaca 2006).
There was also a marked effect of solvent on the temperature-dependent, strain response of
the gels (Figures 2.4-2.6, Table 2.2). In both H2O and PBS, mMC9 formed very weak gels even
at 4ºC, which displayed shear thinning behavior. Interestingly, uMC and mMC2 gels exhibited
shear thinning behavior at 37ºC, while mMC5 and mMC9 did not. In H2O, mMC5 briefly yielded
and decreased in G’ at increased strain but then underwent strain stiffening and did not experience
a gel-sol transition, while in PBS, it did not yield at all and only displayed strain stiffening. In H2O,
very transient strain stiffening behavior in mMC9 was followed immediately by rupture of the gel;
there was no stiffening prior to rupture in PBS. The formulations that underwent true strain
yielding experienced it at moderate strain percentages (1.53 ± 2.64% to 12.88 ± 6.38%) whereas
the rupture of mMC9 occurred at much higher strains (21.22 ± 2.84% and 51.49 ± 9.178% in PBS
and H2O, respectively). As has been previously shown, PBS likely strengthened the hydrophobic
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interactions at the higher methacrylation percentages, rendering the gels more brittle, and for
mMC9, resulting in rupture at a lower strain percentage than in H2O (Thirumala, Gimble, and
Devireddy 2013; Zheng et al. 2004). Similar strain stiffening behavior is seen in many
biopolymers, including type I collagen, actin, and fibrin (Erk, Henderson, and Shull 2010; Motte
and Kaufman 2013).
Concern over whether strain stiffening could potentially make injectability more difficult for
an in situ polymerizing biomaterial motivated investigating the recovery behavior of the MC
thermogels. These tests showed that MC deformed and recovered under rapidly cycling changes
at high strains (Figure 2.7). The strain stiffening seen in the sweep experiments, in which a graded
increase in strain was applied, can be attributed to the gradual ordering of the polymer chains and
associated increases in chain alignment and polymer crystallinity. In contrast, the rapid recovery
at high cyclic strains likely did not allow for increased chain organization, with the material
retaining its amorphous structure.
Having shown the effect of methacrylates on the thermal response of physically crosslinked
gels, further studies focused on characterizing the influence of the thermal response on chemically
crosslinked gels. MC solutions were mixed with redox initiators APS and TEMED in dual-barrel
syringes and extruded via mixing tips onto the rheometer peltier plate at either 20ºC or 37ºC.
Unmodified MC was used as a control to assess the influence of the redox initiators on
thermogelation, as the absence of methacrylates prevents any chemical crosslinking from
occurring. As was expected, uMC did not undergo thermogelation at 20ºC in H2O but did undergo
thermogelation at 37ºC; there was no significant difference when compared to the behavior of
uMC in PBS as presented in Figure 2.5, suggesting that 10 mM concentrations of APS and
TEMED do not strongly influence the thermoresponsiveness of the base polymer (data not shown).
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Redox-initiated gelation resulted in shear moduli 1-2 orders of magnitude greater than physically
crosslinked gels alone, without raising the macromer concentration (Figure 2.8). Increasing the
macromer concentration increases viscosity, which would make injection of high macromer
concentration cellulosic solutions difficult for minimally invasive procedures using fine gauge
needles.
The ability to rapidly transition from a viscous fluid to an elastic solid at physiologic
temperature is a highly appealing feature that combines ease of delivery with structural stability.
It was shown that redox-initiated chemical gelation was accelerated at 37ºC versus 20ºC across all
methacrylated groups (Figure 2.8A). The toe region of the gelation curves observed at 20ºC
appear to indicate where physical interactions were dominating the reaction, as the MC polymer
chains intermixed and arranged in such a way that free radicals produced by the initiators had yet
to substantially crosslink the methacrylates at that point. Thermogelation onset temperature
measurements shown in Figure 2.4 demonstrated that the G’>G” point occurred prior to 20ºC for
mMC9 (< 4ºC) and mMC5 (5.20 ± 5.64ºC), and that for mMC2, 20ºC was within one standard
deviation of the mean (28.26 ±11.46ºC). The gelation onset time of redox-polymerized gels at
20ºC reflected that pattern, with the onset time for mMC2 > mMC5 > mMC9, confirming that the
methacrylate contribution to thermogelation plays a role even when redox initiators are present
(Figure 2.8B). At 37ºC, all formulations began gelation instantaneously, which could be a result
of both thermogelation onset at 37ºC (which occurred within 1 minute for nearly all formulations)
and heat-mediated acceleration of the redox-initiated chemical reaction. Once the redox reaction
began to dominate, there was no effect of the interplay between methacrylation percentage and
thermogelation on completion.
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Redox-polymerized gels increased in stiffness with increasing methacrylation percentage at
20ºC, which is not unexpected (assuming complete conversion of all available methacrylates
during crosslinking), as the theory of rubber elasticity states that hydrogel strength and stiffness
increase with increasing crosslinking density (Flory and Rehner 1943a). Interestingly, this pattern
was not evident at 37ºC, with mMC9 exhibiting lower G’ at completion than mMC5. Additionally,
by gelation completion, all groups except mMC9 achieved higher G’ at 37ºC vs 20ºC. Although
gelation was complete by the accepted definition of reaction completion (Temenoff et al. 2003;
Gold et al. 2014), gels continued to stiffen, and by the end of the reaction, there was no significant
difference in G’ between gels made at 20ºC and 37ºC for both mMC2 and mMC5 (Figure 2.9).
However, the difference between the moduli of gels formed at 20ºC and 37ºC for mMC9 persisted,
with the gels formed at 20ºC continuing to stiffen for an extended period. Not only was G’
significantly lower for mMC9 when gelation occurred at physiologic temperature, but it was also
found not to be significantly different from the two lower methacrylation percentages at the same
temperature. This disproves the hypothesis that thermogelation and redox-initiated gelation would
have an additive effect, resulting in stiffer gels. Moreover, it suggests that there is a point at which
temperature directed network structure formation at 37ºC prevents efficient or complete chemical
crosslinking reactions between methacrylate groups. While it is generally understood that chemical
crosslinks are much stronger than physical crosslinks, steric influences of physical crosslinking
can dictate how many chemical crosslinks are able to actually form. Phase separation and syneresis
may prevent mixing and penetration of free radicals produced by the redox initiators (Sarkar 1979;
Wu et al. 2021; Arvidson et al. 2013; Nasatto et al. 2015). While these effects appear to be
negligible in mMC2 and mMC5, the strength of the hydrophobic aggregate formation in mMC9
demonstrated by G’>G” (even at 4ºC), the lack of shear thinning behavior, and rupture during
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strain sweeps at 37ºC appears to be causing syneresis-driven inefficiency in free-radical
crosslinking at physiologic temperature. Morozova et al. (2019) have also shown that allylmodified MC hydrogels result in softer gels when chemically crosslinked at a higher temperature
versus low temperature, based on the permanent chemical crosslinking of the MC network/fibrils
formed by physical aggregation at higher temperatures.
As tunability is a highly desirable factor in biomaterial development, understanding the
interaction of the thermosensitive nature of MC and the reaction efficiency of redox-initiated
crosslinking will be important for predicting the behavior of these gels when injected and formed
in vivo. It is well established that macromer concentration, degree of methoxy substitution, and
solvent all influence the thermoresponsive behavior and rheo-mechanical properties of MC
solutions (Nasatto et al. 2015; Sarkar 1979). In addition, it was previously shown that chemically
crosslinked Ma-MC can produce highly tunable chemically crosslinked hydrogels for a variety of
applications (Stalling, Akintoye, and Nicoll 2009; Gold et al. 2014; 2015; Varma et al. 2018).
Here, it was demonstrated that increasing methacrylation percentage gave rise to increased interchain hydrophobic interactions, further resulting in lowered thermogelation onset temperature
(Figure 2.3) and stiffer physically crosslinked gels (Figure 2.6). Formulations with higher
methacrylation percentages (i.e., mMC5 and mMC9) showed very strong interchain interactions,
particularly in PBS, which was reflected by G’>G” at 4ºC (Figure 2.3B and Figure 2.5), as well
as strain stiffening behavior. These solutions exhibited significant increases in viscosity at 37°C
(relative to values at 4ºC) without the addition of redox-initiated crosslinking (Figure 2.6B). This
suggests that these specific formulations are less likely to rapidly migrate or diffuse from the
injection site. Further tuning of the methacrylation percentage and a wider range of strain
measurements would provide more in-depth information regarding control of the injectable
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system. Initial complex viscosity of all groups tested was on the lower end of commercially
available dermal fillers (i.e., Teosyal Meso, 0.942 Pa·s), while final viscosity for physically and
dual-crosslinked gels was comparable to medium and high viscosity commercial fillers (Belotoro
(32.9 Pa·s) and Restylane (532.4 Pa·s), respectively), all of which are injectable via 27-30 gauge
needles (Falcone and Berg 2009).
Previous studies in our lab have employed the use of “pre-gelling” redox-initiated crosslinked
systems by warming the dual-barrel syringe containing mMC and redox initiators to 37ºC prior to
injection (Varma et al. 2018). Anecdotal observation has shown that while the thermogelled system
remains injectable (as corroborated here by strain sweep and strain recovery), a large amount of
force is required to eject the pre-gelled solution, which can interfere with handling, particularly in
situations where careful volume control is necessary such as dermal fillers. In addition, the present
data indicate that at high methacrylation percentages, not only is injection of a pre-gelled solution
more difficult (due to strain stiffening), but it may also interfere with complete redox-initiated
crosslinking efficiency. Still, the increase in thermoresponsiveness of mMC at higher
methacrylation percentage is indicative of rapid in situ gelation that would likely resist
extravasation at physiologic temperatures and supports the use of pre-cooled solutions for
injectable applications.
Beyond injectable applications, dual-crosslinked injectable hydrogels show great potential for
3D printing and bioinks (Loebel et al. 2017). Similar dual-crosslinked MC hydrogels have recently
been formulated with tyramine-modified MC, which possess initial storage moduli (uncrosslinked)
on the same order of magnitude as mMC but require higher MC concentrations (8%) (Shin et al.
2020). These formulations resulted in softer thermogelled constructs (G’ ≈ 11 Pa) that maintained
fidelity of the printed shape when extruded at 37ºC, and were then able to be photocrosslinked and
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cured to form gels with moduli up to 250 Pa. As shown previously, mMC can successfully form
stable, biocompatible hydrogels via photo-initiated crosslinking (Stalling, Akintoye, and Nicoll
2009), resulting in much stiffer gels (3-8 kPa) at lower concentrations (2-4%), which holds promise
for future studies that might use cell-laden mMC as a bioink for 3D printing of tissues.
2.5

Conclusion
In this study, increasing methacrylation of MC was shown to increase intermolecular

attraction via hydrophobic interactions, which in turn decreases thermogelation onset temperature
and enhances the strength of the thermal response. Moreover, the methacrylate contribution to
MC thermogelation accelerates the redox-initiated crosslinking reaction and contributes to matrix
stiffening at physiologic temperatures. Nevertheless, there is a limit after which thermal
aggregation of hydrophobic groups prevents efficient chemical crosslinking due to phase
separation. This behavior is not only critical in assessing the injectability of potential
thermoresponsive, dual-crosslinking biomaterials, but also in predicting the in situ behavior of the
gels. Future studies will further characterize the molecular mechanisms and long-term mechanical
behavior of these dual-crosslinked hydrogels.
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Chapter 3: Injectable Sulfonated Methylcellulose Hydrogels with
Tunable Growth Factor Sequestration as Potential Nucleus
Pulposus Replacements
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3.1

Introduction
Degeneration of the intervertebral disc (IVD) has been implicated as a primary cause of lower

back and neck pain, which are responsible for 12-14% of all adult medical visits in the United
States (not counting physical therapy and chiropractic visits) (Bone and Joint Initiative USA 2015).
IVD degeneration is characterized as an aberrant, cell-mediated response to structural failure,
wherein diminished nutrient transport, cellular senescence, increased enzymatic activity, and
changes in matrix composition and hydration progressively and rapidly contribute to the
breakdown of the disc (Adams and Roughley 2006). The etiology of the disease is thought to
begin with the loss of hydration in the central nucleus pulposus (NP) region, which causes a
decrease in IVD height and increased loading on the circumferential annulus fibrosus (AF). This
leads to AF bulging, fissures, and potentially herniation of the NP through the AF, in addition to
vertebral changes such as endplate calcification and osteophyte development (Adams & Roughley,
2006). Symptomatic degeneration is associated with discogenic pain, which is caused by the
infiltration and subsequent stimulation of nociceptive nerve fibers in the AF, or by radiculopathy,
which results from compression of spinal nerve roots, inducing pain, numbness and tingling
throughout the lower back and legs (Peng 2013). Medical treatment for degenerative disc disease
is conservative and generally involves physical therapy, pharmaceutical pain management, or a
combination of the two, although these methods are purely palliative and do not address the
progressive degenerative state. Eventually late-stage degeneration can be treated surgically via
spinal fusion, however, this alters spinal loading further, and does not reduce the progression of
degeneration in adjacent IVD segments (Zhao et al. 2019; Natarajan and Andersson 2017).
Biomaterial replacement of the degenerate NP has been proposed in order to restore IVD
height and mechanical properties and to promote the biological repair of the injured tissue by
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directing cellular behavior within a biomaterial scaffold (Choi, Park, and Lee 2019; Stergar et al.
2019; Tendulkar et al. 2019; Pelletier et al. 2016; Goins et al. 2005). Hydrogels, water-swollen
polymeric matrices, are an ideal class of material for NP repair, as they resemble the highly
hydrated network properties of the native tissue (Peppas et al. 2006; Guan et al. 2017; D’Este,
Eglin, and Alini 2018; Bowles and Setton 2017). Several natural and synthetic hydrogels have
been shown to support NP-like matrix deposition by encapsulated NP cells and mesenchymal stem
cells (MSCs) (Tsaryk et al. 2014; Illien-Jünger et al. 2016; Thorpe et al. 2017; Wang et al. 2019;
Kumar et al. 2016; Gupta, Cooper, and Nicoll 2011). Recent clinical trials exploring such
hydrogels as acellular NP replacements or as cell delivery vehicles for NP regeneration have had
some success targeting patients exhibiting discogenic pain without disc bulging or herniation, and
with no more that 30% to 50% loss of disc height at the treatment level (Amirdelfan et al. 2021;
Ceylan et al. 2019).
Cellulose-derived scaffolds are a unique class of materials in that they are naturally-derived,
plant polysaccharides with similar structure to glycosaminoglycans (GAGs) that are the most
abundant dry constituent of the NP. Moreover, since they are not animal derived, cellulosic
materials are not susceptible to enzymatic degradation by the elevated levels of matrix
metalloproteinases that may be present in the injured and degenerate IVD (Sivan, Wachtel, and
Roughley 2014). Cellulose ethers such as methylcellulose (MC) and carboxymethylcellulose
(CMC) are water-soluble cellulose derivatives that have been FDA-approved for a number of
biomedical and food applications (Rohowsky et al. 2016). We have demonstrated previously that
methacrylation of both CMC and MC allows for the formation of stable, covalently crosslinked
hydrogels via free radical polymerization. The resulting gels exhibit a very mild foreign body
response and can be used for various clinical indications (Gold et al. 2015; 2014; Varma et al.
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2014; Stalling, Akintoye, and Nicoll 2009; Reza and Nicoll 2010a). In particular, photocrosslinked
hydrogels fabricated from methacrylated CMC (Ma-CMC) were investigated for NP tissue
engineering due to the negatively charged carboxyl groups on the CMC backbone, which
contribute to its high swelling capacity and similarity to the polyanionic sulfated GAG-rich
network of the native NP. These Ma-CMC-based hydrogels were shown to promote NP-like
matrix elaboration by encapsulated cells with exogenous delivery of transforming growth factorbeta 3 (TGF-b3) in vitro (Gupta, Cooper, and Nicoll 2011; Gupta and Nicoll 2015). In follow-up
studies employing redox polymerization to impart superior injectability and in situ gelation
properties (in contrast to photopolymerization systems) (Varma, DiNicolas, and Nicoll 2018), MaCMC was not retained within the high-pressure IVD space and extravasated before gelation
completion (Varma et al. 2018). In order to be an effective minimally invasive therapy, the
replacement material (with or without biologics or therapeutics) must remain localized at the
injection site and be delivered via a small gauge needle so as not to compromise the mechanics
and pressurization of the IVD (Elliott et al. 2008; Iatridis et al. 2013). MC has a unique
thermogelation capacity, which allows it to increase in viscosity at increasing temperatures (Sarkar
1979; Haque and Morris 1993). Here, we propose the use of a thermoresponsive, cellulosic
formulation that undergoes redox-initiated crosslinking within the IVD void space may provide
improved intradiscal retention in situ.
The degenerate NP is marked by extremely limited nutrient availability due to the diminished
concentration of sulfated GAGs, which drive the influx of nutrients and cytokines into the IVD (
Huang, Urban, and Luk 2014; Loibl et al. 2019; Ohnishi, Novais, and Risbud 2020; Walter et al.
2016). Artificial sulfation by the addition of negatively charged sulfate (SO42-) or sulfonate (SO3) groups directly onto a candidate biomaterial may be used to mimic the mechanism by which

93

growth factors and other proteins are localized by sulfated GAGs in native tissues (Zhu and
Marchant 2011; Censi et al. 2012; Belair, Le, and Murphy 2014; Wang and Von Recum 2011).
For example, heparin-based growth factor delivery systems have been investigated due to the
affinity of many growth factors such as bone morphogenetic proteins, basic fibroblast growth
factor, and TGF-β to heparin, thus enabling sustained release of the incorporated growth factor
(Liang and Kiick 2014; Jennifer Lei, Trevino, and Temenoff 2016; Park et al. 2012; Hettiaratchi
et al. 2014; Jeon et al. 2011). Interaction of growth factors with matrix macromolecules has also
been shown to enhance growth factor bioavailability, with some growth factors showing greater
resistance to proteolysis and thermal denaturation when bound to heparin or heparan sulfate (Ji et
al. 2009; Park et al. 2008). Previous work has demonstrated that exogenous transforming growth
factor-b3 (TGF-b3) supplementation supports the differentiation of encapsulated NP and bone
marrow-derived stromal cells in cellulosic hydrogels in vitro (Gupta, Cooper, and Nicoll 2011;
Gupta and Nicoll 2014; 2015; Lin et al. 2016; Varma, DiNicolas, and Nicoll 2018). However,
exogenous supplementation of growth factors in culture media is not translatable for an in situ
curing system. A viable therapy utilizing an injectable scaffold would need to deliver the signaling
factors by directly incorporating them into the biomaterial. Recently, polysaccharides such as
alginate (Freeman, Kedem, and Cohen 2008), hyaluronic acid (Feng et al., 2017; Purcell et al.,
2014), and cellulose (Portocarrero Huang et al. 2018; Arora, Mahajan, and Katti 2017; Waghmare
et al. 2018) have been artificially sulfated for affinity-based growth factor delivery, with promising
results, and suggest a similar approach may be employed with MC.
This study presents the characterization of an injectable, in situ-gelling NP replacement
biomaterial capable of growth factor sequestration. Specifically, hydrogels comprised of Ma-MC
macromers at low effective concentrations (2%, 3%, and 4%) were sulfonated with the addition of
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2-sulfoethyl methacrylate (2SEM), which can react with free methacrylate groups on Ma-MC
during redox-initiated, free radical polymerization (Figure 3.1). This method of sulfonation takes
advantage of the hydrogel polymerization reaction and negates the need for extra processing steps.
The addition of charged methacrylate monomers in the formulation may support serum protein
adsorption and enable growth factor sequestration but may also hinder the gelation process during
injection and formation via competition for pendant methacrylate groups. Therefore, the objectives
of this study were to assess the effects of sulfonate modification on the injectability, gelation,
functional material properties (i.e., mechanics, swelling), and TGF-β3 sequestration capability of
MC hydrogels as potential NP replacements.
3.2

Materials and Methods:

3.2.1

Methacrylation of Methylcellulose

Methacrylated methylcellulose (Ma-MC) was synthesized through esterification of hydroxyl
groups based on previously described protocols (Figure 3.1A) (Stalling, Akintoye, and Nicoll
2009; Gold et al. 2014). A 1:1 ratio of 15 kDa and 41 kDa MC (degree of substitution of methoxy
groups: ~1.5-1.9) (Sigma-Aldrich, St. Louis, MO) was dissolved at 1% (w/v) total macromer
concentration in deionized H2O (diH2O) and reacted with methacrylic anhydride (Sigma-Aldrich,
St. Louis, MO) in 20-fold excess (based on a theoretical 10% modification) for 48 hours at 4°C
with periodic adjustments of pH with NaOH to maintain a pH of 8.0 (Varma et al., 2018). The
combination of low and medium molecular weight MC was employed to balance the need for ease
of handling (i.e., mixing and injectability) with producing hydrogels of sufficient structural
integrity (Gold, 2017; Varma et al., 2018). The modified Ma-MC solution was purified of excess
methacrylic anhydride via dialysis using Spectra/Por 1 dialysis tubing (MWCO 6-8 kDa, Spectrum
Laboratories, Rancho Dominguez, CA) against deionized water for three days. During dialysis,
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membranes were changed once daily and diH2O changed twice daily to drive purification. Purified
Ma-MC was recovered via lyophilization, and stored at -20°C.

A

Methylcellulose

Methacrylic Anhydride

Methacrylated Methylcellulose

48 h
4°C & pH 8

B

Unmodified MC

Methacrylated MC

C

Methacrylated Methylcellulose (Ma-MC)

2-Sulfoethyl Methacrylate (2SEM)

TEMED

APS

Sulfonated Methylcellulose
(sMC) Hydrogel

x

y

z

1-x-y-z

y

Figure 3.1: Synthesis and characterization of sulfonated methylcellulose (sMC) hydrogels.
A) Methacrylation of MC and B) 1H-NMR spectra confirming methacrylate proton peaks. C)
Hydrogel fabrication via redox-initiated crosslinking. sMC hydrogels were fabricated with 1, 5, or 10 mM
2SEM, and MC alone hydrogels were fabricated identically, without the addition of 2SEM.
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3.2.2

Proton Nuclear Magnetic Resonance Spectroscopy (1H-NMR)

Purified Ma-MC was acid hydrolyzed and 1H-NMR (Varian 500 MHz, Agilent Technologies,
Santa Clara, CA) was conducted to verify and quantify the degree of methacrylation. The relative
integrations of methacrylate proton peaks (methylene, d=6.2 and 5.8 ppm; methyl peak, d=2.0
ppm) to protons on the methylcellulose backbone were used to determine the molar percentage of
methacrylation.
3.2.3

Hydrogel Fabrication

Hydrogel constructs were fabricated by mixing polymer precursor solutions in dual-barrel
syringes. Ma-MC was dissolved in Dulbecco’s phosphate-buffered saline (DPBS) (Gibco) at final
macromer concentrations of 2%, 3%, and 4% (w/v). Redox initiators ammonium persulfate (APS)
(Sigma) and tetramethylethylenediamine (TEMED) (Sigma) were added at 10 mM final
concentration each in opposing barrels of the syringe for free radical polymerization.
Sulfonation was achieved during polymerization through the addition of 2-sulfoethyl
methacrylate (2SEM) (Polysciences) at 0 mM, 1 mM, 5 mM, and 10 mM final concentrations
(Figure 3.1C). Mixing tips (1:1) were used to mix polymer precursors during ejection to create
hydrogels in custom casting devices; polymer was allowed to cure for 15 min at room temperature
to form cylindrical gels (5-mm diameter, 2-mm height).
3.2.4

Sulfonation Quantification

Hydrogel sulfonation was evaluated via 1,9-dimethylmethylene blue (DMMB) staining and
quantification (n=5). Gels were swollen overnight in DPBS at 37°C and then stained with DMMB
dye overnight. Unbound DMMB stain was removed by rinsing stained gels 2x in PBS. Gross
images of stained gels were captured using a stereomicroscope (Stemi 2000-C) with Zeiss
AxioVision software. Gels were then de-stained using a 4M Guanidine Hydrochloride (GuHCl)
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solution overnight at 37°C with gentle agitation. Desorbed stain was quantified via absorbance at
656 for relative sulfonation (Barbosa et al. 2003).
3.2.5

Mechanical Testing

Compressive mechanics were measured by unconfined compression testing of the hydrogels
on a custom apparatus as previously described (n=5) (Soltz and Ateshian 2000; Gold et al. 2014).
Hydrogels were formed in molds as described in 2.3 and stored at -20°C until testing. Gels were
thawed and equilibrated at room temperature in PBS for 2 hours prior to testing. The testing
protocol consisted of an initial creep test (tare load = 1 g) at a ramp speed of 10 µm/s held at 2700
s until equilibrium was reached (equilibrium criterion: <10 µm displacement in 10 min), which
was followed by a multi-ramp stress relaxation test, consisting of three 5% strain ramps with a
2000 s relaxation period between ramps (equilibrium criterion: <0.5 g change in 10 min.
Equilibrium Young’s modulus (EY) was determined as the slope of the equilibrium stress
(calculated at each ramp) versus applied strain curve. Peak stress (spk) and equilibrium stress (seq)
were calculated at the third ramp corresponding to 15% strain, and percent relaxation was
calculated by the formula
-
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3.2.6

(3.1)

Swelling Properties and Hydrogel Network Characterization
Equilibrium weight swelling ratio (Qw) was measured for all hydrogel formulations (2%, 3%,

4% w/v Ma-MC; 0, 1, 5, 10 mM 2SEM) (n=4). Freshly made hydrogels were swollen in PBS
overnight at 37°C. Gels were removed from PBS and blotted to remove excess liquid and then
placed in pre-weighed 1.5 mL microcentrifuge tubes. Wet weight, (Ws) was taken prior to freezing
at -80°C. Frozen gels were lyophilized and dry weight measured (Wd). Equilibrium weight swelling
ratio was calculated as:
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and volumetric swelling (Qv) was determined from the weight swelling ratio by
1

𝑄0 = 1 + E 1) (𝑄. − 1)H
+

(3.3)

where rp is the density of the dry polymer (0.276 g/cm3) (Leach et al. 2003; Marsano, Gagliardi,
et al. 2000), and rs is the density of the solvent (PBS = 1.01 g/cm3). The average molecular weight
J2 ) was calculated using a modified Flory-Rehner equation (Flory and Rehner
between crosslinks (𝑀
1943b; Mason et al. 2001; Gold et al. 2015; Leach et al. 2003):
𝑄03

⁄4

≅

6- 8
6
5,
7.

L9 − 𝜒N

(3.4)

where 𝜈̅ is the specific volume of the dry polymer, V1 is the molar volume of the solvent (PBS @
water 18.0 mol/cm3), and c is the Flory polymer-solvent interaction parameter (0.473) based on
the assumption that c for MC is comparable to that of other polysaccharides such as hyaluronic
acid and dextran due to similar chemical structures (Gold et al. 2014; 2015; Leach et al. 2003).
The Flory-Rehner model was then used to calculate effective crosslinking density, ne, and
mesh size, x, of the swollen hydrogels using the following equations:
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where R𝑟̅; 9 is the root-mean-square distance between crosslinks (Canal and Peppas 1989; Leach
et al. 2003; Lin et al. 2016). The root-mean-square end-to-end distance previously reported for
CMC (Cleland 1970) as
1
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was used as an approximation for MC, as the polymer backbones are nearly identical (Gold et al.
2014; 2015). Here n represents the degree of polymerization:
𝑛=

,/
,2

(3.8)

where Mn is the number average molecular weight of the polymer and Mo is the molecular weight
of the monomer unit (186.67 g/mol). In this study, a 1:1 ratio of 15 kDa and 41 kDa MC was used
in order to facilitate handling, so we have taken the average, 28 kDa, as the Mn for mesh
calculations, giving an average n of 150. The values calculated for ne, and x are considered
approximations due to the assumptions made in the Flory-Rehner calculations.
3.2.7

Gelation Properties

Rheometric analysis was conducted on 2%, 3% and 4% w/v Ma-MC using an AR2000ex
Rheometer (TA Instruments) equipped with a cone and plate geometry (2°, 20mm). Optimal test
parameters (1% strain, 1 Hz frequency) were selected via strain and frequency sweep
measurements on the base polymer solution (3% (w/v)) in DPBS.(Gold et al. 2015; D. M. Varma
et al. 2018; Gold et al. 2014) Storage modulus (G’), loss modulus (G”), complex viscosity (|h*|),
and dynamic shear modulus (|G*|) were measured for each test. Results were analyzed using TA
Data Analysis software (Advantage v5.4.0).
3.2.8

Thermogelation Onset Temperature

A temperature ramp from 4°C to 40°C (ramp rate: 1°C/min) was conducted to determine the
temperature of thermogelation onset of the polymer solution (n=3). Polymer solutions were
prepared without redox initiators in order to isolate the effect of temperature-sensitive physical
crosslinking of MC polymer. Thermogelation onset was defined as the temperature at which the
storage modulus (G’) increased greater than 2% for 4 or more consecutive points.
3.2.9

Redox-Initiated Gelation
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To assess gelation kinetics of the injectable, redox-polymerized system, a time sweep was
conducted on polymer samples with redox initiators APS and TEMED (10 mM each) mixed into
separate sides of 1:1 dual-barrel syringes (Pearson Dental Supply Co) (n=3). To simulate in vivo
injection, syringes were maintained at ~4°C and the polymer mixture was dispensed directly onto
the pre-heated Peltier plate at 37°C. Time zero was considered as the point at which the initiators
were mixed. Gelation onset, determined by oscillation measurement, was defined as the point at
which the elastic modulus (G’) and viscous modulus (G”) were equal, or G’/G” = 1 (Winter and
Chambon 1986). Gelation completion was defined as the first point at which four consecutive
values of G’ increased by less than 2% (Gold et al. 2014; Temenoff et al. 2003).
3.2.10 In Situ Gelation
Ma-MC and sMC (10 mM 2SEM) hydrogels were evaluated for their ability to gel and be
retained in situ in an ex vivo bovine motion segment model (n=3). Bovine coccygeal bone-discbone motion segments (cc1-2 and cc3-4) were harvested from healthy, skeletally mature bovine
tails acquired from a local abattoir (Lin et al. 2019; Varma et al. 2018; Likhitpanichkul et al. 2014).
Extraneous musculature and ligaments were removed with a scalpel, vertebrae were cut proximal
and distal to vertebral endplates, and facet and transverse processes were removed with a bone
band saw, after which motion segments were wrapped in PBS hydrated tissue to preserve hydration
and frozen at -20°C until future use. Segments were thawed at 37°C in PBS prior to use. Cruciate
incision was created posterolaterally with a #15 blade through the AF and nucleotomy was
performed by removing 0.15-0.20 g (~ 60%) of the NP tissue with a pituitary ronguer via the
incision.(Malhotra et al. 2012) Ma-MC (2%, 3%, and 4% w/v), redox initiators (APS and TEMED,
10mM each), and 2SEM (0 or 10mM) were prepared in dual-barrel syringes as previously
described. Trypan blue stain was added to aid in hydrogel visualization. Polymer solution and
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motion segments were warmed to 37°C and polymer solution was injected with a 20G needle into
the NP void space via the injury site. Initial gross gelation was assessed after incubation at 37°C
for 30 minutes (Varma et al., 2014).
3.2.11 In Vitro Stability
In vitro stability of sMC hydrogel constructs was determined by measuring the dry weight of
hydrogels over an 8-week period (n=3-4). 3% (w/v) MC hydrogels (0, 1, 5, and 10 mM 2SEM)
were fabricated in molds as described in 2.3. Samples were incubated in PBS at 37°C on an orbital
shaker for the duration of the experiment in order to mimic the temperature and fluid flow of the
native IVD environment. PBS buffer was changed 3 times weekly, and at 4 and 8 weeks, gels were
collected and lyophilized, and measured for dry weight (Varma et al. 2014; Lin et al. 2019; Gold
et al. 2015). In addition, stereomicrographs of the gels were captured at each timepoint for visual
assessment.
3.2.12 Cytocompatibility
Human dermal fibroblasts (hDFs) were encapsulated within MC and sMC hydrogels to assess
construct cytocompatibility. Hydrogels were prepared as described in section 2.3 with the addition
of hDFs in the prepolymer mixture. Lyophilized Ma-MC polymer was sterilized under germicidal
UV light for 30 min and dissolved in sterile PBS (3% (w/v)) (Lin et al. 2016). Redox initiators
APS and TEMED (10 mM each) and sulfonate monomer 2SEM (0, 1, 5, and 10 mM) were
prepared as previously described with the additional step of sterilization via syringe filtration (0.22
µm filter size) (Lin et al. 2019). Sterile polymer precursors were prepared in dual-barrel syringes
with the addition of hDFs at a final cell concentration of 4 x 106 cells/mL. Gels were formed as
detailed earlier and cultured for 5 days at 37°C and 5% CO2 in high glucose DMEM with 1%
Penicillin/Streptomycin and 10% fetal bovine serum (FBS). Fibroblasts were used as a general
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screen for cytocompatibility of sMC as the material can also be used for other applications (such
as soft tissue fillers) (Varma et al. 2018; Shin, Olsen, and Khademhosseini 2012).
Total DNA content was measured to assess cell proliferation on days 1 and 5. Gels were
frozen and lyophilized, homogenized and digested in pepsin based on previous protocols (Gupta,
Cooper, and Nicoll 2011). Briefly, lyophilized gels were digested in a pepsin (Sigma) solution in
0.05N acetic acid for 48 hrs. at 4°C, after which the solution was neutralized with 10x tris-buffered
saline. Samples were analyzed using the PicoGreen assay (Invitrogen, ThermoFisher Scientific,
USA) according to manufacturer’s protocol using calf thymus DNA (Sigma) as a standard, at an
excitation/emission of 480/520 nm on a BioTek Instruments plate reader (Synergy 4, Winooski,
VT, USA) (n=5). Cell viability was also assessed visually at 1 and 5 days of culture using the
Live/Dead assay kit (Invitrogen, ThermoFisher Scientific, USA), staining with calcein AM and
ethidium homodimer-1 (0.75 µM each) for live and dead cells, respectively (n=2).
3.2.13 Protein Adsorption
Freshly made hydrogel constructs (3% MC; 0, 1, 5, 10 mM 2SEM) were swollen in PBS for
1 hour and then incubated in sterile FBS at 37°C for 2 hours on an orbital shaker. Gels were rinsed
3x in PBS to remove non-adherent proteins. Gels were then placed in extraction buffer (1% SDS,
1 mM EDTA, and 10 mM Tris, pH 8.0) on an orbital shaker at 37°C for 1 hour. Release buffer
was analyzed using the Bicinchoninic Acid (BCA) protein assay (Pierce, Thermo Fisher Scientific)
according to the manufacturer’s protocol using bovine serum albumin (BSA) as a protein standard
for total protein content (n=4).
3.2.14 Growth Factor Release
Sequestration of TGF-b3 within sMC hydrogels was assessed by encapsulating growth factor
within hydrogels and measuring cumulative release over 14 days. Hydrogel precursors were
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prepared as described in section 2.3, with the addition of rhTGF-b3 (R&D Systems, Minneapolis,
MN). UV-sterilized Ma-MC polymer (3% w/v) was dissolved in sterile PBS and mixed with sterile
redox initiators (10 mM) and 2SEM (0, 1, 5, and 10 mM) in dual-barrel syringes. TGF-b3 was
added to the TEMED side of the dual-barrel syringe only for a final concentration of 2000 ng/mL
(~80 ng/gel), corresponding to the total amount of TGF-b3 that would be supplemented via cell
culture media for 2 weeks based on previous studies (M. S. Gupta and Nicoll 2015). Preliminary
studies showed that direct exposure to oxidizing agent APS denatures the TGF-b3 and reduces its
bioactivity rendering it undetectable via enzyme-linked immunosorbent assay (ELISA). Growth
factor-laden hydrogels were maintained in release buffer (sterile PBS with 1% BSA) for 2 weeks
at 37°C on an orbital shaker for the duration of the experiment. Release buffer was collected and
replaced at various time points and frozen at -20°C for future quantification. The DuoSet TGF-b3
ELISA (R&D systems) was used according to manufacturer’s instructions to quantify total growth
factor released (n=4).
Release behavior was characterized via the Korsmeyer-Peppas power-law model:
,#
,3

= 𝑘𝑡 @

(3.9)

where Mt/M∞ is the fractional release of the solute at time t, k is a constant representing structural
and geometric characteristics of the system, and n is the diffusional exponent indicative of the
release mechanism. Cylindrical gels used in this study had an aspect ratio of 2.5 (diameter/height),
and therefore, n was taken to be 0.43 based on modeling the system as a tablet exhibiting release
via Fickian diffusion (Ritger and Peppas 1987a). Swelling effects were assumed to be negligible
(swelling < 25% of the original volume) (Ritger and Peppas 1987b).
3.2.15 Statistics
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A two-way ANOVA was used to determine the effects of macromer concentration and 2SEM
concentration on hydrogel properties. One-way ANOVA was used to determine effects of
sulfonate concentration on protein adsorption. Two-way repeated measures ANOVA was used to
determine effects of sulfonate concentration and time on cumulative release of TGF-b3. Tukey’s
post-hoc tests were used in all cases to assess significance (p<0.05). Data represent mean ± SD.
3.3

Results

3.3.1

Spectroscopy and Methacrylation Quantification

The percentage of methacrylate substitutions via esterification of hydroxyl groups on the MC
backbone was found to be 5.25%, as determined by relative integrations of methacrylate proton
peaks to protons on the MC backbone (Figure 3.1B).
3.3.2

Sulfonation Quantification

Hydrogels were formed by crosslinking using redox initiators APS and TEMED (10 mM
each) and with the addition of 2SEM in the prepolymer mixture. Sulfonation of sMC formulations
was assessed qualitatively and quantitatively via DMMB stain. Hydrogels showed increasing
intensity of blue stain with increasing 2SEM concentration, with 0 mM 2SEM gels staining faintly
blue, 1 mM 2SEM gels staining a moderate blue, and 5 and 10 mM 2SEM gels staining deep indigo
for all macromer concentrations (Figure 3.2A). For all macromer percentages (2%, 3%, and 4%),
hydrogel sulfonation by inclusion of 2SEM during polymer crosslinking resulted in a dosedependent increase in DMMB staining intensity, as quantified by GuHCl destaining and
spectroscopic analysis (Figure 3.2B). DMMB staining was significantly higher in 5 and 10 mM
2SEM gels than 0 and 1mM gels at 3% and 4% macromer concentration, and significantly higher
in all 2SEM containing groups (1 mM, 5 mM, and 10 mM) at 2% macromer concentration. All
2SEM concentrations showed significantly higher sulfonation relative to gel weight in the 2%
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macromer concentration compared to the equivalent 2SEM concentrations in the other two
macromer concentrations.
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Figure 3.2: Quantification of sulfonation.
A) Relative quantification of DMMB staining exhibiting an increase in staining intensity with
increasing 2SEM (i.e., sulfonate) concentration. B) Stereomicrographs of DMMB stained hydrogels.
Scale bar represents ~5 mm. Significance set at p < 0.05 * — significantly different w.r.t. 0 mM 2SEM
within macromer concentration. # — significantly different w.r.t. same 2SEM concentration of different
macromer concentration.

3.3.3

Compressive Properties

Equilibrium mechanical properties were determined via unconfined compression. Constructs
with the highest macromer concentration (4% w/v) showed the highest EY (24.97 ± 6.79 to 31.60
± 3.80 kPa) (Figure 3.3A) as well as peak stress (speak) (Figure 3.3B) which were all significantly
higher than those of 2% and 3% w/v hydrogels. Percent relaxation was not significantly different
across all groups, averaging 46.00 ± 11.77%. Sulfonate concentration had no significant effect on
all measured mechanical properties.
3.3.4

Equilibrium Swelling and Hydrogel Mesh Characterization

Equilibrium weight swelling (Qw) was measured for all gels, and crosslinking density (ne) and
mesh size (x ) calculated from the acquired data using the Flory-Rehner model (Table 3.1). Qw
was significantly different across all macromer concentrations. The range of Qw was from 16.05 ±
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1.53 to 26.40 ± 0.61 with increasing macromer concentration resulting in decreasing swelling ratio.
Similarly, ne increased with macromer concentration, ranging from 4.75 x 10-5 ± 1.65 x 10-6 to 1.00
x 10-4 ± 1.36 x 10-5 mol/cm3, and x was inversely associated with macromer concentration, ranging
from 19.79 ± 1.89 to 33.07 ± 0.81 nm. Sulfonate concentration had no significant effect on the
swelling behavior or corresponding crosslinking density and mesh size.
A

40

B

*
*

*

15

*

30

20

*

*

σpk (kPa)

EY (kPa)

10

*

*

*a
*a

5

10

0

2% MC

3% MC

0 mM 2SEM

0

4% MC

1 mM 2SEM

2% MC

5 mM 2SEM

3% MC

4% MC

10 mM 2SEM

Figure 3.3 Equilibrium mechanical properties of MC and sMC hydrogels.
A) Equilibrium Young’s modulus, and B) peak stress, spk. Significance set at p<0.05 * —
significantly different from all other macromer concentrations of corresponding 2SEM concentration, # —
significantly different from corresponding 2SEM concentration w.r.t. 2% MC, a — significantly different
from each other.

Table 3.1: Swelling ratio and related physical properties of sulfonated MC hydrogels.
Macromer
2SEM
ne
x
Concentration Concentration
Qw
(mol/cm3)
(nm)
(w/v)
(mM)
0
22.82 ± 1.52
5.94x10-5 ± 5.76x10-6
28.37 ± 1.98
1
26.40 ± 0.61
4.75x10-5 ± 1.65x10-6
33.07 ± 0.81
2%
5
24.96 ± 1.34
5.18x10-5 ± 4.31x10-6
31.17 ± 1.75
10
24.88 ± 0.92
5.20x10-5 ± 2.87x10-6
31.06 ± 1.22
-5
-6 #
0
20.21 ± 1.50
7.12x10 ± 7.58x10
25.02 ± 1.93#
-5
-5
1
20.43 ± 2.68*
7.13x10 ± 1.41x10 *
25.31 ± 3.42*
3%
5
19.08 ± 1.29a#
7.74x10-5 ± 7.18x10-6#
23.58 ± 1.64#a
10
22.95 ± 0.76a
5.87x10-5 ± 2.93x10-6
28.54 ± 0.99a
-5
-5
0
16.69 ± 2.97*
9.74x10 ± 2.61x10 *
20.61 ± 3.68*
-5
-5
1
16.05 ± 1.53*
10.00x10 ± 1.36x10 *
19.79 ± 1.89*
4%
5
16.41 ± 1.13#
9.63x10-5 ± 9.18x10-6#
20.25 ± 1.40#
-5
-5
10
17.96 ± 2.41*
8.60x10 ± 1.68x10 *
22.19 ± 3.03*
Qw = equilibrium weight swelling ratio; ne = effective crosslinking density; x = hydrogel mesh size;
Significance set at p<0.05 a – significantly different from other sulfonate concentration within macromer
concentration * – significantly different from corresponding sulfonate concentration w.r.t. 2% MC
concentration # – significantly different from corresponding sulfonate concentration w.r.t. all other MC
concentration
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3.3.5

Gelation Properties

3.3.5.1 Thermogelation Onset Temperature
The effect of macromer and sulfonate concentration on thermal behavior of the prepolymer
mixture was measured via temperature ramp. Thermogelation onset temperature was defined as
the temperature at which G’ of the polymer solution (without chemical crosslinking agents)
increased by 2% or more for 4 or more consecutive points (Figure 3.4A, arrow indicates
thermogelation onset). This point more accurately identifies the sharp increase in G’ at the onset
of thermally induced physical crosslinking than when G’=G”, which occurs at much lower
temperatures where the rate of increase in G’ is still quite low (not shown). Thermogelation onset
occurred within the physiologic range (<37°C) for all concentrations tested, ranging from 24.6 ±
0.52°C to 34.23 ± 2.40°C (Figure 3.4B). All 2% MC formulations began to gel at a significantly
higher temperature than 3% and 4% gels. There was no significant effect on thermogelation due
to the addition of sulfonate groups to the polymer solution. G’ and |η*| were closely mirrored
throughout the temperature ramp as shown in the representative graph (Figure 3.4A).
3.3.5.2 Redox-Initiated Gelation
Redox polymerization of the prepolymer mixtures with the addition of redox initiators APS
and TEMED (10 mM each) was measured via time sweep. Time zero was defined as the moment
the MC/TEMED mixture was combined with the MC/APS mixture in the mixing tip of the dualbarrel syringe. Gelation onset, when G’ and G” were equal, occurred under 30 seconds for all
polymer solutions at 37°C (Figure 3.4C), followed by a sharp increase in G’. Gelation completion,
defined as the point at which increase in G’ was less than 2% for 4 or more points was achieved
between 4.22 ± 0.45 and 6.61 ± 1.46 minutes for all formulations (Table 3.2). As with the
thermogelation without initiators, |η*| was closely associated with G’ throughout the measured
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gelation time. Initial |η*| and |η*| at gelation completion were dependent on macromer
concentration; at both time points viscosity was significantly different based on the concentration
of MC. Similarly, upon gelation completion, |G*| increased with increasing macromer
concentration. The concentration of sulfonate monomer did not have a significant effect on the
|η*| or |G*| at either timepoint measured.
Table 3.2: Rheological properties of redox-polymerized sulfonated MC hydrogels.
Macromer
2SEM
Gelation
Initial |η*|
|η*| at Gelation
|G*| at Gelation
Concentration Concentration
Completion
(Pa·s)
Completion (Pa.s)
Completion (Pa)
(w/v)
(mM)
Time (min)
0
0.58 ± 0.39*
148.62 ± 104.4 *
993.93 ± 656.54*
5.07 ± 0.17
1
0.53 ± 0.39*
151.33 ± 61.83*
950.63 ± 388.42*
6.61 ± 1.46
2%
5
0.53 ± 0.23#
156.27 ± 5.40#
981.80 ± 33.82#
5.51 ± 0.46
10
0.81 ± 0.34#
145.47 ± 14.45*
913.80 ± 90.66*
5.58 ± 0.41
0
3.10 ± 0.52
564.70 ± 10.05*
3,548.00 ± 63.17*
5.39 ± 0.52
1
3.28 ±0.70*
480.63± 20.32*
3,019.67 ± 127.60*
5.80 ± 0.84
3%
5
2.47 ± 0.70#
387.77 ± 138.85#
2,436.33 ± 871.85#
6.37 ± 1.51
10
1.27 ± 0.44#
603.23 ± 118.87
3,790.00 ± 747.35*
5.20 ± 0.29
0
4.89 ± 1.97*
970.17 ± 81.76*
6,095.00 ± 513.36*
5.11 ± 0.58
1
6.60 ± 0.90*
1,172.33 ± 133.28*a
7,289.67 ± 755.74* a
4.86 ± 0.36
4%
5
5.42 ± 2.12*
952.87 ±138.85*
5,987.00 ± 2206.9*
5.59 ± 1.86
10
6.24 ± 1.70*
865.13 ± 40.78 a
5,435.67 ± 256.14* a
4.22 ± 0.45
|η*| = complex viscosity; |G*| = dynamic complex modulus; Significance set at p<0.05 * – significantly
different w.r.t. corresponding sulfonate concentration in all other macromer concentrations # –
Significantly different w.r.t. corresponding sulfonate concentration at 4% MC a – significantly different
from other sulfonate concentration within macromer concentration.

3.3.6

In Situ Gelation

MC formulations (2%, 3% and 4% w/v) with and without sulfonate (0 or 10 mM 2SEM) and
redox initiators were screened for their ability to form stable hydrogels in situ within the void space
of bovine IVD motion segments post-nucleotomy. Transverse dissection of the motion segments
after gelation was allowed to take place for 30 minutes at 37°C showed that 2% MC formulations
were not retained in situ (not shown), while 3% (Figure 3.4D) and 4% (not shown) formulations
with and without added sulfonates were both retained within the disc space.
Based on the material characterization data, 2% and 3% MC hydrogels exhibited a modulus
and swelling behavior that were closest to the native human NP (Cloyd et al. 2007; Reza and Nicoll
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2010b). The 3% and 4% MC formulations gelled in situ but 4% gels were stiffer than the target
tissue, so 3% MC was selected for further characterization.
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Figure 3.4: Gelation kinetics and in situ gelation.
A) Representative rheometric graph of uncrosslinked MC solution showing G’ and |η*| over a
temperature ramp from 4°C to 40°C. Arrow indicates point of thermogelation onset. B) Thermogelation
onset temperature of MC polymer solutions with 2SEM of varying concentrations. Red dashed line
indicates physiologic temperature, 37°C. C) Representative rheometric graph of redox-initiated gelation
behavior of Ma-MC with 10 mM redox initiators APS and TEMED and varying concentrations of 2SEM,
showing G’, G”, and |η*| over time. Red arrow indicates redox-initiated gelation onset, which occurs
nearly instantaneously before the first data point is collected. Dashed black line indicates redox-initiated
gelation completion. A,C) Representative graphs both show 3% MC, 10 mM 2SEM as examples. D)
Gross images of 3% MC hydrogels with 0 mM 2SEM (left) and 10 mM 2SEM (right) injected into the
void space of nucleotomized bovine caudal IVDs. Hydrogels are stained blue with trypan blue for
visualization. Significance set at p<0.05 * — significantly different from other macromer concentrations.

3.3.7

In Vitro Stability

Mass loss studies of 3% hydrogels with varying sulfonate content demonstrated that all
material formulations maintained their structure (Figure 3.5A) and dry weights (Figure 3.5B) over
8 weeks in aqueous solution in vitro.
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Figure 3.5: In vitro stability of 3% MC hydrogels of varying 2SEM concentration (0, 1, 5, 10 mM)
over 8 weeks.
A) Stereomicrographs of representative gels at 0, 4, and 8 weeks after initial casting. B) Dry weight
of gels showing no significant change in mass over 8 weeks. Significance set at p<0.05

3.3.8

Cytocompatibility

Human dermal fibroblasts were encapsulated within 3% w/v sMC hydrogels for 5 days as
model cells for characterizing scaffold cytocompatibility. PicoGreen analysis of encapsulated
hDFs showed a significant increase in cell DNA content between day 1 and day 5 (Figure 3.6A).
The inclusion of sulfonate monomers had no significant effect on fibroblast viability. Live/dead
staining (Figure 3.6B) confirmed cell survival with minimal cell death.
3.3.9

Protein Adsorption

3% MC gels were incubated for 2 hours in FBS, and adsorbed proteins were extracted and
quantified via BCA assay. Protein quantification showed significantly higher protein adsorption
on 5 mM and 10 mM 2SEM gels in comparison to 0 and 1 mM 2SEM gels (Figure 3.7A), with
protein deposition strongly correlating with sulfonate content (R2 = 0.9546).
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Figure 3.6: Cytocompatibility of 3% MC hydrogels with varying concentrations of 2SEM (0, 1, 5,
10 mM) with encapsulated human dermal fibroblasts (hDFs).
A) DNA content of hDFs cultured within hydrogels on day 1 and day 5, and B) representative
images of live/dead staining of encapsulated hDFs in MC only gels (top) and sMC gels prepared with 10
mM 2SEM (bottom). Significance set at p<0.05 * — significantly different from corresponding 2SEM
concentration w.r.t. day 1.

3.3.10 Growth Factor Release
TGF-b3 was incorporated within hydrogels during gel formation, and cumulative release
measured over 14 days. Release data showed a burst release of growth factor within the first 24
hours from all groups, likely due to initial swelling of the hydrogel. By 24 hours, the growth factor
released from all sulfonated groups was significantly less than the unsulfonated MC hydrogels
(Figure 3.7B). At the end of 2 weeks, the 0 mM 2SEM hydrogels released 52.6 ± 6.9% of the total
loaded growth factor (Figure 3.7C) while the 10 mM 2SEM gels released only 10.6 ± 3.9% of the
total growth factor loaded within the gels. There was no significant difference between the release
from 5 mM and 10 mM 2SEM gels for all time points beyond 24 hours. Because the total loaded
growth factor was not released from any of the constructs, fractional release was calculated as total
mass of TGF-b3 released normalized to the total average released from unsulfonated MC gels (0
mM 2SEM). Under the assumptions for the Korsmeyer-Peppas model, equation (3.9) is applicable
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for the first 60% of solute release. When plotted against tn where n = 0.43 for the given geometry
and aspect ratio of the system, the data for each system show a linear fit with strong R2 values,
indicative of Fickian diffusion (Figure 3.7D). The slopes of the lines, representing k and directly
proportional to the diffusion coefficient, were all significantly different, with the steepness of the
lines (i.e., absolute value of the slopes) inversely proportional to sulfonate concentration.
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Figure 3.7: Protein adsorption and TGF-b3 release from 3% MC hydrogels of varying sulfonate
concentration (0, 1, 5, and 10 mM 2SEM).
A) Serum protein adsorption on hydrogels after 2-hour incubation in sterile FBS as quantified by
BCA assay. B) Cumulative release profile of encapsulated rhTGF-b3 from hydrogels over the course of 2
weeks, as quantified by ELISA. C) Percent of total loaded growth factor released at the end of 2 weeks.
D) Korsmeyer-Peppas model of Fickian release from sMC gels. Significance set at p<0.05 * —
significantly different from all other sulfonate concentrations. # — significantly different w.r.t. 5 and 10
mM 2SEM.
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3.4

Discussion
Affinity-based sequestration of signaling molecules via sulfonation of biomaterials has the

potential to deliver soluble growth factors in the local vicinity of host and seeded cells to promote
sustained matrix elaboration. However, modification of NP replacement biomaterials for growth
factor sequestration has not been investigated. MC has previously been utilized in its
methacrylated, chemically-crosslinked form for soft tissue reconstruction applications due to its
tunable mechanics and resistance to enzymatic degradation in vivo (Stalling, Akintoye, and Nicoll
2009; Gold et al. 2014; 2015). Similarly crosslinked polyanionic Ma-CMC hydrogels have shown
promise as tissue engineering scaffolds for NP regeneration (Reza and Nicoll 2010b; 2010a;
Varma, DiNicolas, and Nicoll 2018), yet despite redox initiators rendering them injectable, the
lack of thermoresponsiveness resulted in incomplete retention in situ and extravasation from the
IVD void space. Therefore, a dual-polymer network (DPN) combining MC along with CMC was
investigated as a biomaterial for NP repair, combining the high swelling capacity of CMC with the
thermogelation feature of MC (Varma et al. 2018). The incorporation of MC was found to be
critical, as the thermogelation property allowed for a rapid increase in viscosity and improved
polymer retention upon injection into the intradiscal void space post nucleotomy (Lin et al. 2019;
Hom et al. 2019). The CMC-MC DPN system, while serving as a promising acellular repair
strategy, is not as favorable for cellular delivery due to its high effective macromer concentration
(6% (w/v)). Numerous studies have shown that increasing macromer concentration is deleterious
to cell proliferation and chondrogenic differentiation of encapsulated MSCs (Erickson et al. 2009;
Gupta and Nicoll 2014; Burdick et al. 2005; Panebianco et al. 2020). Thus, the present study aimed
to explore the effectiveness of sulfonated MC-based gels alone as injectable NP replacements, as
well as potential scaffolds for future cell-laden, tissue-engineered constructs. Sulfonates were
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added to increase hydration of the MC network and more closely mimic the sulfated GAG-rich
matrix of the native NP.
The facile method of sulfonation described here using 2SEM takes advantage of the
methacrylate modification present on the MC macromers to covalently bind sulfonates to the
polymer chains. Alternate techniques for sulfation and sulfonation of cellulosics and other
polysaccharides have been investigated, such as reaction of available hydroxyls with
chlorosulfonic acid, but require further processing, purification, and characterization (Portocarrero
Huang et al., 2017; Wang et al., 2007; Zeng, Groth, & Zhang, 2019). In addition, direct chemical
modification of the MC backbone with charged groups can potentially alter or disrupt the
mechanism of thermoresponsiveness, which relies on the aggregation of hydrophobic methoxy
groups at increasing temperatures (Sarkar 1979; Wu et al. 2021). Usage of sulfonated monomers
as detailed in this study allowed for reliable and controlled tuning of sulfonate content. The
coupling of the sulfonates occurs during the redox-initiated polymerization process to form the
hydrogels, utilizing some of the pendant methacrylates functionalized onto the MC backbone to
attach 2SEM. DMMB staining showed that sulfonates were successfully incorporated into the MC
gels and that staining intensity increased in a dose-dependent manner.
Mechanical and material properties of the sMC constructs were tested to investigate their
potential as NP replacement materials. Since the NP plays a critical role in spine mechanics, it is
necessary to recapitulate the physical behavior of the healthy native NP. Unconfined compression
testing was used to investigate the influence of added sulfonates and macromer concentration to
the elasticity of the Ma-MC hydrogels. The utilization of methacrylate monomers to couple
sulfonates via available methacrylate groups on the modified MC backbone potentially consumes
methacrylates that might be used for crosslinking, thereby altering hydrogel mechanics.
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Unconfined compression demonstrated that, as previously reported, EY may be tuned by varying
macromer concentration (Gold et al. 2014; 2015). Data also showed that the addition of 2SEM at
the concentrations tested did not have a statistically significant effect on the hydrogel elasticity.
Similarly, spk increased with increasing macromer concentration but was unaffected by the
incorporation of sulfonate monomers. EY of 2% gels measured between 3.99 ± 2.49 and 6.18 ±
1.64 kPa, within the range of the native human NP (~5 kPa), and all formulations studied exhibited
elasticity in the range of other injectable hydrogels under investigation for NP replacement (Cloyd
et al. 2007; Smith et al. 2014; Francisco et al. 2013; Kumar et al. 2014). EY values higher than that
of healthy native NP may be necessary to resist matrix breakdown within the degenerative
environment in vivo (Roughley 2004). In addition, our recent study using a similar redoxpolymerized cellulosic hydrogel system revealed that injection into the IVD void space results in
a lower EY in comparison to gelation in a casting device in vitro (16.62 ± 3.59 kPa in situ gelation
versus 34.27 ± 4.53 kPa in vitro) (Varma et al. 2018). This is likely due to the casting device being
rigid and constricted, in contrast to the soft tissue of the IVD void space, potentially resulting in
less efficient mixing and crosslinking, with free radicals lost due to reaction with ambient oxygen
in the air. With this in mind, the proposed material at the concentrations studied is well within the
range of the mechanical properties of the native human NP.
In addition to altering the compressive mechanical properties, the presence of sulfonates in
the MC gels has the potential to alter the swelling behavior of the materials. It was hypothesized
that negatively charged sulfonates would increase the attraction and influx of water molecules into
the hydrogel in a manner similar to sGAGs, which would potentially alter the swelling and
hydrostatic pressure within the gel network. NP hydration is regulated by the abundance of sGAGs
within the tissue, and the addition of sulfonates to MC was intended to replicate the chemistry and
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function of native sGAGs. Previous studies artificially sulfating polysaccharides have shown
increased water retention and swelling ratio in response to the added negative charge (Rother et
al. 2017; Liang et al. 2016; Purcell et al. 2014). However, equilibrium weight swelling
measurements on sulfonated MC constructs demonstrated that the addition of sulfonate groups had
no effect on the swelling behavior of the gels. This may be due to the dominating effect of
interchain covalent crosslinks between methacrylate groups, which stabilize the gel network and
prevent any further swelling caused by the anionic sulfonates attracting water. Interestingly, based
on the calculations of crosslinking density using a modified Flory-Rehner model, the addition of
the 2SEM monomers did not significantly affect the number of crosslinks formed, and thus, the
overall mesh size. This seems to indicate that at the concentrations of 2SEM and redox initiators
used in this study, the available methacrylate groups on the MC backbone are not fully saturated.
This may be a result of temperature-dependent formation of physical crosslinks via aggregation of
hydrophobic moieties within MC, which create rigid structural assemblies that only permit
interchain coupling reactions between methacrylate groups that are accessible and in close
proximity. Indeed, this phenomenon was also observed in the lack of significant differences in
swelling behavior and related network properties (i.e., crosslinking density and mesh size) between
redox-polymerized Ma-MC hydrogels of varying methacrylation percentage (Gold et al. 2014).
Conversely, increased methacrylation percentage did significantly affect swelling ratio and mesh
size in Ma-CMC hydrogels, suggesting that the process of redox-polymerized network formation
is influenced by the formation of hydrophobic aggregates within the MC polymer, a characteristic
which is not shared with CMC (Gold et al. 2014; Lin et al. 2016). This might indicate that within
redox-polymerized Ma-MC hydrogels, a number of unsaturated pendant methacrylate groups
remain available to react with methacrylate monomers such as 2SEM. The evidence that sulfonate

117

monomer concentration had no effect on swelling ratio, crosslinking density or mesh size is
consistent with the lack of 2SEM monomer concentration influence on MC hydrogel mechanical
properties. This is supported by the theory of rubber elasticity, which predicts a proportional
relationship between crosslinking density and hydrogel stiffness (Canal and Peppas 1989; Anseth,
Bowman, and Brannon-Peppas 1996).
One of the primary advantages of MC as a biomaterial is its thermoresponsive character.
Aqueous solutions of MC form thermoreversible hydrogels upon heating, due to the aggregation
of the hydrophobic methoxy groups at higher temperatures (Desbrières, Hirrien, and Ross-Murphy
2000; Haque and Morris 1993). As such, the influence of sulfonates on the temperature-sensitive
behavior of MC was characterized given that this is the first known study to functionalize MC with
charged moieties in this manner. The addition of other solutes, in particular ionic groups such as
sulfates, has previously been shown to alter the thermogelation point of MC (Xu, Li, et al. 2004;
Xu, Wang, et al. 2004). Xu and colleagues have shown that the sol-gel transition of MC can be
shifted to lower or higher temperatures based on the Hofmeister series, an order of ions ranked
based on how strongly they affect the hydrophobicity of a solute in water (Hofmeister 1888). In
this series, SO42- is one of the lowest of the kosmotropes, ions that enhance the hydrophobicity of
a solute or cause a “salt-out” response. This accelerates the sol-gel transition as temperature
increases, effectively lowering the onset temperature of thermogelation. They also showed that
this salt-assisted effect is concentration dependent. Therefore, 2SEM was added to Ma-MC, and
the thermoresponsiveness of the polymer solution was characterized via temperature ramp to
determine whether the presence of negatively charged sulfonated monomers in solution would
have a similar effect on the thermogelation properties of the MC hydrogel. Rheological properties
were measured from 4°C to 40°C, as this was the relevant temperature range to capture for a
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material stored in a standard 4°C refrigerator and injected into physiologic temperature.
Thermogelation onset temperature was defined as the temperature at which G’ increased for 2%
or more for at least 4 consecutive points. This measure was chosen as a true indicator of the
increase in viscosity caused by the aggregation of hydrophobic moieties on MC. The crossover
point of G’ and G”, where the elastic portion of the shear modulus G’ becomes dominant over the
viscous portion G”, is the classical definition of gelation onset in rheometry of viscoelastic
materials (Winter and Chambon 1986; Ferry 1980). However, in cases such as this where the
magnitude of the change is very low (under 10 Pa), the cross-over point is of limited physical
relevance, as the solution does not behave like a gel. In addition, the point of sharp increase in G’
has been shown to more closely correlate with the onset of the endothermic peak when thermal
capacity of MC solutions are measured using differential scanning calorimetry, indicating the
rapid, temperature-dependent aggregation of hydrophobic regions (Li 2002; Xu, Li, et al. 2004;
Zheng et al. 2004). The addition of sulfonated monomers had no significant effect on the
thermogelation of the Ma-MC base polymer, maintaining thermogelation onset temperature above
room temperature but below physiologic temperature (24.6°C ± 0.0°C to 34.23± 2.4°C), an ideal
characteristic for maintaining injectability. It should be noted that the polymer solutions used for
thermogelation experiments were dissolved in 1X PBS (as were all polymer solutions in this
study). The concentration of salts in PBS are an order of magnitude higher than the highest
concentration of 2SEM studied here (137 mM NaCl being the highest salt concentration), and may
likely dominate the thermogelation behavior of the solutions (Zheng et al. 2004).
Sulfonated MC hydrogel solutions were then assessed for injectability and gelation kinetics
in the context of a minimally invasive NP repair strategy. When redox initiators were added to the
polymer solution, gelation onset (G’/G” =1) at 37°C was nearly instantaneous, occurring under
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30 seconds from initial injection. Prepolymer solutions were maintained on ice prior to injection
onto the pre-warmed platform to simulate the instantaneous temperature change of injection into
the body. The thermogelation component of MC without the influence of initiators allows for rapid
aggregation of hydrophobic methoxy groups on the MC backbone; this in turn promotes more
rapid and efficient mixing and reaction between methacrylate groups when in the presence of redox
initiators. In contrast, pilot studies showed that the gelation time (initiation and completion) was
delayed by nearly 6 minutes when the same samples were measured at 20°C. Gelation completion,
defined as the point at which G’ increased less than 2% for 4 consecutive points (<0.3%
change/second), occurred between 4.22 ± 0.45 and 6.61 ± 1.46 minutes for all groups, within ISO
Standard 5833:2002 for injectable acrylic materials (4-15 min). The initial |η*| of all formulations
was on the order of 0.53 ± 0.23 to 6.60 ± 0.90 Pa·s, predicting ease of delivery through a fine gauge
needle (usually 18-20G). In comparison, |η*| of commonly used polysaccharide-based dermal
fillers range from 0.942 to 1,199.0 Pa·s, using even finer needles of 27-30 gauge (Falcone and
Berg 2009). By gelation completion, |η*| increased by two orders of magnitude over the initial
|η*|, indicating likelihood that the injectable material would resist extravasation. The dynamic
shear modulus |G*| also increased with increasing macromer concentration, with 4% Ma-MC gels
approaching the reported range of |G*| for non-degenerate human NP (~7.4 kPa), and all
concentrations were comparable to other injectable constructs under development (Iatridis et al.
1996; 1997; Chen et al. 2013; Frith et al. 2013).
The measured rheological parameters indicate that the sulfonated MC gel can be rapidly
injected and solidify within the time frame of a spinal microdiscectomy procedure and can
therefore be implemented within a clinical workflow. Still, rheometric analysis alone cannot
determine whether the injectable material will form and be retained within the void space. Previous
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work in our laboratory showed that CMC (2% w/v) with 10 mM redox initiators APS and TEMED
initiated gelation in under 90s (the first point of recorded data) and reached gelation completion at
~12 min with a corresponding complex shear modulus, G*, of ~758 Pa (Varma, DiNicolas, and
Nicoll 2018). When injected into bovine motion segments, even with higher macromer content
and initiator concentration (3% w/v, 20 mM initiators), CMC was not retained in situ and required
the addition of MC to provide the necessary thermogelation capacity and allow the hydrogel to
remain localized within the IVD at physiologic temperature (Varma et al. 2018). Therefore, in situ
injections were performed with Ma-MC and sMC (10 mM 2SEM) at all three macromer
concentrations (2%, 3% and 4%) in order to verify that rheometric results were translatable into a
clinically relevant ex vivo model. Pilot studies showed formulations at 2% were not retained in
situ, likely due to the low |η*| upon gelation completion (145.47 ± 14.45 to 156.27 ± 5.40),
however, 3% and 4% were both retained within the IVD space. To strike a balance between
mechanical properties, clinical translatability, and potential future use as cell delivery scaffold, 3%
Ma-MC constructs of varying sulfonate concentration were investigated in subsequent studies
(Panebianco et al. 2020).
Long-term structural integrity of NP replacement materials is important for maintaining IVD
mechanical function. Cellulose-based hydrogels are not susceptible to enzymatic degradation in
the human body, as humans do not produce the enzyme cellulase. This provides an advantage over
other constructs generated from animal-derived ECM components, particularly when considering
the degenerate IVD setting which exhibits higher levels of matrix-degrading enzymes (RodriguesPinto, Richardson, and Hoyland 2014). Previous studies have shown that Ma-MC hydrogels are
generally stable and resist degradation in aqueous environments, whereas Ma-CMC hydrogels lose
significant amounts of their dry weight over time under the same conditions (Gold et al. 2015;
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Varma et al. 2014). Here, Ma-MC-based hydrogels were found to retain their weight and structural
stability and were not significantly impacted by the incorporation of charged sulfonates over 8
weeks in an aqueous environment. This corroborates the swelling results, which showed
sulfonation did not increase hydration or swelling capacity of the construct, and thereby does not
increase susceptibility to hydrolytic degradation. Further study in a clinically relevant ex vivo
motion segment model or in vivo testing, which would incorporate mechanical and biochemical
cues, would be necessary to confirm long-term stability of the constructs (Lin et al. 2019).
Another concern for clinical translation is cytocompatibility. Ma-MC hydrogels have
exhibited robust cytocompatibility in vitro and elicit a minimal immune response in vivo in
subcutaneous rodent models (Stalling, Akintoye, and Nicoll 2009; Gold et al. 2014; 2015; Gold
2017). However, the incorporation of methacrylate monomers in the pre-gel solution adds a
potential source for cytotoxicity (Ansteinsson et al. 2013). As such, the survival of cells
encapsulated within sMC hydrogels was investigated. Human dermal fibroblasts were mixed
directly into the pre-polymer mixture, and thus, were exposed to unreacted 2SEM for a short
amount of time before gels were injected into molds and redox polymerization consumed the
methacrylate monomers. Dermal fibroblasts were used as a general screen for connective tissue
cytocompatibility as the sMC material holds potential for other clinical applications (i.e., soft
tissue reconstruction, dermal fillers, drug delivery vehicle), and as a comparison to our previous
studies with similar cellulosic gels (Varma et al. 2018; Gold et al. 2014; 2015). Studies were
conducted over 5 days in accordance with ISO standard 10993-5:2009 for biological evaluation of
medical devices, which stipulate that cytotoxicity assessments should be performed for 24-72
hours. Live/dead staining showed that there were negligible cells dead at either day 1 or day 5.
Moreover, PicoGreen DNA analysis revealed that there was no significant effect of sulfonate
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content on cell proliferation over the 5-day culture period. Further, proliferation of encapsulated
hDFs demonstrates the potential use of sMC hydrogels for cell encapsulation-based regenerative
therapies.
Aside from influencing the hydration of polymeric constructs, artificial sulfation has been
used as a method of protein attraction and sequestration. Electrostatic interactions between
positively-charged growth factors and negatively-charged sulfates and sulfonates have been
widely utilized as affinity binding methods for growth factor delivery for a variety of tissue
engineering applications, including cartilage repair, but to the best of our knowledge this is the
first study to utilize this method in IVD repair (Jeon et al. 2011; Freeman, Kedem, and Cohen
2008; Waghmare et al. 2018; Re’em et al. 2012; Purcell et al. 2014). Charged polymer scaffolds
can influence adsorption of proteins from the surrounding media, which can alter surface
chemistry, cell-material interactions, and immune responses in vivo (Lin et al. 2014; Freeman,
Kedem, and Cohen 2008; Hartvig et al. 2011; Hoven et al. 2007). Gels were incubated in FBS to
simulate early serum protein adsorption on an in vivo implant. Protein adsorption correlated with
sulfonate concentration (R2 = 0.9621), as MC gels modified with 5 and 10 mM 2SEM exhibited
significantly more adsorbed serum protein than samples polymerized with 0 and 1 mM 2SEM. In
the degenerate IVD, decreased nutrient transport mediated by changes in the cartilaginous
endplates and vertebral vasculature contribute to altered metabolism, which may be exacerbated
by the loss of hydration and osmotic pressure caused by matrix breakdown, and regenerative repair
strategies may require increased nutritional demand (Huang, Urban, and Luk 2014). The ability of
a charged scaffold such as sMC to attract and bind local proteins has the potential to increase
nutrient and cytokine bioavailability to drive endogenous repair.
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Sulfonation of MC hydrogels enabled the sequestration of growth factor encapsulated within
the hydrogels in a manner similar to its adsorption of serum proteins. TGF-b3 was incorporated
within the hydrogels during formation, and release was measured over the course of two weeks.
Previous studies have shown similar methods of growth factor sequestration of heparin-binding
proteins like TGF-b3, however, many do so by taking advantage of the ability of the pre-formed
charged material to absorb proteins into the hydrogel bulk (Waghmare et al. 2018; Portocarrero
Huang et al. 2017). For hydrogels that form in situ, such post-polymerization growth factor loading
is not possible. The pre-polymerized material must contain the growth factor, sequester it within
the forming hydrogel, and protect it from denaturation during polymerization and thereafter. This
may necessitate protection of the growth factor from polymerizing agents (McCall, Lin, and
Anseth 2011). In pilot studies of this project, exposure of TGF-b3 to APS, a powerful oxidizing
agent, denatures the growth factor and renders it unable to be detected by ELISA. Thus, TGF-b3
was mixed only into the TEMED containing barrel of the dual-barrel syringe system, to avoid
overexposure to APS.
TGF-b3 release over two weeks showed decreasing release rate with increasing concentration
of sulfonates. Varying the mesh size is a well-established method of controlling diffusivity of
proteins from within a hydrogel network, which scales relative to diffusivity in a pure solvent by
(1-Rh/x), where Rh is the Stokes radius of the protein and x network mesh size (Mason et al. 2001;
McCall, Lin, and Anseth 2011). Although the hydrodynamic diameter of TGF-b3 has not been
published, it can be approximated based on the molecular weight of its dimeric form (25.5 kDa)
in comparison to other proteins of similar weight, such as PDGF-BB (24.3 kDa, 7 nm), to have a
diameter of ~ 3.0 - 7.0 nm (Rehmann et al. 2017; McCall, Lin, and Anseth 2011). Given that there
was no statistically significant difference in mesh size calculated from swelling data for gels of the
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same macromer concentration regardless of sulfonate concentration (23.58 ± 1.64 to 28.54 ± 0.99
nm for 3% w/v MC gels), and that the calculated mesh size was much larger than the encapsulated
growth factor, it can be inferred that any changes in the release profile of TGF-b3 were due to
chemical differences in the hydrogel composition and not to structural differences in the hydrogel
mesh network (Amsden 1998). This suggests that sulfonated MC hydrogels interact with the
encapsulated growth factor via electrostatic affinity, retarding the overall diffusive release and
sequestering growth factor within the construct, similar to the mechanism by which growth factors
are sequestered within sGAG rich tissues. Affinity-controlled release from hydrogels is driven by
the reversible association (kon) and dissociation (koff) rates between affinity binding groups
(Hettiaratchi and Shoichet 2019). In this study, the affinity-binding moiety 2SEM was the same
between groups, thus it can be surmised that the association/dissociation constants did not change.
Instead, the increasing concentration of 2SEM increased the number of binding sites, promoting
the rapid re-association of TGF-b3 with the hydrogel network, thus limiting the diffusion of
dissociated TGF-b3 outside of the hydrogel (Vo and Meere 2013). Indeed, modulation of sulfation
concentration in heparin-based microparticles has been shown to tune protein release from 5% to
60% (Tellier et al. 2015).
The ability to sequester cationic proteins such as TGF-b3 suggests sulfonated MC hydrogels
may be well suited as scaffolds for cell-based therapies to improve growth factor bioavailability
to encapsulated cells. The amount of TGF-b3 loaded into the hydrogels was calculated based on
the total growth factor that is delivered exogenously to encapsulated cells via cell culture media
(at a concentration of 10 ng/mL) over the course of 2 weeks. Previous studies have shown that
spatiotemporal control of TGF-b3 stimulation is critical for both chondrogenic and NP-like
differentiation of cells in vivo (Martin et al. 2017; Gupta and Nicoll 2015; Huang et al. 2009). The
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precise dosing of sequestered TGF-b3 for direct or extended stimulation of MSCs varies in the
literature and will require titration studies; however, the present investigation shows that growth
factor concentration within the hydrogel system and release rate can be easily tuned by adjusting
sulfonate concentration.
3.5

Conclusions
The results presented here demonstrate the successful fabrication of injectable, sulfonated MC

hydrogels, which form and are retained in situ in a bovine nucleotomy model. The addition of
sulfonates had no significant impact on gelation or mechanical properties, resulting in a sulfonated
biopolymer scaffold with tunable properties relevant to NP replacement. The materials were not
cytotoxic and supported cell proliferation. Moreover, the sulfonated MC hydrogels displayed
affinity for adsorbed serum proteins and encapsulated growth factor, which was proportional to
the concentration of sulfonate incorporated into the constructs. Taken together, these results show
that sMC hydrogels are a promising scaffold material for nucleus pulposus repair. Future studies
will investigate the utility of the sulfonated scaffolds for cell-based, NP tissue engineering
strategies.
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4.1

Introduction
Low back and neck pain continue to be among the leading causes of disability, with up to

80% of the world’s adult population affected by it in their lifetime (Tamrakar et al. 2021). This
has enormous social and economic repercussions, with low back and neck pain ranking as the most
expensive health conditions in the United States, resulting in $134.5 billion in healthcare spending
in 2016 alone (Dieleman et al. 2020). The prevalence of low back pain has increased by over 50%
between 1990 and 2015, and with continually aging populations, both the number of sufferers and
economic cost is only set to grow (Hartvigsen et al. 2018). A large majority of this disability is
caused by degeneration and injury to the intervertebral disc (IVD), the complex fibrocartilaginous
tissue situated between the vertebral bones of the spine (Peng 2013). Degeneration of the IVD
results in loss of disc height, limited mobility, and often discogenic pain associated with ingrowth
of nerves into the IVD, or impingement of spinal nerve roots, causing radiculopathy (Peng 2013).
IVD degeneration is understood to begin in the central nucleus pulposus (NP) region of the
disc. Aberrant cellular responses to loading lead to matrix breakdown, decreased transport of
nutrients and metabolites, and cellular senescence (Zhao et al. 2007). In particular, increased
catabolism and breakdown of the negatively charged proteoglycans that maintain the high water
content of the NP causes a reduction in hydrostatic pressure and the ability of the NP to resist
compressive loads (Sivan, Wachtel, and Roughley 2014). This shifts stress to the outer lamellar
portion of the IVD, the annulus fibrosus (AF) (Adams, McNally, and Dolan 1996), leading to
further IVD degeneration and injury such as bulging, fissures, and potential herniation of the NP
through the AF (Galbusera et al. 2014). Because the IVD is generally avascular, with low
cellularity, it has very little ability for self-repair. Nutrient supply in the healthy adult IVD is
limited mainly to diffusion via the cartilaginous endplates (CEP) that sandwich the disc, which
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receive blood supply from adjacent vertebral bones. This becomes further limited by the
compounding effects of aging and degeneration, which include endplate calcification as well as
regression and occlusion of the vessels originating in the vertebral bones (Huang, Urban, & Luk,
2014). Although prevalence of symptomatic IVD degeneration continues to rise, therapeutic
options have largely not improved. Current treatments largely involve palliative care and pain
management, ranging from over-the-counter pain relief to steroidal injections and physical
therapy; however, these treatments address pain and not the underlying issue, allowing the
degenerative cascade to progress (Zhao et al., 2019).
Tissue engineering strategies incorporating cells, materials and biological signaling molecules
have been explored to restore mechanical function of the IVD and to reverse the existing tissue
damage (Bowles and Setton 2017; Hudson et al. 2013; Tendulkar et al. 2019). In particular, NP
replacements have been investigated as interventions for early-stage degeneration to prevent
further disease progression and the development of more serious injuries (i.e., herniation).
Hydrogels are a class of polymeric scaffold that are ideal for NP tissue engineering, as they mimic
the highly hydrated network of the native NP (Gupta, Cooper, and Nicoll 2011; Halloran et al.
2008; Showalter et al. 2015; Tsaryk et al. 2015; Alinejad et al. 2019; Iatridis et al. 2013; Lewis
2012). Many studies have investigated stem cell-laden hydrogels for NP regeneration, however,
the vast majority of tissue engineering studies are validated first in vitro wherein the constructs
receive nutrients and differentiation cues from cell culture media, which is not readily translatable
to the clinical setting (Risbud et al. 2004; Steck et al. 2005; Kregar Velikonja et al. 2014; Sakai
and Andersson 2015). For example, previous reports have shown promising results with cellulosic
hydrogels as scaffolds for mesenchymal stromal cells (MSCs) that differentiate towards NP-like
phenotypes and elaborate NP-like matrix components (Varma, DiNicolas, and Nicoll 2018; Lin et
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al. 2016; Gupta and Nicoll 2015; 2014). These studies required exogenous delivery of the growth
factor, transforming growth factor-b3 (TGF-b3), a cytokine which is critical for differentiation of
chondrogenic tissues such as cartilage and NP (Chen et al. 2019; Mackay et al. 1998; Madry et al.
2014). Hydrogels, while excellent carriers for cell encapsulation, frequently exhibit burst release
of such soluble factors loaded within them, due to the influx of water into the polymer network
(Lin and Metters 2006; Brazel and Peppas 2000; Ritger and Peppas 1987a; 1987b). To drive
clinical translation, growth factors must be retained within the construct long enough to stimulate
cell differentiation. Studies have shown that transient TGF-b stimulation is sufficient to initiate
chondrogenic differentiation from MSCs, thus a system that maintains growth factor concentration
within the vicinity of encapsulated cells long enough to initiate differentiation is desirable (Huang
et al. 2009; Gupta and Nicoll 2015; Kim et al. 2012).
Recently, we developed and characterized an injectable, in situ forming sulfonated
methylcellulose (sMC) hydrogel that sequesters encapsulated TGF-b3 (Chapter 3).
Methylcellulose (MC) is a thermoresponsive, water-soluble derivative of cellulose, the most
abundant polysaccharide on earth. The addition of sulfonates to the polysaccharide backbone of
MC mimics the structure of the sulfated glycosaminoglycans (sGAGs) that comprise the matrix of
the healthy NP. In addition to facilitating tissue hydration, part of the essential function of sGAGs
is acting as depots for growth factors, extending their bioavailability and functionality via
electrostatic interactions between cationic growth factors and anionic sulfates (Soares Da Costa,
Reis, and Pashkuleva 2017). Similarly, the sMC hydrogels electrostatically sequester loaded
growth factor over the course of 2 weeks of in vitro culture. The release rate of loaded TGF-b3
can be tuned by controlling the concentration of sulfonates added to the MC scaffold. Moreover,
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the resultant scaffold delivers growth factor directly incorporated into the pre-gelled polymer
solution, which can be injected via fine-gauge needle and form stable hydrogels in situ.
The present study aimed to investigate the ability of this growth factor-sequestering hydrogel
system to support MSC growth and differentiation towards the NP-cell phenotype. Bone marrowderived MSCs were thus encapsulated within the sMC hydrogels and evaluated for functional NPlike differentiation by quantifying characteristic matrix elaboration (type II collagen and sGAGs)
and the development of functional construct material and mechanical properties over time. The
potential for the sMC scaffold to drive differentiation in the absence of growth factor was also
investigated in order to evaluate the influence of charged sulfonates on MSC differentiation, as
matrix sulfation has been shown to be critical for the development of healthy skeletal tissues
(Cortes, Baria, and Schwartz 2009; Mertz et al. 2012; Paganini et al. 2020). We hypothesized that
the combination of matrix sulfonation and stimulation by sequestered TGF-b3 would support
functional NP-like differentiation and matrix elaboration by encapsulated MSCs resulting in a
clinically translatable, injectable tissue-engineered construct for NP replacement.
4.2

Materials and Methods

4.2.1

Macromer Preparation

Methacrylated methylcellulose (Ma-MC) was fabricated by esterification of hydroxyl groups
with methacrylic anhydride (Sigma-Aldrich) according to previously described protocols (Gold et
al. 2014; Stalling, Akintoye, and Nicoll 2009; Varma et al. 2018). Briefly, 15 kDa (low viscosity)
and 41 kDa (medium viscosity) methylcellulose powder (Sigma-Aldrich, degree of substitution of
methoxy groups ~1.5-1.9) was mixed 1:1 (for ease of handling and control for injectable
applications) (Varma et al. 2018; Lin et al. 2019) and then added to deionized H2O (diH2O) at 1%
(w/v) at 80°C until it was evenly disbursed, after which the temperature was lowered to 4°C and
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allowed to continue to dissolve fully for ~24 hours. The solution was then reacted with methacrylic
anhydride with a molar excess of 20 (based on theoretical 10% modification) at 4°C and pH 8 for
48 hours. The reaction product was purified by dialysis (Spectra/Por, MWCO 6-8 kDa) over 3
days to remove unreacted methacrylic anhydride. Purified solution was lyophilized and stored at 20°C. Polymer samples were acid hydrolyzed as previously described by 1H-NMR spectroscopy
(500 MHz, Varian Mercury 500) (Stalling, Akintoye, and Nicoll 2009; Reza and Nicoll
2010a). The relative integrations of methacrylate protons (d = 6.1 and 5.7 ppm; methyl, d = 1.9
ppm) to carbohydrate protons were used to determine the molar percentage of methacrylation
(Stalling, Akintoye, and Nicoll 2009).
4.2.2

Human Mesenchymal Stromal Cell (hMSC) Culture

Cryopreserved bone marrow-derived hMSCs were acquired from RoosterBio (Frederick,
MD) and expanded according to the manufacturer’s protocol using proprietary high-performance
expansion media (RoosterBasal™ -MSC medium with RoosterBooster™-MSC supplement). Cell
lots from three healthy biological donors (MSC00115, MSC00175, and MSC00179) were used to
reduce donor variability (Table 4.1). Each lot of hMSCs was expanded separately, to an average
population doubling level (PDL) of 16.24 ± 0.27. Cell lots were passaged according to the
manufacturer’s protocol and then pooled at equal cell number for encapsulation as mixed donor
samples. All cell culture was performed at 37°C and 5% CO2, under normoxic (18.6% O2)
conditions.
Table 4.1: RoosterBio™ hMSC donor lot characterization and differentiation potential profiles
Donor information
Differentiation Potential
MSC Lot #
Age
Sex
Adipogenic
Osteogenic
Chondrogenic
00115
20 y.o.
Female
Yes
Yes
Yes
00175
25 y.o.
Male
Yes
Yes
Yes
00179
21 y.o.
Male
Yes
Yes
Yes
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4.2.3

Hydrogel Preparation and Culture

Lyophilized Ma-MC was sterilized under germicidal UV light for 30 minutes and dissolved
in sterile DPBS for a final concentration of 3% (w/v). Additional polymer precursors, redox
initiators ammonium persulfate (APS) and N,N,N′,N′-tetramethylethylenediamine (TEMED), and
2-sulfoethyl methacrylate (2SEM) were prepared at 200 mM and 500 mM working concentration,
respectively, and sterilized via syringe filtration (0.22 µm filter size). APS and TEMED (SigmaAldrich) were added to separate barrels of dual-barrel syringes (Pac-Dent) for a final working
concentration of 10 mM each. Sulfonated gels were formed by including 2SEM (Polysciences) in
the prepolymer mixture for a final concentration of 5 mM. Gels containing directly incorporated
TGF-b3 were formed by adding rhTGF-b3 (R&D Systems, Minneapolis, MN) to the TEMED side
of the dual-barrel syringe only, for a final concentration of 2 µg/mL (~80 ng/gel) corresponding to
the total amount of TGF-b3 to be supplemented via cell culture media for 2 weeks (when
maintained at a concentration of 10 ng/mL) (Gupta and Nicoll 2015). Pooled-lot hMSCs were
mixed directly into the prepolymer solution for encapsulation in redox-polymerized MC hydrogels
at 20 x 106 cells/mL. Hydrogels were formed by injecting the polymer solution through a 1:1
mixing tip into custom casting devices and allowed to cure for 15 minutes at room temperature to
form cylindrical gels (5-mm diameter, 2-mm height).
Cell-laden hydrogels were cultured in vitro in chemically defined medium (CDM), consisting
of high-glucose DMEM (Gibco), 1% insulin-transferrin-selenium-A (with sodium pyruvate)
(Gibco), 100 U/mL penicillin + 100 µg/mL streptomycin (Gibco), 40 µg/mL l-proline (Fisher
Scientific), 50 µg/mL ascorbic acid 2-phosphate (Sigma-Aldrich), and 100 nM dexamethasone
(ACROS Organics). Negative controls for growth factor supplementation were maintained without
TGF-b3. Positive control gels received media supplemented with 10 ng/mL TGF-b3 (CDM+).
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Culture conditions are outlined in Figure 4.1. Media were changed three times weekly. Hydrogels
were isolated at 1, 7, 21, and 42 days for various forms of analysis. Used media were collected and
stored at -20°C for analysis (n=4).
Hydrogel Formulations & Culture Conditions
3% w/v Ma-MC
10 mM APS/TEMED

hMSCs
20 x 106 cells/mL

5mM 2SEM
TGF-β3

Encapsulated

sMCb

Encapsulated

Media
supplementation

Media
supplementation

MCb

sMC+

MC+

sMC-

MC-

Analyses
Growth Factor Sequestration:
Daily TGF-b3 release
Cumulative TGF-b3 release

Imaging:
Live/Dead staining, Hematoxylin & Eosin,
Alcian blue (sGAG), Col II

Biochemical Contents:
PicoGreen (DNA), DMMB (sGAGs),
Col II ELISA

Material Properties:
Unconfined Compression (Ey, speak, % relaxation)
Swelling Ratio = wet wt /dry wt

Figure 4.1: Schematic of hydrogel formulations, culture conditions and outcome measures
All hydrogels were cultured in chemically defined medium (CDM). Media supplemented with
exogenous TGF-b3 referred to as CDM+. Constructs were cultured for 42 days total and collected at 1, 7,
21 and 42 days for analysis. CDM was collected after each media exchange for analysis of growth factor
release.

4.2.4

TGF-b3 Release

Cumulative release of active TGF-b3 from hydrogels fabricated with incorporated growth
factor (MCb and sMCb) was quantified over the first 3 weeks of culture. CDM was collected after
each media exchange and stored at -20°C until quantification. Solid phase sandwich DuoSet
ELISA (R&D systems) was used according to the manufacturer’s instructions to quantify total
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active growth factor released (n=4). Any potential latent growth factor produced by the cells was
not quantified by skipping the activation step (rhTGF-b3 loaded within gels at fabrication was
already in its active form). Unused CDM was used as a negative control.
4.2.5

Cell Viability

Cell-laden hydrogels were examined for viability and proliferation over the 42-day culture
period. Hydrogels isolated for quantitative analysis were lyophilized, homogenized and digested
with 4560 units/mL pepsin (from porcine gastric mucosa, Sigma-Aldrich) in 0.05N acetic acid (pH
2.8) (Sigma-Aldrich) for 48 hours at 4°C with constant agitation, after which pepsin activity was
neutralized by adding 10x Tris-buffered saline (pH 8.0) (Gupta, Cooper, and Nicoll 2011; Reza
and Nicoll 2010b). Total DNA content was quantified via Quant-iT™ PicoGreen™ Assay
(Invitrogen Molecular Probes, Eugene, OR) against calf thymus DNA (Sigma-Aldrich) standard
curve and analyzed with a BioTek Instruments microplate reader (Synergy 4, Winooski, VT) at
excitation and emission of 480 nm and 520 nm, respectively (n=6). Cell viability was assessed
visually by Live/Dead staining (Invitrogen) using calcein AM (green, indicative of live cells) and
ethidium homodimer-1 (red, indicative of dead cells) (n=2) and imaged on a Zeiss Axio Imager
Z1 (Carl Zeiss, Inc., Thornwood, NY) optical microscope and ZenBlue software (Carl Zeiss, Inc.).
4.2.6

Biochemical Analysis

Hydrogels were isolated on days 7, 21, and 42 to quantitatively measure matrix elaboration.
Gels were homogenized and digested in pepsin as described in the previous section. Sulfated GAG
content was quantified using the 1,9-dimethylmethylene blue (DMMB) assay (Sigma-Aldrich).
DMMB assay reagent was prepared as previously described, with pH 1.5 to minimize the
confounding effects of scaffold and DNA interference (Zheng and Levenston 2015). Absorbance
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was measured at 525 nm and 595 nm against a chondroitin-6 sulfate standard (Sigma-Aldrich) and
the difference in optical density (OD) used to quantify total sGAG present (OD525-OD595).
Collagen production was quantified via indirect enzyme-linked immunosorbent assay
(ELISA), using monoclonal antibodies to type II collagen (Col II, II-II6B3, Developmental Studies
Hybridoma Bank, University of Iowa, Iowa City, IA) as previously described (Gupta et al., 2011;
Lin et al., 2016). Protein values were determined using human type II collagen standards
(Chondrex, Inc., Redmond, WA). Absorbance was measured at 450 nm. Total GAG and collagen
content were normalized to wet weight of the gels (n=6).
4.2.7

Histological/Immunohistochemical Evaluation

Hydrogels were rinsed in DPBS and fixed in a buffered zinc-formalin solution (Z-fix,
Anatech, Battle Creek, MI) overnight at room temperature, and then stored in ethylene glycol
monoethyl ether (EGME, Fisher Scientific). Samples were then dehydrated in a graded series of
ethanol and then embedded in paraffin. Embedded constructs were sectioned to a thickness of 8
µm using a Thermo Scientific Rotary Microtome (MC HC325, Walldorf, Germany) and then
sections were mounted on charged slides and dried at 37°C overnight. Slides were deparaffinized
with Citrisolv™ Hybrid Solvent and rehydrated in graded ethanol. Cellular morphology and
distribution were visualized with Hematoxylin & Eosin Y (alcoholic) (Sigma-Aldrich) staining.
Distribution of sulfated GAGs was determined by staining with 1% Alcian Blue (pH = 1.0)
(Pastewka 1974).
Immunohistochemistry was used to visualize specific matrix macromolecules. Clearer
visualization of Col II and Col VI was achieved by first exposing collagen epitopes by 30-minute
treatment of samples in hyaluronidase (type IV-S, Sigma-Aldrich) at 37°C to remove interfering
GAGs. Sections were further swollen in 0.5 N acetic acid (Sigma-Aldrich) for 2 hours at 4°C to
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increase access to epitopes. Slides were blocked in 10% horse serum for 20 minutes at room
temperature, followed by incubation in primary antibodies (1 µg/mL in 10% horse serum)
overnight at 4°C (Col II II-II6B3 monoclonal mouse IgG, Developmental Studies Hybridoma
Bank (DSHB)). Non-specific mouse IgG was used as a control. Alexa Fluor™ 488 (Invitrogen)
Goat anti-Mouse IgG (H+L) secondary antibody was applied at 1:200 dilution and 4′,6-diamidino2-phenylindole (DAPI, Sigma-Aldrich) was used to counterstain cell nuclei. All stained sections
were imaged and captured using the Zeiss Axio Imager optical microscope and AxioVision
software (Carl Zeiss) (n=2-3).
4.2.8

Swelling Behavior

Equilibrium weight swelling ratio (QW) of cell-laden hydrogels was measured at day 1, 7, 21
and 42 (n=3-6). Constructs were isolated and blotted to remove excess liquid, and then weighed
to determine the wet weight (Ws), after which gels were frozen at -80°C, lyophilized and weighed
again to measure the dry weight (Wd). Equilibrium weight swelling ratio was calculated as
/

𝑄. = /+

,

4.2.9

(4.1)

Mechanical Testing

Cell-laden hydrogels were characterized for their mechanical properties under unconfined
compression using a custom-built apparatus as previously described (n=5) (Soltz and Ateshian
2000; Gold et al. 2014). Gels were isolated at days 1, 7, 21 and 42 and stored at -80°C until testing.
Gels were thawed and allowed to equilibrate completely in PBS overnight at 4°C prior to
mechanical testing. The testing protocol consisted of a creep test (tare load = 1 g) at a ramp speed
of 10 µm/s held at 2700 s until equilibrium was reached (equilibrium criterion: <10 µm
displacement in 10 min), followed by a multi-ramp stress relaxation test, consisting of three 5%
strain ramps with a 2000 s relaxation period between ramps (equilibrium criterion: <0.5 g change
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in 10 min). Equilibrium Young’s modulus (EY) was determined as the slope of the equilibrium
stress (calculated at each ramp) versus applied strain curve. Peak stress (spk) and equilibrium stress
(seq) were calculated at the third ramp corresponding to 15% strain, and percent relaxation was
calculated by the formula
-

𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝑅𝑒𝑙𝑎𝑥𝑎𝑡𝑖𝑜𝑛 = @1 − -"( B
)*

(4.2)

4.2.10 Statistical Analysis
Data are represented as the mean ± standard deviation. A two-way ANOVA with a Tukey’s
post-hoc test was used to determine the effects of sulfonation and growth factor supplementation
at each time point, and subsequent one-way ANOVA of time across each group on hMSC-laden
hydrogel constructs. Two-way repeated measures ANOVA was used to determine the effect of
sulfonation and time on TGF-b3 release. All statistical analyses were carried out using GraphPad
Prism v.9 (GraphPad Software, San Diego, CA) with significance set at p < 0.05.
4.3

Results
Methylcellulose was methacrylated to enable redox-initiated crosslinking at 5.84%

modification as confirmed by 1H-NMR (not shown).
4.3.1

Growth Factor Release from Sequestering Hydrogels

TGF-b3 that was incorporated into hydrogels during formation was measured during media
exchange to track sequestration in sulfonated vs sulfonate-free gels (sMCb vs. MCb, respectively).
Each media change was collected and assayed for TGF-b3 present in the media, and daily and
cumulative release was calculated for the duration of the culture. Both conditions experienced a
burst release in the first day (42.62 ± 11.59 ng, MCb and 21.71 ± 5.77 ng, sMCb), with the
unsulfonated gels releasing significantly more TGF-b3 per day over the first 5 days (Figure 4.2A).
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Cumulative release from sMCb reached a plateau by day 3, while MCb gels continued to release
growth factor until reaching a plateau by day 16, Figure 4.2B shows sulfonate-free gels released
the total amount of calculated TGF-b3 loaded (indicated by dotted grey line). The wide standard
deviation (shown by the shaded region) is indicative of the variability in loading efficiency during
hydrogel fabrication (78.73 ± 18.66 ng/gel). Sulfonated gels released 37.35 ± 6.87% of the
calculated total amount of TGF-b3 loaded within the gels over the time measured (29.33 ± 5.39
ng/gel).
4.3.2

Cell Viability, Distribution, and Morphology

hMSC-laden MC hydrogels were fabricated at a seeding density of 20 x 106 cells/mL
(~800,000 cells/gel) and exhibited DNA values ranging from 51.33 ± 23.54 ng/mg to 77.01 ± 19.67
ng/mg (DNA/wet weight). There was a statistically significant decrease in cellularity over time, as
indicated by decreasing DNA content (Figure 4.3A), for all groups except sMCb and sMC+.
Significant differences in cellularity between groups were seen at day 21, with nonsulfonated
constructs displaying DNA levels significantly lower than sulfonated constructs (24.45 ± 9.30
ng/mg to 29.08 ± 7.52 ng/mg versus 41.77 ± 11.11 ng/mg to 48.04 ± 9.51 ng/mg, respectively).
By the end of the 6-week culture, there were no significant differences in cell density across all
groups (ranging from 48.65 ± 18.16 ng/mg to 30.04 ± 9.86 ng/mg). These findings were
corroborated by the decrease in staining of live cells over the course of the 6-week study (Figure
4.3B).
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Figure 4.2: Daily A) and cumulative B) release of encapsulated TGF-b3 from hMSC-laden
hydrogels.
Shaded regions indicate SD. * - Significant difference in amount of TGF-b3 released between
groups. Significance set at p < 0.05.

Hematoxylin and eosin staining (Figure 4.4) also confirmed the decrease in cellularity,
showing much more sparsely populated constructs on day 42 versus day 7 across all groups.
Although fewer in number and distribution, cells in sulfonated gels at day 42 still displayed a large,
rounded cell morphology, characteristic of an NP-like phenotype. Conversely, the majority of cells
seen in MC only gels at day 42 appeared small or showed evidence of membrane disruption and
cellular lysis.
4.3.3

NP Matrix Elaboration and Distribution
The sGAG content in the hydrogels increased over time only in groups with both sulfonates

and growth factor supplementation (sMCb and sMC+) (Figure 4.5A). By day 42, sMCb produced
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significantly more sGAGs (836.24 ± 181.89 ng/mg) than sulfonate-free constructs with and
without exogenous growth factor delivery, and sMC+ constructs produced more sGAG than all
other groups (1,242.35 ± 286.11 ng/mg). Alcian blue staining of day 42 samples was strongest in
sMCb and sMC+ sections, consistent with the DMMB results, and concentrated pericellularly,
rather than spreading diffusely throughout the bulk of the construct (Figure 4.6A). Not all cells in
those constructs were producing sGAG, however, as smaller, unstained cells can be seen adjacent
to larger cells that did stain positively for sGAGs. Alcian blue staining of the charged sulfonated
constructs unrelated to sGAG production was observed, as seen in the staining of sMC- gels, where
cells were clear of any blue dye. Faint blue staining was seen diffusely around the cells in MC only
constructs, which were smaller and less rounded.
Type II collagen production increased in all groups over time except in MC+ (averaging 25.83
± 6.58 ng/mg over all time points) (Figure 4.5B). Col II production peaked at 21 days of culture
in sulfonated gels (82.68 ±16.91 ng/mg, 70.93 ±4.38 ng/mg, and 57.26 ± 10.68 ng/mg in sMCb,
sMC- and sMC+, respectively), with a decrease in Col II accumulation in sMC- constructs (43.42
± 6.31 ng/mg) and no significant change between day 21 and 42 for sMCb and sMC+ constructs
(67.26 ± 30.92 ng/mg and 62.14 ± 13.60 ng/mg, respectively). At 21 days, each sulfonated group
showed significantly greater Col II accumulation compared to all non-sulfonated constructs. By
day 42, MCb and MC- had increased Col II elaboration and values were not statistically different
from the sulfonated gels (48.34 ± 16.34 ng/mg and 49.17 ± 9.93 ng/mg, respectively).
Immunohistochemical staining of day 42 constructs for Col II showed positive staining in all
constructs, although not all cells in each construct elaborated matrix (Figure 4.6B). Faint
pericellular staining was evident in MCb gels, and few cells demonstrated staining in MCconditions. Staining was more abundant in MC+ and sMC- constructs, but still faint. Consistent
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with results of the Col II ELISA, staining in sMCb and sMC+ gels was more abundant
pericellularly, with some staining in the interterritorial space.

Figure 4.3: Viability and survival of hMSCs encapsulated within MC and sMC hydrogels.
A) DNA content over 42 days as quantified by PicoGreen assay. Significant difference between
time points within the same group: *– p < 0.05, **– p < 0.01, ***– p < 0.0005, ****– p < 0.0001, $–
significantly different from all other constructs of different scaffold sulfonation within the same time
point. a– significantly different from each other. Significance set at p < 0.05. B) Representative Live/Dead
stained images of hMSCs in hydrogels over time (Live = green; Dead = red). Scale bar = 100 µm.
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Figure 4.4: Hematoxylin & Eosin staining of hMSC-laden hydrogels at day 7 and day 42.
Scale bar = 50 µm.

Figure 4.5: Biochemical content of hMSC-laden MC hydrogels over time.
A) Sulfated GAG and B) Col II. Significant difference between time points within the same group:
*– p < 0.05, **– p < 0.01, ***– p < 0.0005, ****– p < 0.0001, $– significantly different from all other
constructs of different scaffold sulfonation within the same time point. a,b,c,d,e,f,g,h– significantly different
from each other. Significance set at p < 0.05.

143

A

B

Alcian Blue (sGAG)
Exogenous GF
(+)

Encapsulated GF
(b)

No GF
(-)

Exogenous GF
(+)

sMC

sMC

MC

No GF
(-)

MC

Encapsulated GF
(b)

Col II (+DAPI)

Figure 4.6 ECM localization within hMSC-laden MC hydrogels at 42 days.
A) Alcian blue staining of sGAGs, and immunofluorescence of B) Col II and C) Col VI localization
(green), with nuclei stained with DAPI (blue). Scale bar = 50 µm..

4.3.4

Material Properties of Constructs

Construct mechanics were stable and showed very little change over time. There was no
significant change in EY between day 1 and day 42 for all groups studied (Figure 4.7A). Final EY
for all groups ranged from 7.57 ± 2.02 kPa (MCb) to 12.34 ± 1.55 kPa (sMC-). At day 21, sMC+
and sMC- (but not sMCb) were significantly stiffer than all unsulfonated constructs, regardless of
growth factor delivery. By day 42, sulfonated gels without growth factor supplementation (sMC-)
exhibited a significantly greater equilibrium Young’s modulus than unsulfonated gels with
encapsulated growth factor (MCb) and without growth factor supplementation (MC-, 8.42 ± 1.67
kPa). Similarly, at intermittent time points sulfonated gels achieved greater speak than unsulfonated
samples, irrespective of growth factor supplementation. However, by day 42 there were no
significant differences in the speak achieved by any groups, ranging from 1.83 ± 0.45 kPa (MCb)
to 2.60 ± 0.52 kPa (sMC-) (Figure 4.7B). Growth factor delivery and scaffold sulfonation had no
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significant effect on % relaxation. Despite % relaxation decreasing within MC- and MC+ groups
over time, relaxation behavior was also relatively stable, with an average % relaxation of 35.23 ±
4.49% across all groups (Figure 4.7C).

Figure 4.7: Material properties of hMSC-laden MC hydrogels over time.
A) Equilibrium Young’s modulus (EY), B) peak stress (speak), C) % relaxation, and D) equilibrium
weight swelling ratio (Qw). Significant difference between time points within the same group: *– p < 0.05,
**
– p < 0.01, $– significantly different from all other constructs of different scaffold sulfonation within the
same time point. a,b,c,d,e,f,g– significantly different from other group within the same time point.
Significance set at p < 0.05.

Swelling ratio (Qw) did not change significantly over time for most groups, with
MCb showing the only significant change in swelling ratio by 42 days (Figure 4.7D). Growth
factor delivery method and scaffold sulfonation had no effect on swelling ratio over the first 3
weeks of culture; by 6 weeks, however, MCb and MC- displayed higher equilibrium swelling ratio
(20.77 ± 2.82 and 19.95 ± 0.51, respectively) than the sulfonated constructs (14.9 ± 1.82 to 16.66
± 2.23).
4.4

Discussion
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Tissue engineering repair of the NP is a promising strategy for treatment of IVD
degeneration that aims to prevent further downstream breakdown of the disc by restoring the
mechanical and biological function of the healthy NP. A clinically-viable tissue-engineered
replacement for the NP requires that the traditional triad of tissue engineering components –
scaffold, cells, and signals – are delivered together in a minimally invasive manner, such that
differentiation and development of the replacement tissue can proceed in situ. To this end, we
recently developed a GAG-mimetic cellulosic biomaterial system that is injectable, forms robust
hydrogels in situ, and sequesters TGF-b3 directly within the scaffold for ease of delivery (Chapter
3). By incorporating negatively charged sulfonates onto the backbone of the physically and
chemically crosslinked MC scaffold, we have been able to sequester TGF-b3 via electrostatic
interactions to serve as a depot for growth factors in a mechanism similar to sGAGs found in the
native NP. TGF-b is critical in the development of the IVD and other cartilaginous tissues (Chen
et al. 2019; Reza and Nicoll 2010b; Haberstroh et al. 2009; Gupta, Cooper, and Nicoll 2011; Barry
et al. 2001; Mackay et al. 1998). Thus, the present study aimed to investigate the ability of this
scaffold to support differentiation and NP-like matrix elaboration of encapsulated MSCs. The
effect of TGF-b3 sequestration and enhanced bioavailability was examined with and without the
influence of sequestering sulfonates, while TGF-b3 delivered exogenously through supplemented
media was included as a positive control. Studies have shown that artificially sulfated scaffolds
can promote early chondrogenic differentiation in the absence of soluble differentiating factors,
therefore, constructs with and without sulfonates were also cultured without TGF-b3 in order to
isolate the effect of matrix sulfonation on MSC growth and differentiation (Kwon et al. 2010;
Kwon 2012).
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Artificially sulfated scaffolds and sGAG-mimetics have become increasingly popular
methods of sustained growth factor delivery for tissue engineering applications, but to the best of
our knowledge, this is the first study to utilize the method specifically for IVD tissue engineering
(Zeng, Groth, and Zhang 2019; Arslan, Guler, and Tekinay 2016; Yaylaci et al. 2016; Freeman,
Kedem, and Cohen 2008; Portocarrero Huang et al. 2017; Waghmare et al. 2018; Feng et al. 2017).
Sulfonated MC gels successfully sequestered incorporated TGF-b3 for the duration of the culture,
with characteristic burst release on the first day of culture, followed by sustained release for all
gels. The concentration was loaded at 2 µg/mL, the equivalent of 2 weeks of supplementation at
10 ng/mL in chondrogenic medium (Madry et al. 2014). Previous studies have shown transient
exposure to TGF-b for 2 weeks is sufficient to stimulate chondrogenic differentiation in MSCs
(Kim et al. 2012; Huang et al. 2009; Gupta and Nicoll 2015). The wide disparity in release from
non-sulfonated gels may be due to variations in mixing while loading or to variability in individual
gel network formation; if it is not the former, it is conceivable that some gels maintained trace
amounts of TGF-b3 within them. Release from these gels reached a plateau corresponding to the
total theoretical loaded growth factor within 2 weeks, crossing below the threshold for therapeutic
concentration at approximately 1 week. Sulfonated gels also experienced a burst release that was
significantly lower than the non-sulfonated gels. Interestingly, the release quickly plateaued and
did not appreciably increase beyond the 27.5 ng/mL released, indicating true sequestration rather
than delayed or sustained release. Preliminary data (not included) have shown that 2SEM does not
denature or reduce the detectability of TGF-b3 by the ELISA, and as all the theoretical load was
released from the unsulfonated gels, we are able to discern that the loaded growth factor was not
denatured. Because affinity-based sequestration techniques rely on association-dissociation
reactions between the therapeutic and binding ligand, release behavior is dependent on the strength
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of the affinity between the ligand and therapeutic, with diffusion-based release kinetics driven by
the amount of unbound therapeutic at a given time (Vulic et al. 2015). The data here suggest very
strong binding interactions between the sulfonates and TGF-b3.
Based on the release data alone, it is not immediately obvious whether sequestration translates
into increased presentation to encapsulated cells or to reduced bioavailability due to oversequestration. Strong sequestration of growth factors has been observed in chondroitin sulfate- and
heparin-containing biomaterials, in which selective de-sulfation increased the release of
encapsulated growth factors (Lei, Trevino, and Temenoff 2016; Lim and Temenoff 2013). In prior
studies, we showed that sequestration of TGF-b3 is tunable by titrating the sulfonate concentration.
Fluorescence recovery after photobleaching (FRAP) is a technique that has been previously
employed to determine the ratio of mobile to immobile TGF-b by visualizing the rate of influx of
fluorescently-labeled growth factor into an area of interest that had been photobleached (Jha,
Mathur, et al. 2015). Further investigation of the movement and distribution of TGF-b3 within the
sulfonated scaffolds using FRAP may provide greater insight into the bioavailability of the
sequestered growth factor. It is important to note that tethered TGF-b3 has successfully been used
to induce chondrogenesis in encapsulated MSCs (McCall, Luoma, and Anseth 2012),
demonstrating that even immobilized growth factor can promote differentiation, provided the
spacer arm of the tethering polymer is long enough to prevent steric hinderance from impeding
cellular access and ligand binding.
The combined effects of sulfonation and TGF-b3 appear necessary for maintaining cell
survival within this crosslinked MC hydrogel system. This is evidenced by the finding that DNA
content decreased over time in all groups except for those with both sulfonate and TGF-b3
supplementation (sMCb and sMC+). Neither scaffold sulfonation nor TGF-b3 supplementation
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alone (sMC-, or MCb and MC+, respectively) were sufficient in preventing significant decrease
in cellularity. The reduction in cellularity was clearly visualized both in live/dead staining and
H&E histological sections. H&E staining showed those cells that remained in the sulfonated
constructs displayed a large, rounded morphology, typical of the chondrocytic cell phenotype, but
that the vast majority of cells in the non-sulfonated gels were shriveled and seemed unhealthy,
appearing to have disrupted membranes or have lysed. Similar results were observed in heparinmodified hyaluronic acid hydrogels, where heparin-bound TGF-b1, but not unbound incorporated
or exogenous delivery of TGF-b1, enhanced survival and proliferation of encapsulated cardiac
progenitor cells by retaining the active form of the growth factor in close proximity to the cells for
an extended amount of time (Jha, Tharp, et al. 2015). In our development of the sMC hydrogel
(Chapter 3), there was no indication of cell death, and in fact, there was evidence of proliferation
over the course of the study. Nevertheless, the focus of that cell study was on cytocompatibility,
in accordance with ISO standard 109935:2009, and lasted 5 days to assess the cytotoxic potential
of the hydrogel components during and immediately following gel formation, and not on longterm survival. The fact that a significant decrease in cell number was observed in MCb gels as
early as 7 days of culture despite direct encapsulation of TGF-b3 was surprising, as TGF-b has
been shown to inhibit disc cell apoptosis (Ni et al. 2014; Xie et al. 2020). The burst release of
TGF-b3 from the unsulfonated hydrogel seen in the release study may be responsible for the lack
of response. MC+, which received continuous exogenous TGF-b3 delivery, did not display
significant cell loss until 21 days. Still, sulfonated MC gels without TGF-b3 supplementation
(sMC-) showed a significant drop in cellularity only by day 42, suggesting that the sulfonation of
the scaffold alone may have assisted in maintaining cell survival. Qualitative inspection of
live/dead staining showed an obvious decrease in the density of live cells across all groups,
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although there was no statistically significant change in cell number. From morphological analysis
alone it is not possible to discern whether cell death was caused by apoptosis or necrosis. In the
absence of phagocytic cells to engulf apoptotic bodies, apoptotic cells go through secondary
necrosis (Silva 2010). Staining of cleaved caspase-3, an apoptotic marker, was not performed, but
could be used in the future to elucidate whether apoptosis or necrosis was the cause of cell death
in these scaffolds.
The decrease in cell viability and proliferation observed in most of the MC hydrogel
formulations may be due to subtle alterations in gel material properties (i.e., stiffness, hydration,
nutrient transport) attributed to the hydrophobic character and thermoresponsive nature of the
biomaterials. Earlier studies directly encapsulating bovine NP cells into similar hydrogels of
photocrosslinked methacrylated MC (3% w/v) reported only 20-30% survival by 21 days of culture
(culture medium contained serum and no TGF-b3 supplementation), which is comparable to the
survival at day 21 in sulfonate-free gels (MC-) in the present investigation (Reza, Stalling, and
Nicoll 2006). We hypothesized that this may have been caused by the limited hydration of MC
that results from the presence of hydrophobic methoxy substitutions on its backbone. When MC
is in solution, the methoxy groups (as well as the methacrylates on modified MC) aggregate at
increasing temperatures to form thermoreversible physical crosslinks. Few studies have
investigated dual-crosslinked MC systems similar to the one presented here, wherein the reversible
thermally induced physical crosslinking of MC is combined with permanent redox-initiated
chemical crosslinks to form more stable and mechanically robust hydrogels (Pakulska et al. 2015;
Morozova et al. 2019; Shin et al. 2020). Morozova et al. (2019) have recently shown that allylmodified, photocrosslinked MC formed at lower temperatures (~20°C) form amorphous
crosslinked hydrogels that retain some of their thermoresponsive nature, with increasing storage
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modulus and decreasing volumetric swelling with increasing temperatures, but it was not clear if
this increase was significant within the range of 20°C to 37°C. Shin et al. (2020) have also recently
formulated tyramine-modified photocrosslinkable MC for use as a bioink and found that dualcrosslinked MC (chemically and thermally at 37°C) result in stiffer gels than those chemically
crosslinked at room temperature, regardless of the order of stimuli. While the chemical and
material specifics of these studies are different, they exhibit the strength of the hydrophobic
interactions in MC, even when chemical crosslinking dominates the material behavior. In the
present study, hydrogels were chemically crosslinked for 15 minutes at room temperature, as
maintaining the developing system at 37°C was not feasible while ensuring sterile conditions. It is
possible that once the hydrogels were moved to 37°C, the gels contracted or stiffened, which has
implications both on the mechanical stimuli experienced by the cells, as well as on the transport
of fluid and nutrients within the constructs. We have generally operated under the assumption that
the methacrylate-derived crosslinks dominate the properties of the gels, as these permanent
chemical bonds result in storage moduli 1-2 orders of magnitude higher than gels stabilized solely
by physical thermal crosslinks (see Chapter 2). Nevertheless, the thermally driven contributions
to the network structure may still influence the viability of cells encapsulated within the cellulosic
scaffolds.
Despite evidence that cells were not apparently proliferating within the constructs and cell
death was observed across many of the groups, metabolic activity via production of matrix
components in all constructs suggests the observed cell death was apoptotic rather than necrotic,
as necrotic cells would not be actively producing matrix components (Strehl et al. 2002). As might
be expected, the groups that produced the most NP specific matrix components (sGAG and Col II)
were also the groups with the best cell survival. Both sMCb and sMC+ exhibited increasing sGAG
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accumulation over the course of culture, with the greatest amount of sGAG accumulation exhibited
in constructs with exogenous growth factor delivery. The finding that all sulfonate-free groups,
even with TGF-b3 stimulation, did not display a significant increase in sGAG accumulation over
time indicates that the inclusion of the negatively charged moieties was necessary for matrix
stimulation. This is likely attributed to the sequestration and presentation of TGF-b3 in the vicinity
of the cells, as growth factor-free, sulfonated constructs (sMC-) showed no significant increase in
sGAG production, nor any improvement over any of the non-sulfonated constructs. Interestingly,
sMC- gels presented with intense non-specific Alcian blue staining not localized to cells. As
Alcian blue dye is cationic and attracted to negative charges, the stronger blue staining throughout
the sMC- gels may be interpreted as uniform staining of the construct with evenly distributed fixed
charge distribution. In contrast, the sMC+ and sMCb gels that produced more sGAGs (as
confirmed by the DMMB assay) presumably had a higher concentration of negatively charged
sulfates and associated fixed charge density in the vicinity of the pericellular neomatrix. This
would result in the observed sequestration of Alcian blue dye in the pericellular space and less
non-specific staining of the sulfonated scaffold. Moreover, this was confirmed via Alcian blue
staining of all day 7 sulfonated gels, which also exhibited stronger non-specific background
staining, as did acellular sulfonated gel sections (not shown).
With respect to Col II production, there was a significant increase in all groups except MC+
over the course of the 6-week culture. All sulfonated groups exhibited marked, significant
increases in Col II production between days 7 and 21, regardless of growth factor stimulation.
However, sMC- demonstrated an equally significant drop in Col II content by 42 days. The
decrease in accumulated Col II may be relative to the loss of cellularity; when normalized to DNA,
Col II in sMC- gels was not significantly different at day 42 than 21. Even though Col II
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production was more rapid in the sulfonated gels, the non-sulfonated gels did catch up, and by 42
days there was no significant difference between Col II production in non-sulfated and sulfated
gels, except for those where TGF-b3 was delivered exogenously. Data normalized to DNA suggest
again that the combination of scaffold sulfonation and continuous exogenous TGF-b3 stimulation
resulted in the most robust anabolic activity, as well as the most consistent increase in Col II over
time.
The distribution of dead cells and elaborated matrix did not exhibit any spatial pattern that
would indicate nutrition or diffusional constraints, as has been exhibited in previous studies (Gupta
and Nicoll 2015; Varma, DiNicolas, and Nicoll 2018). As mentioned earlier, labeling of TGF-b3
to image distribution, motility, and consumption may be useful in determining whether
sequestration played a role in limiting the growth and differentiation of the encapsulated cells.
Additionally, this study used a pooled batch of 3 distinct hMSC donors. Pooled-donor usage has
been shown to have no negative effects on viability, proliferation, or differentiation when
compared to single donor studies, and is intended to eliminate the need for biological replicates
(Hejretová et al. 2020; Widholz et al. 2019). However, lack of an evident pattern in the distribution
of dead cells and metabolically active cells (as exhibited by GAG and Col II staining around some,
but not all cells) raises the question of whether one or more donor cell source was exhibiting a
more robust response than others. Pooling donors eliminates the ability to discern minute
biological differences that could influence cellular response, and future studies may need to take
that into account. Yet, this issue has not been raised in other NP tissue engineering studies that
used pooled donors (Thorpe et al. 2010; Frith et al. 2014; Potier and Ito 2014).
In this study, matrix production was analyzed to provide evidence of NP-like differentiation,
as the goal of tissue engineering is to develop de novo healthy tissue. Hence, the production of the
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major matrix components responsible for healthy NP functionality were the primary outcome
measures to assess cell-driven repair. Type II collagen and proteoglycans, specifically aggrecan,
are the most abundant matrix components of the NP as well as hyaline cartilage. Indeed,
differentiation of NP cells is often somewhat loosely referred to as chondrogenesis despite the two
tissues being distinct. The mechanical role and behavior of the two tissues are quite different,
which is reflected in the ratio of these matrix components. The high hydration and soft viscoelastic
behavior of NP tissue is afforded by the abundance of sGAGs, which appear at a ratio of 27:1 to
hydroxyproline, as opposed to ~2:1 in healthy adult cartilage (reaching a maximum of 5:1 in
degenerate cartilage) (Risbud et al. 2015; Mwale et al. 2004). As the mass ratio of hydroxyproline
to collagen has been reported as 1:7.5, the effective sGAG:Collagen ratio was calculated as 3.6:1
in healthy adult NP and 1:1.5 to 1:3.75 in cartilage. Type II collagen accounts for nearly 100% of
the collagen content in the NP (other collagens like type VI, IV, and XI are present but their relative
quantities are so much lower as to be negligible for the current approximation) (Antoniou et al.
1996). Due to the slower apparent collagen production in sulfonate-free MC constructs, the
sGAG:Col II ratio was significantly higher in MC-only constructs versus sMC constructs (~3440:1 versus 16-19:1, respectively) at day 21 but by day 42 the differences in ratio were no longer
significant between groups, averaging ~22:1. While relative matrix production is a useful tool in
phenotypic distinction, absolute quantity allows for better assessment of the regenerative potential
of the system. By 42 days of culture, sGAG production was nearly 50-fold lower than the native
NP (525 µg/mg dry weight) at 2.33% across all conditions, and collagen production was lower
still, at 0.36% (250 µg/mg dry weight) (Antoniou et al. 1996).
The production of sGAG and Col II were evaluated as the primary endpoints for successful
differentiation and tissue regeneration in the present study. NP-specific gene markers have been
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identified such as N-cadherin (CDH2), keratin 19 (K19) (Lv et al. 2014) , PAX1, FOXF1, HBB,
and CA12 (Minogue et al. 2010), and can be useful in determining early differentiation. However,
in the absence of downstream protein translation, gene expression profiles provide limited
functional information. Given the limited matrix deposition and cell survival exhibited in this
study, further genetic characterization was not pursued. As future studies optimize the system for
cell survival, gene expression will become a more relevant tool for identifying differentiated NP
cells.
Histological images showed that matrix accumulation was generally limited to the pericellular
area for both Col II and sGAGs. Only sMCb constructs showed some faint interterritorial staining
for Col II. The limited diffusion of matrix components into the hydrogel is likely due to the
combined effects of the low swelling capacity of MC and lack of matrix degradation. Numerous
studies investing the effects of hydrogel material properties have shown that matrix deposition by
cells is a function of the available volumetric space and diffusivity (Bian, Hou, et al. 2013;
Erickson et al. 2009; Lin et al. 2016; Gupta and Nicoll 2014). The effective mesh size of these MC
based hydrogels has been previously calculated from equilibrium swelling ratio to be on the order
of ~20 nm (Chapter 3). Bryant and Anseth (2002) first reported that diffusion and distribution of
elaborated sGAGs in hydrogels requires a mesh size of a minimum 9 nm. While these hydrogels
satisfy that requirement, this assumes uniform distribution of the mesh and no steric or
electrochemical interference that would limit Fickian diffusion of sGAG molecules. The largest
mesh size of the poly(ethylene glycol diacrylate) hydrogels investigated in that study was 14 nm;
despite being fairly close to the size of the matrix molecules, the construct showed good diffusion
and distribution of sGAGs throughout the hydrogel. Given that the MC hydrogels have a mesh
size that is permissive for sGAG diffusion, it is not clear why elaborated sGAGs would remain
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within the pericellular region. Degrading hydrogels have shown promise as scaffolds for cartilage
and NP tissue engineering as controlled breakdown of the scaffold is conducive to the elaboration
of matrix, particularly larger matrix molecules like collagen (~300 nm fibril diameter) (Bryant and
Anseth 2003; Chung et al. 2009; Reza and Nicoll 2010a). Ma-MC-based hydrogels exhibit
excellent long-term stability and are typically not susceptible to hydrolytic degradation, both in
vitro and in vivo (Stalling, Akintoye, and Nicoll 2009; Gold et al. 2015; Lin et al. 2019). Ester
bonds formed between the methacrylate groups are susceptible to hydrolytic cleavage, however,
actual hydrolysis is dependent on the hydration of the network and steric factors, with higher water
content (and frequently larger mesh size) corresponding to increased exposure of the ester linkage
to water (Reza and Nicoll 2010a; Varma et al. 2014; Jeon et al. 2009). The low swelling capacity
of MC hydrogels due to the hydrophobic methoxy groups supports the long-term stability of the
gel, but also prevents the hydrolysis-mediated creation of void space necessary for accumulation
of neomatrix (Chung et al. 2009; Bryant and Anseth 2003).
There was virtually no net change in compressive properties or swelling in any of the
constructs over time. Given the limited matrix deposition shown via histology, it can be assumed
that the stability of the mechanical properties is derived from the lack of scaffold breakdown. Some
significant differences were observed in percent relaxation of MC-, MC+ and sMC- gels over time,
however, this cannot readily be explained by the limited matrix accumulation. It may be an artifact
of variability between gel casting, which could be reduced in further studies by increasing the
sample size. All constructs were within the range of the mechanical and material properties
reported for NP, which has been reported as having an EY of 5.39 ± 2.56 and percent relaxation of
34.23% ± 11.30% (as calculated in Eq. 4.2) for human tissue in unconfined compression, and an
equilibrium weight swelling ratio of 19.94 ± 3.09 for bovine tissue (Cloyd et al. 2007; Reza and
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Nicoll 2010b). From the perspective of mechanical replacement and restoration in the IVD, the
stability of the constructs is promising, as it is not ideal to have an NP replacement that is too soft
to withstand the compressive forces of the disc. Having a compressive modulus slightly higher
than the native NP in unconfined compression has shown promising results for the restoration of
motion segment mechanics in ex vivo models (Varma et al. 2018). Nevertheless, it has been well
established that increasing scaffold stiffness by modulating macromer concentration and
crosslinking density has negative effects on differentiation and matrix elaboration of cartilaginous
tissues (Erickson et al. 2009; Gupta and Nicoll 2014; Lin et al. 2016). In the previous study
(Chapter 3), it was determined that although the components of the sMC hydrogel system are
tunable and allow for a wide range of mechanical properties, a minimum of 3% w/v macromer
concentration was necessary to form stable hydrogels that gelled in situ and were retained when
injected into the void space of a bovine disc explant model. Thus, this was the formulation
employed for the current cellular investigation.
The goal of a clinically translatable formulation for an NP replacement material is that it must
be injectable and minimally invasive in order to preserve AF integrity, as well as immediately able
to restore mechanical deficiencies of the degenerate disc. The challenge for in situ-based, tissue
engineering strategies is that soft substrates that mimic the developmental milieu and promote NP
cell differentiation (Navaro et al. 2015; Francisco et al. 2014; Francisco et al. 2013) provide little
to no immediate biomechanical support or restoration of disc height, range of motion, and most
importantly, reduction in pain for patients suffering from degenerative disc disease. Panebianco et
al. (2020) have recently presented a systematic review of cell-based injectable biomaterials for
IVD repair highlighting the ongoing competitive balance that exists between biomechanical and
biological performance and asserted that materials that are able to combine high modulus with
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controlled degradation and ability for cellular remodeling are likely to be the best candidates for
successful translational tissue engineering of the IVD.
Future work in developing this platform should consider incorporating hydrolytically or
enzymatically cleavable crosslinks, in order to make the scaffold more permissive for matrix
elaboration. As mentioned earlier, gels were formed at room temperature in rigid molds, neither
of which truly recapitulate in situ gelation. Prior work has shown that redox-initiated gelation of
methacrylated cellulosic hydrogels in situ resulted in gels with EY half that of gels made within
custom molds (Varma et al. 2018). The softer gels are likely due to inefficient crosslinking with
exposure to oxygen. While our previous investigation showed that this formulation is able to form
stable hydrogels within the void space of the IVD post-nucleotomy, softer gels may also be better
able to support MSC differentiation, matrix elaboration, and nutrient transport. Additionally, the
current work was performed under static culture conditions. As the native disc is constantly
mechanically loaded, dynamic culture will be necessary to ascertain the construct’s performance
in supporting differentiation and survival of MSCs under more physiologically relevant conditions.
Mechanical loading can stimulate differentiation of embedded cells and drive convective transport
of TGF-b3 and elaborated matrix, all of which can potentially increase the success of this tissue
engineering platform (Safshekan et al. 2012; Shah and Chahine 2018; Tsai et al. 2014; Huang et
al. 2010; Li et al. 2010; Thorpe et al. 2010; Mauck et al. 2003).
4.5

Conclusion
This study examined the ability of artificially sulfonated MC scaffolds to support hMSC

differentiation toward an NP-like phenotype as a potential injectable NP repair strategy. TGF-b3
was successfully sequestered within sulfonated hydrogels and the combined effects of enhanced
growth factor bioavailability and stimulation due to presumed sulfonate interactions were able to
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maintain cell viability and promote the elaboration of NP-specific matrix components, namely
sulfated GAGs and type II collagen. All the MC-based scaffolds maintained stable mechanical and
swelling behavior over time that were within the range of compressive and swelling properties of
the native NP. Matrix elaboration was limited to pericellular regions and did not distribute evenly
throughout the construct, nor did gross levels of ECM components approach the quantities found
in the NP, which was likely due to the limited ability to diffuse through the construct. The stability
of the sMC hydrogels demonstrates its strong potential as a candidate for acellular NP replacement
therapies; however, the limited matrix elaboration and low cell survival suggest further
optimization is necessary to make the platform amenable to cell differentiation and biological
repair. Future studies will investigate the efficacy of this platform for MSC-driven NP repair when
combined with degradable linkages.
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Chapter 5: Conclusions, Limitations, and Future Directions
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5.1

Overview
The global objective of this thesis was to develop an injectable, MC-based hydrogel system

as a functional NP replacement for both cell-based and acellular therapies for early IVDD.
Previous studies have shown successful NP-like differentiation of encapsulated hMSCs within
CMC hydrogels but were unsuccessful in forming gels directly in the disc, and it was found that
the thermogelling capacity of MC combined with redox-initiated covalent crosslinking was
necessary for retaining the injectable NP replacement within the disc. Thus, the focus of this work
was to optimize a tissue engineering platform for the NP, centered on MC and taking cues from
the successes of the previous CMC-based tissue engineering studies while preserving the
thermogelation of MC that was necessary for clinical translation.
Although there is anecdotal evidence that the thermogelling behavior is preserved in
methacrylated MC, the effect of methacrylate modification and percent modification on the
thermoresponsive behavior of MC had not been investigated. As methacrylate groups are
hydrophobic, it was hypothesized that methacrylates would enhance the thermogelation of MC.
Thus, rheometric analysis of the influence of temperature and time was explored for various
methacrylation percentages (Chapter 2). The addition of methacrylate groups was shown to lower
the thermogelation onset temperature and increase the thermoresponsiveness of MC hydrogels. It
was also seen that there was a threshold of methacrylate concentration above which redox-initiated
crosslinking efficiency was limited at physiologic temperatures, thus informing the most desirable
degree of methacrylation for future studies.
MC hydrogels have a much lower swelling capacity than CMC hydrogels. The swelling
capacity of CMC is afforded by the negatively charged carboxyl groups on the polysaccharide
background that increase hydration and subsequently make CMC more susceptible to hydrolytic
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degradation of ester bonds within methacrylate crosslinks. Sulfonates were incorporated onto MC
during redox polymerization in order to fabricate a “GAG-mimetic” sulfonated MC (sMC)
hydrogel (Chapter 3). Using factorial design, sulfonated MC hydrogels were investigated for
material properties and injectability. Sulfonate incorporation did not have any effect on the
swelling ratio of MC hydrogels, which was tunable by modifying macromer concentration. Ex vivo
bovine motion segment models for injection and retention showed that a minimum of 3% MC
crosslinked with 10 mM APS and TEMED each was necessary to form hydrogels in situ. As
another challenge to translation of tissue-engineered NP replacements has been delivery of TGFb3 within the hydrogel system, the ability of the GAG-mimetic sMC to sequester encapsulated
TGF-b3 was investigated as well. Sulfonate concentration allowed for sequestration of TGF-b3 in
a tunable fashion proportional to the concentration of sulfonates.
Using the results of the factorial study in Chapter 3, 5 mM sulfonate concentration with 3%
MC macromer concentration was selected for encapsulation of hMSCs. Sulfonation and TGF-b3
delivery for hMSC-laden MC scaffolds was investigated over 6 weeks. The constructs showed
moderate matrix deposition, with clear superiority in the groups that were both sulfonated and
received TGF-b3 stimulation, regardless of delivery route, although cell viability decreased over
time in all groups except those with both sulfonates and TGF-b3, indicating a potentially
synergistic effect on survival and differentiation. The hydrogels exhibited no change in mechanical
or swelling properties over time, indicating that MC remained resistant to hydrolytic degradation.
The results suggested that scaffold sulfonation and encapsulated TGF-b3 delivery hold promise
for cellulose-based hydrogels for NP tissue engineering, and elucidated areas for further
optimization. The major findings and limitations of these studies, as well as recommendations for
future work, are presented in this chapter.
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5.2

Rheological Analysis of the Effect of Methacrylation on the Thermoresponsive
Gelation of Methylcellulose in Aqueous Solutions (Chapter 2)
Methylcellulose is a unique cellulose derivative that is water soluble and exhibits reverse

thermogelation behavior, forming a physically crosslinked hydrogel at increasing temperatures.
The modification of hydroxyls on cellulose with methoxy groups interrupt the strong interchain
hydrogen bonds that render cellulose insoluble in water. Somewhat paradoxically, this solubility
is afforded by methoxy groups which are hydrophobic themselves. Thus, the thermoresponsive
behavior is mediated by the aggregation of hydrophobic groups at increasing temperatures.
Previous studies in our lab have explored the effect of macromer concentration, molecular weight,
and methacrylation percentage on hydrogel mechanics in unconfined compression, as well as
swelling behavior. Additionally, the gelation kinetics of redox-polymerized gels were only
investigated at room temperature, and so the effect of the thermoresponsive nature of MC on redoxinitiated gelation was not explored. Methacrylate groups are hydrophobic; thus, it was
hypothesized that methacrylation of MC would enhance the thermal response and lower the
gelation temperature of MC.
Rheology was chosen as the primary means for measuring the thermal response of MC as it
was directly relatable to the physical behavior of the gel and has implications for its handling and
injectability. A preliminary challenge lay in the fact that the definition of thermogelation
temperature varies widely in the literature, and so it is difficult to compare studies without first
comparing the definition used in each study. As such, MC with varying methacrylation percentages
was tested over a temperature ramp of 4°C to 80°C, and the onset of thermogelation was
determined using three different methods based off of the literature. While the trend of decreasing
thermogelation onset temperature with increasing methacrylation percent was mostly preserved
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across all methods, the meaningfulness of the physical behavior depended how the definition is
applied. For example, when the traditional Winter-Chambon definition of a gel, G’>G” is taken
as indication of thermogelation, it can be seen that methacrylated MC frequently gels at
temperatures well under physiologic temperature, but that this crossover point does not correspond
to the sharp increase in G’ associated with the ordering of MC chains in response to increased
temperatures. Rather, it likely has to do with the passive aggregation of hydrophobic moieties at
a higher concentration. Similarly, taking the derivative of the log of G’ as the point of sharpest
increase in G’ to be the point of thermogelation onset (when it is more accurately the midpoint of
the thermogelation process) selects for a higher temperature above 37°C for all groups, and may
cause researchers to artificially and inaccurately conclude that a particular material does not
achieve thermoresponsiveness at physiologic temperatures.
The influence of methacrylation on thermogelation was then investigated under the formation
of purely physically crosslinked gels at 37°C. As the temperature ramp data indicated, increasing
methacrylation percentage resulted in stiffer gels at 37°C, and that the contributions of salts in PBS
nearly doubled the stiffness at higher methacrylation percentages, while it had little effect with the
low and unmethacrylated groups. Interestingly, strain stiffening behavior was observed at 37° in
MC of higher methacrylation precents. This was attributed to the gradual ordering of MC chains
at 37°C, along with a steady rate of increasing strain that strengthened the interchain bonds rather
than slowly breaking them. This had direct implications on the injectability of the gels, so cyclic
strain tests were employed to see how quickly the gels responded to rapid changes in strain. Even
at high methacrylation percentages the gels were immediately able to respond to high strain, and
that the recovery at low strain was gradual, a classic behavior of thixotropic materials.
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The combined effects of methacrylation percentage and redox-initiated polymerization on the
gelation kinetics at room temperature versus physiologic temperature were then examined.
Gelation was observed to begin much more rapidly at 37°C than at 20°C, although it is likely that
this can at least partially be attributed to the effect of temperature on the reaction chemistry; the
observed “toe” region in the gelation profile at 20°C did not decrease significantly with increasing
methacrylation, indicating that the process of free-radical formation and crosslinking was
independently influenced by temperature and not the interaction of MC chains. The predefined
completion of the redox-initiated reaction was reached at approximately the same time for all
methacrylation percentages, which was predictably faster at 37°C than at 20°C. At this completion
point, gels formed at 37°C were significantly stiffer than those formed at 20°C, but gels continued
to stiffen slightly, and it was observed that if the reaction was allowed to continue, the maximum
stiffness was reached by 20 minutes and was no longer significantly different between
temperatures. The rapidity of the reaction at physiologic temperature is important for injectability
and retention. In addition to decreasing the amount of time unconsumed free radicals would persist
in situ, faster gelation could potentially prevent extravasation from the injection site.
Interestingly, there was not an additive effect of the dual crosslinking mechanism on final
stiffness, but rather the dual crosslinking played more of a role in kinetics of network formation.
What was surprising to observe was the difference in stiffness measured between high
methacrylation MC at differing temperatures. Specifically, the highest methacrylated MC (9.54%)
formed significantly stiffer gels at 20°C than at 37°C, the opposite effect of what was observed at
lower methacrylation percentages (5.84%, 2.44%). Furthermore, rather than reaching equivalence
at the end of the reaction time, the G’ of mMC9 continued to diverge, with the stiffness at 20°C
more than double that at 37°C. This seems to indicate that unused free radicals persist and that at
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37°C the network formation of mMC9 may have been strong enough to resist chain movement and
mixing to allow for completion of chemical crosslinking. Such network formation may also have
contributed to microphase separations, which pushed free radical-containing water from the
vicinity of hydrophobic methacrylate groups, diminishing the reaction efficiency. These
observations have implications for the usage of methacrylated MC at room temperature versus
physiologic temperature. If high methacrylation percentage MC macromers form stiffer gels at
room temperature rather than physiologic temperature, it brings into question the comparison of
data acquired with room temperature formed gels compared with their behavior in situ. Because
this divergence was not observed in methacrylation percentages of ~6% and lower, only macromer
methacrylated below that threshold was used for future studies so as not to introduce confounding
factors. Overall, the results of this study show that methacrylation influences the
thermoresponsiveness of MC, which is proportional to the modification percentage of the
macromer and should inform future decisions in designing MC-based hydrogel systems.
5.3

Injectable Sulfonated Methylcellulose Hydrogels with Tunable Growth Factor
Sequestration as Potential Nucleus Pulposus Replacements (Chapter 3)
Extensive investigation of methacrylated CMC has shown that it is a promising candidate

material for NP tissue engineering applications. In particular, the negatively charged carboxyl
groups on the polysaccharide backbone allow CMC to behave as a sort of GAG-mimetic material,
with a high swelling capacity. Being a non-animal derived natural polysaccharide, it is not
susceptible to hydrolytic degradation, which is a concern for implantation within the degenerate
IVD space characterized by increased catabolic enzyme activity. The hydration of CMC also
exposes the ester linkage within methacrylate crosslinks to hydrolytic degradation, which renders
the scaffold permissive to matrix elaboration by encapsulated cells. As recent studies showed,
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despite the adoption of a redox-initiated polymerization system which is amenable to injectable
applications, CMC did not gel rapidly enough within the disc space to be retained in situ. Earlier
preliminary studies with NP cells encapsulated in MC hydrogels showed less encouraging results
than those generated with CMC gels. Thus, modification methods for MC hydrogel system were
sought that would retain the thermogelling characteristic that allowed for in situ gelation and
retention in the IVD, while incorporating similar features as CMC that would make it more
supportive of cell differentiation. In addition, TGF-b3 was directly loaded into CMC hydrogels
previously in order to examine the ability of negatively charged carboxyls to deliver cellinstructive factors within the scaffold together with cells in a fully contained tissue engineering
construct. Despite the negative charge of the carboxyl groups, CMC was not able to
electrostatically sequester encapsulated TGF-b3. Incorporation of heparin into the CMC system
also did not improve biological performance of cells encapsulated with growth factor, which was
attributed to over-sequestration of TGF-b3, although this was not definitively proven. As such,
development of a GAG-mimetic using MC as the base polymer was pursued, in order retained
thermogelation behavior but increased swelling capacity and sequestered growth factors as a result
of the incorporation of charged sulfonates at varying concentrations. coupled negatively charged
sulfonates to the MC polymer was network using sulfonated methacrylate monomers during redox
polymerization. Interestingly, no effect of the addition of sulfonates on any of the material
properties of the scaffolds was observed. Thermogelation behavior was preserved, attributed to the
fact that sulfonates were not covalently attached to the MC backbone until redox polymerization.
It is likely that directly attaching negatively charged groups to the MC backbone would counteract
the hydrophobic effects of the methoxy groups and reduced the thermogelation capacity of the
polymer. As thermogelation was measured on uncrosslinked polymer, 2SEM was in solution,
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rather than attached to the polymer, so hydrophobic aggregation continued as normal and was not
affected. Interestingly, the incorporation of sulfonates had no effect on the swelling behavior of
the hydrogels, further supporting the assumption that the sulfonates did not change the network
formation of MC. Injection into ex vivo bovine motion segments showed that a minimum
macromer concentration of 3% was necessary for gelation and retention when using 10 mM redox
initiator concentration (higher initiator concentrations were not attempted, as were used in the prior
in situ study using CMC-MC with 20 mM initiators (Varma et al. 2018). 3% MC hydrogels were
further characterized for long-term stability, cytocompatibility, and growth factor sequestration.
Similar to the swelling results, it was found that sulfonation had no effect on the stability of MC
gels, which showed no evidence of hydrolytic breakdown over 8 weeks. Also, all sulfonate
monomer concentrations were cytocompatible. Growth factor retention studies showed successful
sequestration of TGF-b3 that correlated with the concentration of sulfonates. The combination of
3% MC with 5 mM 2SEM for future hMSC encapsulation studies was chosen, as there was no
significant difference between 5 mM and 10 mM 2SEM concentration. Although the hydrogels
did not show evidence of increased swelling or hydrolysis despite the addition of negatively
charged sulfonates, the ability to sequester growth factor, which was not achieved in the CMC
system, was a promising step in the development of a clinically translatable, injectable NP tissueengineered system.
5.4

TGF-b3 Sequestering, Sulfonated Methylcellulose Hydrogels Support Nucleus
Pulposus-Like Matrix Elaboration by Encapsulated Human MSCs (Chapter 4)
The sulfated GAGs of the NP play a critical role in NP mechanics and hydration, as well as

cell homeostasis. Negatively charged sulfates attract and sequester growth factors within the ECM,
extending their half-life and making them more locally available to cells. Disorders of sulfation
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cause profound defunction in musculoskeletal development, resulting in debilitating and
sometimes fatal chondrodysplasias. As such, a sGAG mimetic sMC hydrogels as potential cellinstructive scaffolds was investigated. Having previously shown the injectability and ability to
sequester growth factors in the prior chapters, the sMC material holds promise as a potentially
translational tissue engineering platform. Here, hMSCs from a pooled batch of donors were
encapsulated and investigated the effects of sulfonation and growth factor delivery over the course
of 6 weeks in vitro. Similar to previous results, the hydrogels still exhibited a burst release of
unbound growth factor, but the sulfonated hydrogels retained the majority of the loaded growth
factor for the course of the study, while unsulfonated hydrogels released the entire payload in under
2 weeks. Cell viability decreased in most groups, which was not unexpected based on earlier
preliminary studies of NPCs in photocrosslinked MC. There was no statistical change in cellularity
in gels that were both sulfonated and received growth factor, indicating that the two variables
combined may have provided a synergistic protective effect on cells. Still, gross images showed
that cells were more sparsely distributed even within those gels. Though it is not immediately clear
what drove cell death, particularly as there was no spatial pattern indicative of limited nutrient
distribution or diffusion, it is hypothesized that the resistance of the MC scaffold to degradation
limited the cells ability to proliferate and elaborate matrix, which can also influence cell survival.
Sulfonated gels with TGF-b3 stimulation exhibited greater production of matrix components Col
II and sGAGs, although the absolute values of the ECM components were extremely small and
did not begin to approach native levels. There was no net change in swelling and mechanical
properties across any of the groups over the course of the study. While this is in keeping with
previous data showing the long-term stability of MC hydrogels and their resistance to hydrolysis,
it was interesting to note that the matrix produced was not enough to have an effect on the material
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behavior of the scaffolds, likely due to the scaffolds’ resistance to degradation, which limited the
permissiveness of the hydrogel to hMSC matrix deposition. Taken together, the results
demonstrate that scaffold sulfonation and TGF-b3 sequestration show promise for future NP tissue
engineering studies, but that the stability of MC may not be amenable to cell survival or matrix
elaboration. It is possible that sMC + TGF-b3 can be used as a potential acellular NP replacement
that delivers growth factor to local cells, or that this scaffold system can be made more permissive
to cell differentiation by incorporating degradable crosslinking sites.
5.5

Limitations and Future Directions
This thesis has advanced the development of an injectable, MC-based hydrogel for cellular

and acellular NP replacement and repair. However, there are several limitations to be noted and
considerations to be made in determining future development of these biomaterials for clinical
translation.
The first study presented here focused on the rheological behavior of methacrylated MC as a
thermoresponsive polymer. Rheological analysis was used to determine thermogelation rather than
other methods, including differential scanning calorimetry (DSC) and turbidimetry, because
rheology gives the most clinically relevant data in terms of material behavior. The conclusions
with regards to the contribution of hydrophobic methacrylates to the hydrophobic aggregation of
MC was based on knowledge of the thermogelation mechanism of MC from the literature and
interpretation of the experimental results. Further analysis of the mechanism and structure of
aggregating MC could be determined with cryogenic transmission electron microscopy (cryoTEM) and small-angle neutron scattering (Lott et al. 2013), however, it is not immediately clear
whether this would provide any clinical relevance, and the investigation may be purely academic.
Still, MC has been shown to exhibit unique behaviors related to the interaction of hydrophobic
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groups even when chemically crosslinked. As such, a deeper understanding of network formation
at 37°C and its impact on parameters such as gelation kinetics and mesh size may have important
implications on solute transport and hydration within the construct. Scanning electron microscopy
(SEM) of chemically crosslinked gels would also potentially provide more insight into the gel
structural network at a scale relevant to cell encapsulation. Even observation of MC
thermogelation via optical microscopy can sometimes provide information about the clustering of
MC at increasing temperatures, although the resolution would be low (Wu et al. 2021).
Thermogelation of MC has been extensively characterized with respect to macromer concentration
and molecular weight previously, so they were not further characterized here. The results observed
here are expected to scale with different molecular weight distributions and macromer
concentrations. With increasing macromer concentration, the differences between methods for
determining thermogelation onset temperature disappear, as higher concentrations of macromer
respond to temperature with greater magnitude, and so the distinctions in this study may not be
relevant. However, for low macromer concentrations, which are more desirable for cell-based
studies, the distinction is still important. Finally, the difference in G’ of high methacrylation %
MC between 20°C and 37°C, which was not observed at lower methacrylation percentages,
presents a number of questions. Firstly, methacrylation between 5.84% and 9.54% was not titrated
in order to find the point at which this diversion in behavior begins, so an accurate threshold could
not be identified beyond stating that 5.84% methacrylated MC did not exhibit such behavior.
Elucidating the mechanism of this diversion is important as it does have implications on the
biological performance and clinical translation of MC-based materials. All our previous studies
investigating gelation kinetics and material properties of methacrylated MC were performed at
room temperature; the assumption was that the chemical crosslinks would dominate the behavior
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and that the hydrophobic interactions of MC would not factor in. This is clearly not the case in
terms of the gelation behavior, and it raises the question of whether compressive mechanics and
swelling behavior are significantly different between room temperature and physiologic
temperature. If they are significantly different, this may impact the assumptions made from all
tests of MC-based materials at room temperature, and future studies should all be performed under
careful temperature control.
The second study attempted to modify MC such that it would behave more like CMC
hydrogels, which are well suited for NP matrix elaboration, while retaining the thermogeling
capacity of MC. Sulfonates were incorporated during the redox gelation reaction; this made
characterization of the sulfonates difficult, as the size of the hydrogels was not amenable to zpotential analysis. Using the same gelation procedure, it may be possible to generate
microparticles, or thin hydrogel films which may more easily undergo z-potential measurement to
ascertain the charge of these gels. Preliminary ATR-FTIR analysis was not able to identify
sulfonate peaks on the spectra of these gels, despite the fact that the intensity of DMMB staining
correlated with the amount of 2SEM incorporated, indicating the presence of sulfonates in the
hydrogel. Further optimization of the chemistry of the material will be necessary for validating the
system. The finding that the inclusion of sulfonates had no effect on swelling behavior was
surprising, but further points to the fact that the network formed by chemically crosslinked MC
was unperturbed by the introduction of negatively charged groups. The negatively charged
sulfonates did have an effect on protein adsorption and TGF-b3 sequestration, showing that they
influence the electrochemical behavior of molecules in their vicinity. It is possible that the
hydrophobic portions of MC resist the influx of water, which seems paradoxical for hydrogels in
general, but also may be problematic for cell encapsulation. It is not immediately obvious whether
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this can be overcome without risking losing the thermogelation capacity of MC. Direct sulfation
of MC was not attempted, as has been performed previously with cellulose and other non-sulfated
polysaccharides (Portocarrero Huang et al. 2018; Zeng, Groth, and Zhang 2019; Freeman, Kedem,
and Cohen 2008; Purcell et al. 2014). It was hypothesized that the addition of a negatively charged
group to the backbone of MC would inhibit its thermogelation. It may be worth attempting,
however. Hydroxypropylmethylcellulose (HPMC) and hydroxyethylcellulose (HEMC) are
derivatives of methylcellulose that contain both hydrophobic and hydrophilic moieties, and can
form thermoresponsive hydrogels, albeit less strong than MC. The observed thermogelation
behavior is proportional to the balance between hydrophobic methoxy groups and hydrophilic
groups. This may give insight into the functionality a partially sulfated MC via direct modification,
which may result in diminished, but not lost, thermogelation of MC. Still, it should be noted that
the hydrophilicity of hydroxypropyl and hydroxyethyl are much less than that of sulfates and
sulfonates, and so direct sulfation of MC still carries the risk of obliterating the thermogelling
capacity of MC.
Gross quantification of protein was performed when examining the adhesion of serum
proteins on sMC gels. Further investigation could involve selectively exposing sMC to proteins of
various charges to determine the mechanism of protein adsorption. Mass spectrometry of adsorbed
serum proteins may also give insight into the types and features of serum proteins that adsorb onto
the material, which would enable better understanding of potential cell adhesion and immune
responses to sMC, particularly for applications outside of the IVD that are more vulnerable to
immune reactions. Additionally, if sMC is to be used as an acellular growth factor depot in the
intradiscal space, titrating the sequestration to promote some, but not total release of sequestered
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TGF-b3 may be necessary to provide controlled release of the growth factor to local cells within
the IVD.
Bioactivity of TGF-b3 was not directly measured in this study. As the ELISA used only
detects active TGF-b3, a cell-based bioactivity assay. Furthermore, the remaining TGF-b3 within
the gels was not able to be extracted in order to quantify the total actual loaded within gels, and so
calculations of percent release were based on the amount of theoretical load, assuming 100%
loading efficiency. Placing TGF-b3 in the TEMED barrel of the dual-barrel syringe system
protected it from the oxidizing effects of APS, but upon mixture during gel formation, it is possible
some growth factor was denatured, and so break down of the gels and quantification of
encapsulated TGF-b3 would give a more accurate understanding of both encapsulation and
sequestration efficiency. While the results from chapter 4 appear to indicate that the encapsulated
TGF-b3 is in fact bioactive (based on responsiveness of encapsulated hMSCs with encapsulated
TGF-b3, as compared to exogenous delivery), a mink lung epithelial cell growth inhibition study
to quantify the activity of released and encapsulated TGF-b3 could provide a more complete
understanding of the effect of the encapsulation process on the growth factor.
In the final study, hMSCs were encapsulated within the sMC hydrogel system optimized in
Chapter 3. The first and most obvious limitation is the lack of degradation of the MC-based gels.
Numerous studies have shown that matrix elaboration within hydrogels is limited when the
hydrogels do not degrade, and so the main modification to the system should be the incorporation
of degradable crosslinks. Given the hydrophobicity of MC, introducing hydrolytically cleavable
crosslinks like those that contain lactic acid may not actually influence the degradation of the gels.
Incorporation of MMP-sensitive crosslinks may allow the cells to break down the matrix as
necessary, or MMPs could be incorporated into the cell culture media to simulate the catabolic
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environment of the degenerate NP. This study was also conducted in neutral pH media. While
previous studies have shown that acidic culture conditions that attempt to replicate the degenerate
NP are not amenable to MSC differentiation (Wuertz, Godburn, and Iatridis 2009; Li et al. 2012),
the fact is that the construct would be exposed to an acidic environment in the clinical scenario.
Acidic medium may be better able to hydrolytically cleave the ester bonds within the methacrylate
crosslinks. A short study investigating the effect of an acidic environment on hydrogel stability
and encapsulated MSC survival would be able to give more insight into in vivo performance.
Gene expression was not investigated in this study; instead, matrix elaboration was used as a
more functional evaluation of hMSC differentiation, as mRNA expression does not always
translate to actual protein production. Additionally, there is still no consensus on gene markers for
the NP-phenotype, and so the chondrogenic markers COL II, ACAN and Sox9 would give an
indication of chondrogenic differentiation but not necessarily distinguish between NP and AC
phenotypes.
Further analysis for apoptosis, such as the TUNEL assay or cleaved caspase-3 staining, was
not performed. Production of matrix components was indicative of active metabolism; as such it
was assumed that the cells were not necrotic, and that instead cell death was occurring via a
controlled mechanism. Still, the presence of lysed and potentially hypertrophic cells on the H&Estained sections raises the question of mechanism of cell death, and so further analysis should be
pursued. Cells that die via apoptosis and are not able to be consumed by macrophages (as is the
case in in vitro cell culture, proceed on to secondary necrosis, and so visual inspection is not
sufficient to ascertain the mode of cell death. Moreover, staining for the hypertrophic marker, type
X collagen, would determine whether the remaining cells were undergoing hypertrophy.
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The cell-laden sMC study was conducted under static culture, while it is known that the native
tissue environment experiences cyclic loading. A dynamic culture system might contribute to
convective transport of TGF-b3 and water throughout the hydrogel, which could promote cell
survival and nutrient transport. As it stands, the mechanical testing system used in this study
utilizes unconfined compression; while there are data on NP tissue in unconfined compression for
comparison, it is not directly relevant to the in vivo condition, and confined compression would
not only be more relevant to the in situ behavior of any NP replacement, but can give information
about the constructs permeability, which is relevant to transport of nutrients and encapsulated
growth factor into and out of the gel. In general, a more physiologically relevant loading regime
must be incorporated into the analysis of any NP replacement.
General limitations to this approach must also be addressed before clinical translation can be
achieved. Reduced nutrient transfer within the degenerate IVD puts any cell-based therapeutic at
a disadvantage; the introduction of a tissue-engineered construct with higher cell count than the
adult disc might further stress the system by increasing nutritional demands on the already
compromised tissue. Also, the constructs studied here are of a much smaller scale than the size of
the human disc. Scaling up would not only require enormous amounts of cells and growth factor
but would alter the transport of nutrients. Even within studies on successful NP-like differentiation
in CMC, limited nutrient diffusion into some gels was observed as limiting the differentiation and
matrix elaboration of cells within the center of the constructs. As mentioned above, dynamic
culture might alleviate some of the diffusional issues presented with scale up, and so it is critical
that the relevant in vitro models and testing be done to ensure that even preclinical in vivo studies
are conducted with the best possible chance of success, having eliminated as many unknowns as
possible before committing valuable resources.
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The cells used in this study were acquired from a commercially available supplier and pooled
from 3 donors. The usage of pooled donors is meant to eliminate the need for repeated studies in
which donor cell quality is a variable added on top of variables that come naturally between
studies. Pooled donor studies have shown that they can eliminate confounding donor variability
without any negative impact on viability, proliferation, and differentiation, and have
immunomodulatory effects equivalent to those of individual donors (Widholz et al. 2019;
Hejretová et al. 2020). Pooled donor studies have frequently been used in NP tissue engineering
(Frith et al. 2014; Potier and Ito 2014; Wang et al. 2016; Thorpe et al. 2010). Still, the donors used
in this study were all young and healthy (in their 20s), and a study using donors from a more
representative population may give better insight into the actual clinical performance of the
construct.
The mechanics and swelling behavior of the sMC gels both with and without encapsulated
cells matched those of the native NP. Additionally, injectability of the material was validated by
performing ex vivo injections into a bovine motion segment nucleotomy model. The motion
segment was not subjected to further mechanical testing, however. Further motion segment testing
should be performed to measure the restoration of disc height, compression and torsional
mechanics, and resistance to extrusion/reherniation and failure before this material is tested in
preclinical in vivo models.
Finally, as mentioned earlier, direct sulfation of MC, or the use of HPMC or HEMC may
alleviate some of the MC-specific issues of this culture platform while maintaining thermogelation
and injectability but would require a full repeat of the studies performed here to determine the
rheological behavior of the pre-gelled polymers, as well as a complete materials characterization
of acellular HPMC or HEMC hydrogels before moving forward with any cell-based studies.
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5.6

Final Conclusions
Collectively, this thesis has contributed to the characterization and development of an MC-

based hydrogel system with potential as both an acellular and cell-laden NP replacement for IVD
repair and regeneration. MC is a fascinating biopolymer with unique behaviors that require further
investigation in order to anticipate the behavior of an MC-based system within a clinical setting.
The dual-crosslinking mechanism of thermogelation and methacrylate-mediated free-radical
polymerization results in a robust hydrogel with many potential applications outside of the disc
and should be explored. Sulfonation of the MC hydrogel generated an effective growth factor
sequestration depot that retained its mechanical and structural integrity over time. Although the
sMC hydrogel supported NP-like matrix elaboration by encapsulated hMSCs, cell survival was
not optimized, and matrix elaboration was limited by the lack of available void space for diffusion
of freshly synthesized matrix components. Future work should focus on incorporation of
degradable moieties within the sMC hydrogel to enhance cell survival and differentiation.
Additionally, as sMC gels in situ and can achieve relevant NP-like mechanical properties, ex vivo
motion segment testing should be the next step in validating the material’s acellular performance
before moving forward. Despite the study limitations, we were able to produce a stable hydrogel
material that is injectable and retained in situ, that exhibits mechanical and material properties
relevant to the healthy human NP and sequesters encapsulated TGF-b3. This scaffold supported
the deposition of relevant NP matrix components by encapsulated MSCs in vitro, and although
gross matrix production was limited, it is an important first step in further developing an MCbased platform for injectable NP tissue engineering therapeutics. In summary, this thesis has
advanced the development of injectable NP biomaterials and has laid the groundwork for future
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development of MC-based hydrogels for IVD repair and may be translated into beneficial uses in
numerous other medical applications in soft tissue replacement.
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Appendix: Detailed Protocols
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Methacrylated Methylcellulose Macromer Synthesis
Materials
Large Beaker (flat bottom)
Stir bar
Methacrylic anhydride (Aldrich, 27, 668-5, 760-93-0, MW = 154.17, density = 1.035g/mL)
1N NaOH
1N HCl
Spectra/por membrane, MW cut-off 6-8kDa, flat width 110mm
Day 1
1. Dissolve 1.5g methyl cellulose (MC) in sterile H2O to a volume of 150mL. (adjust as
necessary for desired volume)
2. Heat ~100mL of sterile water to 80°C on a hot plate.
3. Cool ~200mL of sterile water to 4°C in an ice-water bath.
4. Measure 1.5g of methyl cellulose. (for low/med mix, measure out equal amounts of low
viscosity and med viscosity MC and mix)
5. Check the temperature of the heated and cooled sterile water before continuing.
6. Pipet 50mL (1/3 of the total final volume) of 80°C sterile water into a new beaker
containing a magnetic stir bar. Place the beaker on the heated stir plate.
7. Slowly add MC as the hot water is stirring. As the clumps begin to dissolve, add more
MC. Continue this process until all of the MC is added.
8. Place the MC solution on an UNHEATED stir plate.
9. Add 50mL of 4°C sterile water to the MC solution and allow the solution to continue
stirring. The solution should become less cloudy with the addition of cold sterile water.
10. Add an additional 50mL of 4°C sterile water to the MC solution making up a total
volume of 150mL.
11. Allow the MC solution to stir at 4C overnight or over weekend before using in
macromere reaction
Day 4
1. Standardize the pH meter. Make sure the hole at the top of the electrode is in the open
position prior to standardizing in the 4.0, 7.0, & 10.0 buffers.
2. Place ~100mL of 1% MC in a 250mL round bottom flask containing a football stir bar.
The entire flask should be on ice for the entire reaction.
3. Calculate the amount of methacrylic anhydride (MA)
4. Grams x (1/335 g/mol) x (percent modification) x (amount excess) x (154.17 g/mol of
MA) x (1/1.035 g/mL)
5. Example: (1.0)(1/(335g/mol))(0.1)(20)(154.17g/mol)(1/(1.035g/mL))
6. In the hood, on ice, adjust pH to 8 with NaOH.
7. Note the initial pH of the solution.
8. Add 1/3 the calculated amount of MA all at once (note the lot # of MA used).
9. Every 15 minutes readjust the pH to 8.5 for an hour (this is equivalent to 4 adjustments in
1 hour).
10. Note the pH after adding NaOH and at the end of each 15 minute interval.
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11. After adjusting the pH to 8.5 for the 4th time, add the second 1/3 of the calculated
amount of MA all at once.
12. Every 15 minutes readjust the pH to 8.5 for an hour (this is equivalent to 4 adjustments in
1 hour)
13. Note the pH after adding NaOH and at the end of each 15 minute interval.
14. After the 4th time, place the reaction in cold room overnight at 4°C (in ice, on stir-plate).
Day 5
1. In the morning note the reaction pH.
2. Standardize the pH meter. Make sure the hole at the top of the electrode is in the open
position prior to standardizing in the 4.0, 7.0, & 10.0 buffers.
3. Readjust the pH to 8.5.
4. Add the last 1/3 of the calculated amount of MA all at once (make sure you are using the
same batch of MA from Day 1).
5. Every 15 minutes readjust the pH to 8.5 for 45 minutes (for a total of 3 adjustments).
6. Note the pH after adding NaOH and at the end of each 15 minute interval.
7. Begin setting up for dialysis:
8. Cut a piece of dialysis membrane.
9. Place the membrane in sterile water to soften.
10. Fifteen minutes after the third adjustment, the pH should be close to 7.0. If not, readjust
the pH to between 7-7.5 until it is stable.
11. Note the pH at which the reaction stabilizes.
Day 6-8
1. Dialyze the solution against sterile water for a total of 5-6 water changes (~8hrs between
each water change) and 2 membrane changes (1 each day).
Day 9
2. Check to make sure all of the MA is dialyzed out by the 5th/6th water change. If it is,
continue to the next step. If it is not, dialyze for longer.
3. Filter dialyzed solution through a 40µm filter into a 200mL beaker. Make sure the
resulting solution does not smell of MA. If it does, distribute the filtered sample into
50mL conical of equal volumes and place on the centrifuge for ~5 minutes at ½ the
centrifuge speed.
4. Remove the supernatant avoiding the pelleted MA and pipet it into a NEW 200mL
beaker.
5. Distribute this solution into 50mL conical (~25mL per conical).
6. Freeze all tubes at -80°C at an angle to prevent cracking of the plastic conical when the
sample expands with freezing.
Day 10-12
1. Lyophilize sample for 2-3 days or until the sample looks completely dry.
2. Store at -20ºC.
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Methylcellulose Acid Hydrolysis
Materials
50mL Round bottom flask
Small football stir bar
1N NaOH
1N HCl
Protocol
1. Warm oil bath to 80°C. Make sure electronic temperature probe and analogue
thermometer are both in the oil and read the correct temperature.
2. While oil bath is heating, place 20mg (0.02g) of polymer and 20mL of DI H2O in 50mL
round bottom flask.
3. Place round bottom flask with cork base on stir plate and stir at room temperature for ~5
minutes, making sure all the polymer gets wetted.
4. Polymer should be mostly dissolved. Place on ice and stir 15-20 minutes to complete
dissolving.
5. Once dissolved, move polymer back to room temperature. Allow solution to warm up to
room temperature (17-20°C).
6. Calibrate pH meter.
7. Use pH probe to check temperature of solution. Record initial pH and temperature. If up
to 17-20°C, begin to pH down to 2 using 1N HCl (~150µL total, add 100µL at once, then
finish in 10-25µL increments to pH 2).
8. Let sit at room temperature ~5 minutes to ensure pH is steady at 2. Record final pH and
temperature.
9. Cover with rubber stopper top and use wire to tighten around rubber stopper. Use ring
stand to hold round bottom flask and lower into oil bath (at 80°C) for 2 hours and 20
minutes (the 20 minutes are to allow solution temperature to heat up, can see MC drop
out of solution and solution become cloudy). Stir at 200rpm. Make sure the liquid line in
round bottom flask is below that of bath oil level (so that the total polymer solution is
submerged).
10. After 2 hr 20 minutes in oil bath, move straight to ice for ~10 minutes to dissolve
polymer back into solution and come to room temperature.
11. TURN OFF OIL BATH.
12. Once solution goes from cloudy back to clear, move back to room temperature. Wait for
solution temperature to move up to 17-20°C, the pH to 7 using 1N NaOH. (Use small
increments of NaOH, as you get closer to pH 7, jumps in pH will happen more
dramatically and you may overshoot. Use HCl to bring pH back down if needed).
13. Once stable at pH 7, transfer solution to 50mL conical tube and place at -80°C to freeze
overnight.
14. About 4 days before scheduled NMR session, place frozen sample on lyophilizer for 2-3
days and then immediately dissolve in 1 mL D2O once off the lyophilizer for NMR
analysis. Do not take sample off the lyophilizer if you can’t run NMR immediately –
need to have ALL water removed from sample in order to minimize water peak in NMR
spectrum.
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1

H-NMR Analysis

Sample Preparation
Day 1:
1. The day before scheduled NMR session, remove modified, hydrolyzed, lyophilized
sample off lyophilizer.
2. Use a metal probe to quickly compress polymer into a ball at the bottom of the 50mL
conical tube.
3. Use a micropipette to transfer 1 mL of D2O into the conical tube; make sure that the
entire polymer is wetted. Try to minimize exposure to air to reduce the water peak in
NMR graph.
4. Parafilm the conical tube. Place the tube in a beaker of ice then place into the 4oC fridge
to dissolve the polymer overnight.
Day 2:
1. Using a 200μL-micropipette, transfer 700μL of dissolved, hydrolyzed sample solution
into a NMR tube (200 + 200 + 200 + 100). If the solution gets stuck, put on the tube cap
and carefully shake/flick the tube.
Varian 500 Protocol
Login: Nicoll
Password: sbn428
Sample preparation & shimming:
1. Start menu -> Lock On -> click “Eject”
2. Remove placement tube and insert sample tube -> click “Insert”
3. Lock On (lock magnetic field)
4. Click “Find z0” to automate
a. Z0 ~20
b. Lock level ~40-50
c. Power ~27 (should be <40)
d. Gain ~38 (should be <40, usually = power + 10)
e. Phase ~112
5. Shim menu
a. Can click “gradient shim” to automate shimming z1-z4
b. Or manually adjust z1 & z2 to maximize lock level (~50-60; indicative of homogeneity
of sample)
Spectra acquisition:
1. Settings
a. Spectral width: -2 to 14
b. # of scan (nt=): 92 or 128
c. Relaxation (dl=): 5 sec
d. Pulse angle: 45 degrees
2. Check autogain box
3. Type in command: bs = 8
4. Click “acquire” or type command “go” to start experiment (usually take ~10 minutes to
complete)
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Spectra integration:
Type “wft” to show spectra
Use mouse scroll to adjust height of the spectra
Type “aph” for autophasing
Type “lb=0.2” for line broadening to reduce noise
Use right-hand side tool box to phase
a. Click “phase mode” icon -> click left area of spectra, hold left click to drag and even out
baseline
b. Adjust spectra so that the baseline is even/horizontal
6. After phase completion, click “redraw” icon
7. Integrate peaks
a. Process tab -> Integration tab
b. Partial mode
c. “Clear integral”
d. Integration level -> scroll up/down over region so that the green line at the left side of
the spectra is as flat as possible
e. Command “dc” for digital correction
f. “redraw” after operation
g. Click “scissors” icon to cut peaks
h. Click “red vertical line(s)” icon and place a single red vertical line on methyl peak
(~2.0ppm)
i. Integration -> “set integral area” -> single peak -> integral value = 1.00 -> click “set int
value”
j. Click “show integral values”
k. Command “wp = 7p” and “sp = -0.2p”
1.
2.
3.
4.
5.

Save & Email/Print:
1. Save file as .fid file
2. Plot -> autplot preview -> okay: will produce a pdf file of the spectra with integral values
and text descriptions
3. Can email or print the pdf file

•
•
•

Additional notes:
To load old settings: “file” -> “open” -> pick an old file to open -> now the settings for the
old file should be loaded (check?)
“wp=7p” and “sp=-0.2p” after setting integral values, not sure what it means?
Lp = 0 (<100); rp = 0 (<100) to check shimming?
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Rheometry
Instrument:
Geometry:

AR2000ex
Cone & Plate
Cone angle 1:59:28
Cone diameter 20 mm
Truncation 53 µm

***Protocol settings optimized for methacrylated methylcellulose by Gittel Gold. May need
adjustments based on different materials***
SET UP MACHINE
1. About an hour before working, make sure water tower (behind rheometer) is turned on and
set to 3˚C so that peltier plate will cool properly.
2. MAKE SURE AIR IS ON. Red knob should be parallel to open air valve. Machine will not
work otherwise. Gauge should read ~30 psi
3. Take black cap off spindle and white cover off of base
4. Turn on power from surge protector, then power switch on back of rheometer
5. Raise upper platform if necessary to attach Peltier plate (bottom plate)
a. Magnet snaps Peltier plate into place
b. Attach smart swap and flow & return tubes (push hard to snap in)
6. Open software: AR Instrument Control
7. Options à instrument à inertia à Calibrate
a. After calibration, attach geometry from bottom. Tighten from top spindle. Stop at first
bit of resistance
8. Geometry à open à 20 mm 2˚ steel cone
a. “Invalidate any zero point” à Yes
b. “Map instrument now” à Yes à Perform Mapping
9. Instrument à oscillatory mapping
a. Constant amplitude
b. Frequency: 0.1000 to 100.00
c. % strain: 1.00
d. # points: 15
e. Click perform new mapping
10. Click zero gap
a. Use arrows to bring platform down to ~5mm above base, taking care not to hit the
base
b. Continue
c. When finished, back of distance à Yes (may need to change to 15000)
SET UP EXPERIMENTAL PROCEDURE:
11. Change file name/experiment name. Make sure destination of file is in the correct folder.
12. Oscillation procedure: set up as necessary for your experiment
a. Conditioning step (if necessary)
i.
Good if starting with specific temperature, may not be good if you’re under time
constraint (i.e. with redox initiators)
b. Example Frequency Sweep:
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i.
Frequency: 0.1 – 10 Hz
ii.
Mode: log
iii.
Points per decade: 20
iv.
Temp: whatever temp desired
v. % strain: 1.000
c. Example Temperature Ramp (good for measuring thermogelation, without
redox initiators):
i.
Temperature: 4 to 40 ˚C
ii.
Ramp rate: 1˚C/min
iii.
Delay time: 15 sec
iv.
% strain: 1.000
v. Frequency: 1 Hz
d. Example Time Sweep (good for gelation with initiators):
i.
Delay 00:00:00
ii.
Duration: minimum 30 min
iii.
Temp: 37 ˚C
iv.
% strain: 1.000
v. Frequency (single): 1 Hz
e. Example Strain Sweep:
i.
Delay 00:00:00
ii.
Duration: 20 min
iii.
Temp: 4˚C or 37˚C
iv.
% strain range : 0.001 to max desired (100 to 500%)
v.
Frequency (single): 1 Hz
f. Example Cyclic Strain Recovery:
i.
Time sweep
1. Duration: 2 min
2. Temp: 37˚C
3. % strain range : 0.001%
4. Frequency (single): 1 Hz
ii.
Time sweep
1. Duration: 2 min
2. Temp: 37˚C
3. % strain range: 500%
4. Frequency (single): 1 Hz
iii.
Repeat for as many cycles as desired
iv.
Plot against global time
g.
Post experiment step usually not necessary (can help to return temp to starting temp if
doing a ramp)
13. Double click everything on main page to zero (0àsetàgo)
14. Fill top chamber of geometry with dH2O for moisture
15. For analysis without initiators (not time sensitive):
a.
Place ~200 µl in center of bottom plate, using pipet top to spread it a little. Avoid
bubbles
b.
START (machine will come down to proper height based on input geometry)
c.
During conditioning step, check for overflow.
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d.

Cover geometry with cover chamber, taking care to keep it centered and not bump the
geometry.
16. For analysis with initiators (time sensitive):
a.
Lower geometry to ~2000 (close to peltier but allowing enough space for injecting
sample)
b.
Have a timer nearby to record lag-time
c.
Click START. Machine will ask if you want to bring geometry down. Don’t click yes
until polymer has been dispensed.
d.
Using dual barrel syringe and mixing tip, inject a small amount of polymer onto a
kimwipe to avoid bubbles, then inject 150-200 ul of polymer on to center of peltier.
i.
Immediately click yes to bring geometry down and start the procedure. Do not
spread polymer out.
ii.
Start timer to record lag time. Stop when first data point is taken.
e.
Cover geometry with cover chamber, taking care to keep it centered and not bump the
geometry.
17. When sample is finished, remove cover, clean bottom Peltier plate and upper geometry, first
with dry kim-wipe, then with ethanol and kim-wipe. If necessary, reset temperature before
adding next sample.
DATA COLLECTION
18. Open software: TA Data Analysis
19. File à Open à select file
20. View à Table
21. Copy table data into excel spreadsheet
22. Switch between experimental steps using bar at the top. Make sure to copy table data from
all experimental steps
23. You can access the procedure and notes from the experiment in this program as well. (Not
able to edit)
24. Save excel spreadsheet(s) on desktop and send to yourself/copy to flashdrive.
CLOSE EVERYTHING IN BACKWARDS ORDER THAT YOU SET UP:
25. Close software
26. Remove water from geometry well
27. Raise platform and gently remove geometry
28. Detach smart swap and flow & return tubes
29. Push release button on machine to remove Peltier plate. Store in box in drawer
30. Turn off power from back of rheometer.
31. Turn off water tower.
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Differential Scanning Calorimetry
Instrument:

TA Instruments DSC Q200

*may want to do in conjunction with TGA to account for mass loss*
1. Turn on nitrogen gas
a. Delivery pressure should be 15 PSI
2. May need to turn on using on/off switch on back of machine
3. Open TA Instruments explorer
4. Control à lid à open
5. Prepare reference dish
a. For samples in solution, use same solvent as reference
b. Use cover for liquid sample and reference
6. Weigh sample
a. For liquid samples, use deep dish with lid
b. Weigh dish and lid first, then add material
c. 9-13 mg (do not exceed 13 mg)
d. Close lid (poke hole in lid with needle if concerned about pressure build up)
e. Don’t touch anything else after weighing (don’t want to add anything to weight of
sample)
7. Place sample on top of thermocouple.
a. Make sure to remove any left over ash/debris
b. Far thermocouple is for reference
c. Close thermocouple is for sample
8. Control à lid à close
9. Summary (sample info)
a. Mode: standard
b. Test: custom
c. Pan: Tzero Aluminum
d. Sample size (- pan)
10. Data file: Network à TA-PC à TA à Data à Your folder
11. Procedure: editor
a. *don’t use “initial temp”
b. Remember to Apply changes
12. Green button to start
13. Don’t open lid until temperature comes back down to at least 40C (there’s no active
cooling system)
14. Sample purge flow ~ 30 Ml/MIN
a. May change if using a coolant?
15. Shutting Down
a. Close Nitrogen gas – close main valve first
b. When pressure on both gauges is 0, close second valve
16. TA universal data analysis
a. Right click – label point
b. Integrate peak, select endpoints
i. Right click: accept limits
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Hydrogel Mechanical Testing
Unconfined Compression using Multi-Ramp SRL
Preparation
1. Let frozen gel sample rehydrate in PBS for overnight at 4°C before testing.
2. Turn on SENSOTEC 250 gram load cell 1 hour before testing to warm up.
I. Setup
1. Change multimeter wiring so that voltmeter is reading load cell.
a. Multimeter should be in –V setting.
b. Clip alligator clips to read load cell (far left black/red wires on board).
2. Calibrate load cell.
a. Adjust by using screwdriver to turn “zero” until display on load cell zero setting
read 000.0 (no + or – signs). The display on the multimeter should read <0.002V.
b. Press and hold “calibration” button, meanwhile use screwdriver to adjust “span”
in order to obtain values taped on load meter. Both the multimeter and the load
cell should read appropriate values. (If too jumpy, pop off front face of Sensotec
load cell read-out. Unscrew face plate, adjust screw 2nd from bottom, between
span and zero; this is the fine adjust for zero. The screw above span is the fine
adjust for span. Be careful, these are very sensitive to small movements.)
3. Switch alligator clips so that the multimeter reads from LVDT wires (on right on DAQ
board).
4. Clean platform and chamber with ethanol. Tape on the chamber so that it is suspended
around the load cell but not touching. The load meter should read 19-20g.
5. Clean the indenter with ethanol. Screw on the indenter tight but be careful not the push
up on load cell.
6. Clean the glass base plate with ethanol. Place the plate at the center of the platform.
7. Lower the indenter so that it is approximately 5mm above the base plate. Adjust the
stage so that the multimeter reads -3 to -5V.
a. Note that the multimeter voltage should be between -5 and 5V during the entire
testing process to stay within the linear range.
b. To raise or lower the top stage, use the 340-RC knob. Be sure that the inner rod
does not touch QB condenser.
c. Glass plates should be entirely parallel when touching, if not adjust front center
hold with Allen wrench.
8. Turn on stepper motor. Connect stepper motor to the testing device via rainbow wires.
9. Check Labview document folder to ensure that previous crp.dat and srl.dat files have
been deleted.
10. Open National Instrument software. Open VI “creep_with_daq(cont
pulse)_250g_Initial_AIC”. Adjust load window axes so that load meter values are within
display window. Press “run”. Once the load jumps, stop the run, disconnect rainbow
wires, and raise the indenter.
11. Open crp.dat file [time/load/displacement/voltage]. Scatterplot load vs. time. Determine,
highlight, and record a base voltage, then save the excel file.
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II. Sample Placement
12. Image gel sample in order to obtain area
13. Wet glass base plate with a few drops of PBS. Load gel onto plate using a metal spatula;
center gel. Add more PBS to submerge gel. Place plate with gel onto the platform
14. Lower indenter until indenter barely touches the gel. Bring down and seal chamber
15. Slowly add PBS along the wall of the chamber, make sure the gel does not slip out. Add
PBS until chamber is ¾ full.
16. Slowly raise indenter such that it hovers right above the gel.
III. Initial Creep – Sample Height
17. Delete crp.dat file from previous base voltage step.
18. Connect rainbow wire.
19. Open initial creep VI “creep_with_daq(cont pulse)_250g_Initial_AIC”.
20. Adjust load window axes accordingly. Make sure ramp velocity is 10μm/s. Run
program.
21. Watch load read out to determine when the indenter hits the gel sample; there should be a
sharp increase in load. Once the indenter has touched the sample, stop the program.
Disconnect the rainbow wire and raise the indenter slightly.
22. Open crp.dat file. Scatterplot time (x) vs. load (y). Paste table. Determine, find, and
highlight contact point. Copy/paste contact point information into table. Enter base
voltage and LVDT constant. Record initial thickness and initial tare load. Save excel file
time
load
disp
voltage
Contact point:
47.662
-18.509
412.763
0.419
Base voltage (V):
Desired Tare Load (g):
change in voltage:
LVDT #1 (um/V):

-3.768
1
4.187
558.21

thickness (um):

(set to 1)
(contact point voltage - base voltage)
(a constant value, calculated prior by calibrating
LVDT)
2337.225 (change in voltage * LVDT)

Initial Tare Load:

-17.509

(contact point load + desired tare load)

IV. Creep Test
23. Delete crp.dat file from previous initial creep step.
24. Open creep vi “creep_w_daq(cont pulse)_250g”.
25. Change load limit to calculated initial tare load. The input ramp velocity should be
10μm/s. Run the program. Start timer when load reaches initial tare load then let the
program run for 45min.
26. After 45min, stop the program. Open crp.dat file. Scatterplot time (x) vs. load (y). Paste
table. Determine, find, and highlight final test point and the point 10min/600sec before
that final point (choose points in the middle for representative points). Copy/paste
information for those two points into table. (note that <10μm thickness change over
10min is Alice’s equilibrium criteria.) Enter base voltage and LVDT constant. Record
post-creep thickness. Save excel file.
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Final Point:
10min prior Point:
Base voltage (V):
Desired Tare Load
(g):
change in voltage:
LVDT #1 (um/V):
thickness (um):

time
load
disp
voltage
2755.528 -17.395 392.662 0.112
2156.614 -17.41 390.447 0.116
-3.768

displacement(um)

1
3.88
558.21
2165.855

2.215

< 10um displacement

V. Stress-Relaxation Test
27. Delete any old crp.dat or srl.dat files.
28. Open stress-relaxation vi “Desktop SRL (multi_ramp)_250g”.
29. Enter post-creep thickness. Set ramp velocity to 10μm/sec. Set strain to 0.05. Set #ramps
to 3. Set relaxation time to 2000sec. And set stop time to 6500sec. Then run the
program.
30. When test is complete, open srl.date file. Scatterplot time (x) vs. load (y). Then save the
excel file. Delete the srl.dat file. Close National Instrument software.
VI. Sample Removal and Clean-Up
31. Raise indenter all the way.
32. Remove PBS using a plastic transfer pipette.
33. Carefully remove the plastic chamber. Carefully unscrew the indenter. Clean the
platform, indenter, and glass base plate with ethanol. Clean all remaining surfaces.
34. Place tested gel in original Petri dish, parafilm, and store at -20°C freezer.
35. Turn off step motor/power strip.
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Bovine Tail Motion Segment Injury and Repair
Materials:
•
•
•
•
•
•

Cleaned, thawed motion segment (soak in PBS and leave in 4°C the night before; leave in
37°C room for 1 hr prior to experiment)
Dissolved polymer solution in double-barrel syringes
Initiator stock; trypan blue;
#4 scalpel and #20 or #22 blade for cleaning motion segment
#3 scalpel and #15 blade for creating injury
Rongeur, curette, and forceps

Procedure:
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.

Work on blue pads
Add initiators, trypan blue to polymer solution and mix with glass stir rod for
visualization
Leave polymer solution mixture in 37°C for 30 min
Measure disc diameter and height
Use #20/22 blade to clean segment
Use #15 blade to make X annular tear (up to the length of sharpened part)
Use curette to dislodge NP tissue
Use rongeur to remove 0.15-0.2g of NP (Might need to repeat curette & rongeur action a
few times)
Once injury is complete, inject polymer solution
Leave motion segment in 37°C for 30 min for gel to form (wrap motion segment in PBS
soaked Kim-wipe to avoid tissue dehydration)
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Live/Dead Staining of Hydrogels
Materials:
-1 mM Calcein AM (dissolved in DMSO)
-2 mM Ethidium homodimer (dissolved in DMSO)
-Sterile PBS
-24-well plate
Protocol:
1. Warm PBS in water bath.
2. Remove calcein AM & ethidium homodimer from the -20ºC freezer and thaw to room
temperature by placing in a drawer (both are light sensitive and must be protected from
light while thawing). Once thawed, vortex to ensure homogenous mixture.
3. In the tissue culture hood with the lights turned off, measure out 3.2 mL of PBS and place
in a 15 mL conical wrapped in foil. (this is for 2 gels)
4. Add 2.4 μL of 1 mM calcein AM to the PBS
5. Add 1.2 μL of 2 mM ethidium homodimer to complete the Live/Dead solution. You can
scale up the mixture accordingly for the # of samples you have, just keep everything in
the same proportions.
6. Return calcein AM and ethidium homodimer stock solutions to -20ºC.
7. Vortex Live/Dead solution and return to tissue culture hood.
8. Remove gels from incubator and transfer them into a new 24-well plate.
9. Wash samples twice with 1.5mL PBS.
10. Transfer samples into new wells. Add 1.5 mL of Live/Dead solution to each well
containing a gel.
11. Wrap the 24-well plate in foil and place allow the gels to incubate for 45 minutes at room
temperature, protected from light.
12. Turn on fluorescence lamp for imaging at least 20 minutes prior to end of incubation
period. The fluorescence lamp requires at least 20 minutes of warm-up time prior to use
and must be on for at least one hour total, so make note of the time you turn the lamp on.
13. After 45 minute incubation, in the TC hood, rinse each gel twice with 1.5 mL PBS.
14. Take microscope images of each sample while leaving the other samples in 1.5mL PBS
covered.
Imaging:
1. Focus condensor at 10X. Using Phase 1 filter, take a phase picture of gel. Change light
source from all to eyepiece to all to camera (this is especially important for fluorescence
pictures).
2. Using FITC filter, take live images (cells should be green).
3. Using TRITC filter, take dead images (cells should be red).
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Pepsin Digest
Digest to break down cell culture gels prior to PicoGreen Assay and ELISAs. Needs to be done 2
days prior to these assays.
Prior to digestion:
1. Collect gels in preweighed 1.5 ml microcentrifuge tubes. Blot excess liquid prior to saving
gels.
2. Immediately record wet weight and then freeze at -80°C
3. Lyophilize gels for ~3 days until completely dry.
4. Remove gels from lyophilizer, record dry weight. Store at -80°C until digestion protocol.
5. Calculate swelling ratio for each gel.
Materials and Solutions to Prepare:
Pestle (one for each gel, to prevent cross contamination)
0.05N Acetic Acid:
0.05N CH3COOH in sterile water, pH 2.8-3.0 with formic acid.
Add 1.437mL of 17.4M acetic acid stock to 498.56mL of sterile water. Adjust pH to 2.8
with formic acid (starts ~3.0)
Pepsin (4560 units/mL AA):
13.22mg/mL solution in 0.05N Acetic Acid (for pepsin at activity of 345 units/mg solid).
Alter mg/mL concentration (13.22) for different lot or activity of pepsin to keep units/mL
consistent.
10X TBS #2:
1.0M Tris, 1.5M NaCl
For 100mL: 12.114g Tris, 8.766g NaCl
Dissolve in 70mL sterile water. pH down to 8.0 (starts ~10.5). Fill to 100mL. Readjust pH to
8.0 [Start with 12N HCl ~400µL increments.]
Digest:
1. Pulverize dry gel using 0.5mL pestle. Add 425µL 0.05N Acetic Acid per tube. Pulverize
more.
2. Add 100µL pepsin solution. Vortex to mix.
3. Rotate samples at 4°C for 48hours.
4. Stop pepsin digestion reaction.
a. Add 100µL of 10X TBS#2 (1:1 ratio with how much pepsin was added) and vortex
sample. Sample pH should be ~8.0 (pH must be >5 to neutralize pepsin).
5. Aliquot 20 μL of each sample into new tubes and add 5 μL 5% Triton-X and store at -20°C
for PicoGreen Assay.
6. Use remaining sample for Collagen ELISAs and DMMB assay.
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Collagen ELISA
ELISA Protocol for both Type I and Type II Collagen in parallel
2 days before ELISA, start Pepsin Digest: (See Pepsin Digest Protocol for reagents and
instructions) Pulverize and digest gels with pepsin, rotating at 4°C for 48 hours.
Associated Spreadsheets:
ELISA-setup
Supplies:
ELISA plates: Nunc Maxisorp 96-well plates (Fisher Item # 12-565-136)
25X Wash Buffer: R&D Systems Item # WA126
TMB Substrate Kit: Vector Labs Item # SK-4400
Streptavidin HRP: R&D Systems Item # DY998
Human Collagen (type I and type II) Standards:
Collagen Type I: Chondrex CN: 1005
Collagen Type II: Chondrex CN: 2015
Primary antibody (Col I: Sigma; Col II: DSHB)
Secondary antibodies (Vector Labs Item # BA-1400)
Buffers & Solutions:
Store all buffers and solutions at 4°C
Complete ELISA with all standards/samples held at 4°C
Do not use ultrapure water for any of the below solutions. It may contain inhibitors of the
peroxidase reactions.
Coating Buffer:
1.59g Na2CO3
Sodium Carbonate
2.94g NaHCO3
Sodium Bicarbonate
0.2g NaN3
Sodium Azide
Dissolve in 850mL DI water and adjust pH to 9.6 (starts ~ 9.7). Fill to 1L and readjust.
Washing Solution (PBS-T):
5% (v/v) Tween 20 in PBS
Make from 25X stock solution in 4°C fridge. Dilute in DI H2O.
Stopping Solution:
1N sulfuric acid
Add 13.3mL of sulfuric acid to 487mL of distilled water.
10X TBS:
1.0M Tris, 2M NaCL, 50mM CaCl2
To 250mL of deionized water, add:
30.285g of Tris (MW: 121.14)
29.22g of NaCl (MW: 58.44)
1.8378g of CaCl2 (MW: 147.02)
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Adjust pH to 8.0 (starts ~10.7)
10X TBS #2:
1.0M Tris, 1.5M NaCl
For 100mL:
12.114g Tris
8.766g NaCl
Dissolve in 70mL sterile water. pH down to 8.0 (starts ~10.5). Fill to 100mL. Readjust pH to
8.0 [Start with 12N HCl ~400µL increments.]
Blocking Solution: (make fresh)
2% BSA Fraction V and 0.1% NaN3 in non-sterile PBS
Dissolve 2g of BSA in 100ml PBS. Add 0.1g of NaN3 to the solution and stir.
AA/Pepsin/TBS#2:
To dilute Coll II Standards when using DSHB 1° Ab – from digestion solution ratios:
425µL 0.05N Acetic Acid
100µL Pepsin
100µL 10X TBS#2
Scale up for total volume needed.
DAY 1:
1. Prepare plate layout and calculate amount needed for standards and solutions using Excel
spreadsheet. Col I and Col II ELISAs run on separate plates – Primary antibodies are
different, but all other steps are the same.
2. Label all tubes
14 standards + 3 stock tubes for each type Col
1 for each sample and standard (50/50 dilution in coating buffer)
3. Prepare all standards on ice. Dissolve collagen I standard in 0.05N acetic acid and collagen
II standard in AA/Pepsin/TBS#2 solution to make 0.1mg/mL stock solutions. Make serial
dilutions in 0.05N AA or AA/Pepsin/TBS#2 for standards.
a. Collagen I (stock concentration = 0.5mg/mL)
i. For 0.1mg/mL solution – 2:10 dilution of Col I standard (at 0.5mg/mL) in
0.05N acetic acid
ii. For 10µg/mL solution – 1:10 dilution of 0.1mg/mL solution in 0.05N acetic
acid
iii. For 1µg/mL solution – 1:10 dilution of 10µg/mL solution in 0.05N acetic acid
b. Collagen II (stock concentration = 0.5mg/mL)
i. Prepare same way as collagen I standards except that the diluent is
AA/Pepsin/TBS#2 instead of acetic acid.
4. Stop pepsin digestion reaction.
a. Add 100µL of 10X TBS#2 (1:1 ratio with how much pepsin was added) and vortex
sample. Sample pH should be ~8.0 (pH must be >5 to neutralize pepsin).
5. Vortex standards and samples, and then prepare 50/50 dilutions of each with coating buffer
in 1.5mL microcentrifuge tubes (Take solutions from top of tube).
6. Add 100µL per well of CB/standards and CB/samples to Nunc maxisorp plates.
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7. Parafilm plates and incubate overnight at 4°C.
8. Set aside samples for other Biochemistry (at least 20 µL needed for PicoGreen and 20 µL for
DMMB)
DAY 2:
1. Wash plate 4 times in PBS-T (one quick wash and three 5 minute washes).
2. Add 100µL of blocking solution per well and incubate at room temperature for 1-2 hours.
(1hr).
3. Remove Blocking Solution but DO NOT WASH.
4. Prepare 1° immediately before use. Add 100µL of primary antibody to each well (0.5µg/mL
of antibody per well).
a. 1:10,000 Collagen I (Sigma) primary antibody diluted in blocking solution
b. 1:100 Collagen II (DSHB) primary antibody diluted in blocking solution
5. Parafilm plates and incubate overnight at 4°C.
DAY 3:
1. Wash 4 times in PBS-T (one quick wash and three 5-minute washes).
a. Make 2° Ab solution - 50 µL of 2° Ab in 10mL of blocking solution (Collagen 2°:
biotinylated anti-mouse IgG/anti-rabbit IgG H+L)
2. Add 100µL of secondary to each well and incubate for 30 minutes.
3. Wash 4 times in PBS-T (one quick wash and three 5 minute washes).
4. Add 100µL of Streptavidin HRP to each well and incubate for 30 minutes.
a. 1:200 dilution in PBS
5. Wash 4 times in PBS-T (one quick wash and three 5 minute washes).
6. Make TMB Substrate Solution (immediately before use)
a. Add 2 drops of Buffer Stock Solution to 5mL of dH2O and mix well
b. Add 3 drops of TMB Substrate Solution and mix well
c. Add 2 drops of Hydrogen Peroxide and mix well
7. Add 100µL of TMB Substrate Solution and allow blue color to develop at room temperature
for 10-30 minutes. (4 min. for Col I, Col II, and CSPG)
8. Add 50µL of Stopping Solution and read plate at 450nm absorbance. Wells should turn from
blue to yellow with the addition of Stopping Solution. (TMB absorption may be read without
use of Stopping Solution (650nm), but stopping the reaction increases the absorbance of the
reaction product two- to four-fold.)
REFERENCES: Chondrex, Inc. (www.chondrex.com) Human Type I Collagen Detection Kit
(Catalog #6008) digestion protocol
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PicoGreen Assay
Hydrogel constructs must go through pepsin digest before assaying (See pepsin digest protocol).
Before performing PicoGreen assay, make sure that samples have gone through two freeze/thaw
cycles.
Associated spreadsheets:
PicoGreen-Setup: Solution Additive, PicoGreen Solution and Plate Setup
PicoGreen-Analysis
Supplies:
96 well plates
PicoGreen reagent
Reagents:
Pepsin digested samples (see Pepsin Digest Protocol
5% Triton-X (from Triton-X 100 in Acetic Acid)
Pepsin Solution Additive
425 μL 0.05N Acetic Acid
100 μLPepsin
100 μL 10X TBS
156.25 μL 5% Triton-X (for a 1% solution)
DNA standard
1X TE (Tris-EDTA Buffer)
10X TBS
1.0M Tris, 2M NaCL, 50mM CaCl2

To 250mL of deionized water, add:
30.285g of Tris (MW: 121.14)
29.22g of NaCl (MW: 58.44)
1.8378g of CaCl2 (MW: 147.02)
Adjust pH to 8.0 (starts ~10.7)
METHODS:
1. Calculate volumes for 1X TE, DNA Standards, and PicoGreen solution. (solutions and
plate set up excel sheet)
DNA standards:
1mL for absorbance + ~120μL for standards (x 3 to run in triplicates x number of plates)
1X PicoGreen (diluted from 200X stock from Molecular Probes, diluted in 1X TE):
Volume for standards (~100μL per standard x 5 standards x 3 to run in triplicate x number of
plates) +
Volume for samples (~100μL per sample x 3 to run in triplicate x total number of samples)
1X TE (diluted from 20X TE in sterile H2O – dilute TE immediately before use):
Volume for standards (~100μL per standard x 5 standards x 3 to run in triplicate x number of
plates) +
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Volume for samples (~100μL per sample x 3 to run in triplicate x total number of samples) +
1mL for DNA absorbance +
Volume to dilute DNA standard into 2μg/mL +
Volume to dilute 200X PicoGreen stock to 1X
2. Turn on plate reader; set up for DNA absorbance reading. Thaw PicoGreen samples and
Solution Additive on ice.
3. Prepare samples (usually done immediately after Pepsin digest): 20µL sample + 5µL 5%
Triton-X for 1% solution, then go through 2 freeze/thaw cycles to lyse cells.
4. Dilute 20X TE in sterile H2O to obtain an appropriate amount of 1X TE.
5. Dilute DNA stock in 1X TE to obtain an appropriate amount of DNA with concentration
approximately equal to 2μg/mL.
µg
2 ]mL` ∗ 𝑉𝑜𝑙𝑢𝑚𝑒HIJKLMHCNOPCQLRSHRTHCSMMHMH [µL]
𝑉𝑜𝑙𝑢𝑚𝑒AB&CDEF2G [µL] =
µg
𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛AB&CDEF2G [mL]
6. Read DNA absorbance at 260nm using cuvettes.
• Protocol name: Biocell PicoGreen Std
• Include blank: add 1mL 1X TE to Biocell cuvette #1
• Include 2μg/mL DNA sample: add 1mL DNA standard to Biocell cuvette #2
• Note: reading/opening of Biocell cuvette are on opposite sides. Make sure that there
are no air bubbles, especially on the reading side.
• Read plate and save plate reading.
• Calculate actual DNA concentration (µg/mL):
µg
𝐷𝑁𝐴𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 − 𝑏𝑙𝑎𝑛𝑘 1𝑋 𝑇𝐸
𝐷𝑁𝐴2F@2:@E>#EUF@ ] ` =
mL
0.02
• From Molecular Probes PicoGreen product sheet, absorbance260 of 0.04 corresponds
to 2µg/mL double-stranded DNA solution, which is where 0.02 in the equation above
comes from.
7. Read blank black plate with clear bottom.
• Protocol name: PicoGreen Assay (ex/em: 485/528)
• Plate reader may ask you to wait 3 minutes for fluorescence to warm up before
reading plate, in this case, place the plate on an orange plastic base (to protect clear
bottom film) and leave in a drawer to incubate.
• Read plate and save reading.
8. Prepare standards in triplicates.
• In general, add solutions directly into wells along the sides in order to avoid
puncturing the bottom of the wells. Run each standard in triplicate.
• Add appropriate amount of 1X TE according to the chart below.
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•
•
•

Standard
1
2
3
4
5

Add appropriate amount of DNA according to the chart below.
Add appropriate amount of Solution Additive according to the chart below.
Note: do not add PicoGreen until samples have been plated as well since PicoGreen
solution is light-sensitive.
Vol. of DNA
Stock (~2µg/mL)
(µl)
100
10
1
0.1
0

Vol. 1X
TE (µL)
0
89
98
98.9
99

Sample Solution
Additive
(pepsin/acetic acid) (µl)
1
1
1
1
1

Vol. 1X
PicoGreen
(µL)
100
100
100
100
100

Final DNA
Concentration
1 µg/mL
100 ng/mL
10 ng/mL
1 ng/mL
0 (Blank)

9. Add samples; run each sample in triplicate.
• Vortex and spin down (~1min) samples before adding to plate.
• Using a multi-channel pipette, add 99μL of 1X TE to all the wells that will contain
samples.
• Add 1μL sample to each appropriate well; take sample from the top of the
microcentrifuge tube).
10. Add 1X PicoGreen to all wells.
• Dilute 200X PicoGreen stock in 1X TE to obtain an appropriate amount of 1X
PicoGreen solution.
• Using a multi-channel pipette, add 100μL of 1X PicoGreen to all wells containing
either standards or samples. Mix by pipetting up and down but make sure to not
introduce any air bubbles! Also make sure to switch to new tips when appropriate.
• Incubate plate in a drawer for ~3min while setting up the plate reader.
• Protocol: PicoGreen Assay.
• Read plate (excitation/emission: 485/528) and save reading.
11. Clean up and analyze
• Note that PicoGreen has its own waste bottle!

201

DMMB Assay
DMMB binds to sulfated GAGs
Preparation:
1. Have prepared DMMB Dye (see next page).
2. Have prepared Chondroitin Sulfate C stock (1µg/µL, 0.25µg/µL, 0.1µg/µL, 0.01µg/µL).
Assay:
1. Turn on plate reader approximately 20min before beginning the assay.
2. Read blank plate.
• Place a new 96-well plate into the plate reader.
• Open DMMB protocol. Read absorbance at 525nm and 595nm.
3. For standards, add appropriate volumes of both stock solution and DI H2O per well in
triplicate.
• Make sure to vortex stock solution in order to obtain homogeneous aliquots. See
next page for further notes.
4. For each sample, vortex sample, then add 5µL of sample per well in triplicate.
• Samples may have to be diluted depending on absorbance values relative to
standards.
5. Set up plate reader for reading.
• DMMB protocol should be already open.
• Add a new plate for actual sample readings.
6. In a dark room, pour DMMB dye into multichannel pipette reservoir immediately prior to
use, as it is light sensitive.
7. Using a multichannel pipette, add 200µL of DMMB dye to each well for both standards
and samples. Mix by pipetting up and down but be careful to not introduce bubbles.
8. Read samples at 525 and 595nm. Subtract 595 from 525 and extrapolate values.
Standards

µg GAG

Stock Solution

Amt of stock (µL)

Amt of DI H2O (µL)

1
2
3
4
5

0
0.05
0.1
0.2
0.5

N/A
0.01 µg/µL
0.1 µg/µL
0.1 µg/µL
0.1 µg/µL

0
5
1
2
5

5
0
4
3
0

6
7
8

0.75
1
1.25

0.25 µg/µL
0.25 µg/µL
0.25 µg/µL

3
4
5

2
1
0

9

2

1 µg/µL

2

3

Associated spreadsheets:
1. DMMB analysis (include plate setup)
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Preparing DMMB Dye:
(light sensitive)
Materials:
8mg DMMB (1,9 dimethylmethylene blue)
2.5mL 100% ethanol
1g sodium formate
1mL formic acid
Procedures:
1. Weigh out DMMB. Place DMMB into a 15mL conical tube, covered in aluminum foil.
2. Add 2.5mL of 100% ethanol and vortex thoroughly to get DMMB into solution.
3. In a 600mL beaker with a stir bar and covered in aluminum foil, add 350mL DI H2O.
Add 1g sodium formate and 1mL formic acid. Pour in DMMB/ethanol solution.
4. Use a 1mL pipette and 10mL DI H2O (to bring to a total of 500mL DI H2O) to rinse out
DMMB conical as dye gets stuck along walls and cap of conical.
5. pH DMMB dye down to 1.5 (original dye pH ~3-3.5) using formic acid.
• Adjusting pH may take 20-80mL of formic acid.
6. Add appropriate amount of DI H2O to obtain a final volume of 500mL of DMMB dye.
7. Read absorbance at 525 nm and 595nm. Subtract 595 from 525.
• pH 1.5 and subtracting absorbances eliminates errors from non-GAG specific
artifacts (carboxyls, DNA…) without sacrificing sensitivity, particularly for tissue
engineered samples
• Reference: Zheng and Levenston, “Fact versus artifact: Avoiding erroneous
estimates of sulfated glycosaminoglycan content using the dimethylmethylene
blue colorimetric assay for tissue-engineered constructs,” European Cells and
Materials (2015)
Standard Curve:
The stock solutions should be prepared ahead of time from Chondroitin Sulfate C (Sigma C-4384)
and stored at -20°C until use. The stock solutions can be refrozen and used again. Dissolve the
stock in a solvent applicable to your samples, or be sure to include a blank on your plate with the
solution your samples are in.
Note: Vortex stock solutions well and frequently so that you are taking aliquots from a
homogenous mixture. Also wear gloves as it is easy to contaminate the samples/standards with
GAGs, which may be on your hands.
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Hematoxylin and Eosin (H&E) Staining (Paraffin Embedded Slides)
Materials
• CitriSolv ® - Fisher Scientific, cat. # 22-143-975
• Absolute Ethanol - Fisher Scientific, cat. # A406P-4
• Hematoxylin Gill no. 2 – Sigma, cat. # GHS-2-32
• Eosin Y Alcoholic – Sigma, cat. # HT110-1-32
• Cytoseal-60 – Richard and Allan Scientific cat. # 8310-4
• Coverglass – Corning - Thickness-1 22X50mm cat. # 2975-225
Acid Alcohol (for H&E):
Combine
Scott’s Buffer:
Combine

95% Ethanol
Concentrated HCl

495mL
5mL

Sodium Bicarbonate
Magnesium Sulfate
Distilled Water

2.0g
20.0g
1Liter

Staining Procedure:
1. CitriSolv ®
3 min
2. 100% EtOH
1 min
Repeat steps 1-2 if necessary
3. 95% EtOH
1 min
4. 70% EtOH
1 min
5. 50% EtOH
1 min
6. Distilled H2O
1 min
7. Hematoxylin Solution (Gill no.2)
10 min
8. Tap H2O
3 min
9. Acid Alcohol (for H & E)
20 sec
10. Tap H2O
3 min
11. Scott’s Buffer
20 sec – 1 min
(this is the bluing step for the nuclear stain, longer incubation leads to more intense bluing
and thus contrast between nuclei and other structures)
12. Tap H2O
3 min
13. Eosin Y Solution Alcoholic
1 min
14. 95% EtOH
1 min
15. 95% EtOH
1 min
16. 100% EtOH
1 min
17. CitriSolv ®
1 min
18. Mount and coverslip with Cytoseal-60. Seal with nail polish the next day.
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Alcian Blue Staining (Paraffin Embedded Slides)
Materials
• CitriSolv ® - Fisher Scientific, cat. # 22-143-975
• Absolute Ethanol - Fisher Scientific, cat. # A406P-4
• Alcian Blue 8GX – Sigma, cat. # A-9186
• Glacial Acetic Acid – Fisher Scientific, cat. # A38-212
• Cytoseal-60 – Richard and Allan Scientific cat. # 8310-4
• Coverglass – Corning, cat. # 2975-225
3% Acetic Acid (500mL):
Combine
Acid Alcohol (for Alcian Blue):
Combine

Glacial Acetic Acid
Distilled Water

15mL
485mL

70% Ethanol
Concentrated HCl

495mL
5mL

pH to 1.0 with concentrated HCl

1% Alcian Blue Dye (500mL):
1. Dissolve 5.0 g of Alcian blue 8GX in 450 mL of 0.1N HCl by stirring for at least six
hours at room temperature.
2. Adjust pH to 1.0 and fill volume to 500mL.
3. Filter dye with büchner funnel and filter paper. This process takes approximately 1020min.
Staining Procedure:
1. CitriSolv ®
3 min
2. 100% EtOH
1 min
Repeat steps 1-2 if necessary
3. 95% EtOH
1 min
4. 70% EtOH
1 min
5. 50% EtOH
1 min
6. Distilled H2O
1 min
7. 3% Acetic Acid
3 min
8. 1% Alcian Blue (pH 1.0)
15 min
9. Acid Alcohol (for Alcian Blue)
3 min
10. Acid Alcohol (for Alcian Blue)
3 min
11. 95% EtOH
1 min
12. 100% EtOH
1 min
13. CitriSolv ®
1 min
14. Mount and coverslip with Cytoseal-60. Seal with nail polish the next day.
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Collagen ImmunoHistoChemistry
Materials:
• Water resistant Pen - Silver Permanent Marker – PILOT – Staples (on shelf)
• Hyaluronidase Type IV-S – Sigma Cat# H-4272 (stored at -20ºC)
• Hydrogen Peroxide – Fisher Scientific Cat# H325-100 (stored at 4ºC)
• Methanol – Fisher Scientific Cat# A412-1 (stored at room temp, in 5th floor chemical hood)
• 10% Horse Serum – (stored at -20ºC)
• IgG from Mouse – Sigma Cat# I8765 (stored at -20ºC)
• Type I Collagen antibody – Sigma Cat# C-2456. (stored at -20ºC)
• Type II Collagen antibody – Developmental Studies Hybridoma Bank Antibody #II-II6B3-S
(stored at 4ºC)
• Type VI Collagen antibody – Developmental Studies Hybridoma Bank Antibody 5C6-s
(stored at 4ºC)
• Type X Collagen antibody – Developmental Studies Hybridoma Bank Antibody X-AC9-s
(stored at 4ºC)
• Biotinylated secondary antibody anti-mouse anti-rabbit IgG (H+L) – VECTOR Laboratories
BA-1400 (stored at 4ºC)
• VECTASTAIN Universal Elite ABC Kit – VECTOR Laboratories Cat# PK-6200 (stored at
4ºC)
• DAB Peroxidase Substrate Kit – VECTOR Laboratories Cat# SK-4100 (stored at 4ºC)
• CLEAR-MOUNT with TRIS Buffer – Electron Microscopy Sciences Cat# 17985-12 (stored
at 4ºC)
• FITC-conjugated secondary antibodies
• Invitrogen™ Fluoromount-G™ Mounting Medium
Day 1:
1. IHC can be performed on 4-6 slides at a time. For paraffin-embedded samples: Deparaffinize and rehydrate.
a. CitriSolv®
3min
b. 100% EtOH
1min
Repeat steps a-b if necessary
c. 95% EtOH
1min
d. 70% EtOH
1min
e. 50% EtOH
1min
f. Distilled H2O
1min
2. For 4 slides, thaw ~2mL of 0.5mg/mL hyaluronidase (in PBS, aliquots stored at -20ºC). Turn
on oven and set temperature to 37ºC.
3. Use a water-resistant pen to mark around samples. Make sure edges and corners are touching
and boxes are complete. Each slide should have 1 non-immune control and 3 experimental
samples.
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4. Incubate all samples in ~300µL of 0.5mg/mL hyaluronidase for 30 min at 37°C. Use oven in
the backroom; add a few drops of H2O in the glass PetriDish. (Hyaluronidase step is
necessary to expose collagen antigens)
5. Rinse 2X with PBS. Use gel-loading 200μL pipette tips for aspirating liquids.
6. Incubate samples in 0.5N acetic acid for 2 hours at 4°C. (Be gentle with fridge doors; leave a
note.)
7. Rinse 2X with PBS.
(Step 8 ONLY for DAB Protocol; Skip to step 11 if doing Fluorescence)
8. Incubate samples in 3% H2O2 (hydrogen peroxide) in methanol for 10 min at room temp
(25°C). To prepare, perform 1:10 dilution from stock solution of 30% H2O2. (prepare ~2mL
for 4 slides)
Note: H2O2 has low surface tension. Also cover samples during incubation so H2O2
does not evaporate too quickly
9. Take out 10% horse serum to thaw. Keep on ice.
10. Rinse 2X with PBS.
11. Apply ~300µL of 10% horse serum to cover samples and incubate for 20 min at room temp
(25°C).
12. Remove horse serum (blocking solution) but do not rinse.
13. For non-immune controls apply ~300µL of 10% horse serum with 1μg/mL IgG-from-mouse
to cover sample and incubate overnight at 4°C. (prepare ~2mL for 4 slides)
14. For experimental samples, apply ~300µL of primary antibody (diluted in 10% horse serum in
PBS) to cover sample and incubate overnight at 4°C.
a. Primary antibody dilution should have a final concentration of 1μg/mL.
b. Prepare ~2mL for 4 slides.
Day 2 (DAB):
1. Thaw 10% horse serum. Keep on ice.
2. Rinse 2X with PBS. Aspirate non-immune controls first, then change tip for actual samples,
as to eliminate chances of cross-staining.
3. Apply ~300µL of biotinylated secondary antibody (biotinylated horse anti-mouse/anti-rabbit
IgG (H&L)) to cover samples and incubate for 30 min at room temp.
a. Biotinylated horse µ-mouse/µ-rabbit IgG secondary antibody dilution: 1:50 in 10%
horse serum.
b. Prepare ~2mL for 4 slides.
4. While incubating: Make VECTASTAIN ABC Reagent: 1 drop Reagent A and 1 drop of
Reagent B in 2.5mL PBS, vortex and allow to stand for 30 min prior to use.
5. Rinse 2X with PBS. Use different tips for non-immune controls and actual samples in order
to eliminate chances of cross-staining.
6. Apply ~300µL of VECTASTAIN ABC Reagent to cover samples and incubate for 30 min at
room temp.
7. At the end of 30 min, turn on oven and set temperature to 45ºC.
8. Rinse 2X with PBS. Use different tips for non-immune controls and actual samples in order
to eliminate chances of cross-staining.
9. Apply ~300µL of DAB substrate solution to cover samples for 5 min exactly. Immediately
remove DAB and rinse with tap water 3X. Leave tap water on slide after 3rd rinse.
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a. DAB: In 2.5mL DI H2O, add 1 drop of Buffer Stock Solution and vortex. Then add 2
drops of DAB Stock Solution and vortex. Then add 1 drop of Hydrogen Peroxide
Solution and vortex.
b. Add DAB to 2 slides at a time, spaced 2 min apart in order to avoid hecticity.
10. If counterstain desired: use hematoxylin to visualize nuclei:
• Apply hematoxylin stain directly to slides for 5 min (submerging slides in slide box
runs the risk of samples sliding off slide)
• Rinse 2x with tap H2O
• Acid alcohol (for H&E) for 20 seconds
• Rinse 2x with tap H2O
• Scotts buffer for ~20 seconds
• Rinse 2x with tap H2O
11. Aspirate tap water. Use Kim-wipes to remove excess water. Cover samples using Clearmount, use 200μL pipette tip to spread mounting medium evenly, then place slide in oven at
45˚C for at least 30min.
12. All DAB containing solutions must be treated with DAB Neutralizing solution. Dispose of
all DAB containing solutions and pipette tips in the appropriate waste containers.
13. Remove slides from oven, leave at room temp (in plastic box) overnight to ensure that
mounting medium is solidified before putting slides back into histology boxes.
Day 2 (Immunofluorescence):
1. Thaw 10% horse serum. Keep on ice.
2. Rinse 2X with PBS. Aspirate non-immune controls first, then change tip for actual samples,
as to eliminate chances of cross-staining.
3. Apply 100 µl of FITC-conjugated secondary antibody (diluted 1:200 in 10% goat serum in
PBS) to cover cells and incubate for 30-60 (30) min. Protect slides from light from here
on.
4. Rinse cells three times with PBS, 2 min. per rinse.
5. If using DAPI for nuclear stain. Apply DAPI diluted at 1:15,000 in PBS for 10 minutes at
room temperature.
6. Rinse once with distilled water, 2 min.
7. Mount using fluorescence protecting mounting medium (Invitrogen™ Fluoromount-G™
Mounting Medium). Let dry (in the dark) and then store at 4°C.
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ﺴِﻤﯿُﻊ ٱْﻟﻌَِﻠﯿُﻢ
َ َرﺑﱠﻨَﺎ ﺗ َﻘَﺒﱠْﻞ ِﻣﻨﱠﺎ ٓ ۖ◌ ِإﻧﱠَﻚ أ َﻧ
ﺖ ٱﻟ ﱠ
Rabbana taqabbal minna inaka Antas Samee’ul Aleem
Our Lord, accept [this] from us. Indeed, You are the Hearing, the Knowing.
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